Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Phosphinicacid, dimethyl-, ethyl ester (6CI,7CI,8CI,9CI) | 2511-19-5 | C4H11 O2 P | 122.1027 | AURORA KA-1301; DIMETHYL ETHYLPHOSPHONITE; DIMETHYL ETHANEPHOSPHONITE; ETHANEPHOSPHONOUS ACID DIMETHYL ESTER; dimethylphosphinic acid ethyl ester |
Phosphinic chloride,P-ethyl-P-methyl- | 13213-38-2 | C3H8 Cl O P | 126.521781 | ethylmethylphosphinic chloride; Ethylmethylchlorophosphine oxide; Methylethylchlorophosphine oxide; Einecs 236-182-5 |
Phosphine,tris[3,5-bis(trifluoromethyl)phenyl]- | 175136-62-6 | C24H9 F18 P | 670.27 | TRI[3,5-DI(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-DI(TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[BIS(3,5-TRIFLUOROMETHYL)PHENYL]PHOSPHINE; TRIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]PHOSPHINE 97%; Tris[3,5-bis(triflu |
Phosphine,tri(phenyl-d5)- (8CI,9CI) | 24762-44-5 | C18D15 P | 277.38 | TRIPHENYLPHOSPHINE-D15; TRI(PHENYL-D5)PHOSPHINE; TRI(PHENYL-D5)PHOSPHINE, 99 ATOM % D |
Phosphine,[4-(trifluoromethyl)phenyl]- | 473808-83-2 | C7H6 F3 P | 178.09 | (4-TRIFLUOROMETHYLPHENYL)PHOSPHINE |
Phosphine,(1,1-dimethylethyl)- | 2501-94-2 | C4H11 P | 90.1039 | TERT-BUTYLPHOSPHINE; T-BUTYLPHOSPHINE; (1,1-dimethylethyl)-phosphin; (1,1-dimethylethyl)phosphine; 1,1-Dimethylethylphosphine; tert-Butyl-phosphane; tert-C4H9PH2; Tertiarybutylphosphine |
Phosphine, ethyl-(6CI,7CI,8CI,9CI) | 593-68-0 | C2H7 P | 62.05 | Ethylphosphin; Ethylphosphine; ethylphosphane; Phosphine,ethyl-; EtPH2; 593-68-0 |
Phosphine, dicyclohexyl[2-(9-phenanthrenyl)phenyl]- | 405919-41-7 | |||
Phosphine, dibutyl- | 1732-72-5 | C8H19 P | 146.21 | Dibutyl-phosphane; dibutyl-phosphin; dibutyl-Phosphine; DI-N-BUTYLPHOSPHINE |
Phosphine E | 2391-28-8 | C20H18N4O3 | 362.38192;g/mol | PhosphineE; Phosphine3R; 2391-28-8; 3-Acridinamine,9-(4-aminophenyl)-2-methyl-,nitrate; 9-(4-aminophenyl)-2-methylacridin-3-amine; nitricacid |
Phosphatidylserines (bovine) | 1446756-47-3 | C42H78NO10P (foroleoyl) | 788.1 | PtdSers (bovine) |
Phosphatidylserine | 51446-62-9 | C42H82NO10P | 792.08 | Distearoyl phosphatidylserine;(2S)-2-Amino-3-((((R)-2,3-bis(stearoyloxy)propoxy)(hydroxy)phosphoryl)oxy)propanoic acid;PS(18:0/18:0);Phosphatidylserine(36:0);Dioctadecanoylphosphatidylserine;1,2-Distearoyl phosphatidyl serine;1,2-Distearoyl-sn-3-glyceroph |
Phosphatidylinositol | 383907-36-6 | C46H80O13P.Na | 895 | |
Phenylpropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 220341-05-9 | C23H31NO9 | 465.49 | |
Phenylpropyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 220341-09-3 | C17H25NO6 | 339.38 | |
Phenylphosphorodichloridite | 3426-89-9 | C6H5Cl2OP | 194.98 | dichlorophenoxyphosphine; phenoxyphosphorusdichloride; Phenyl dichloridophosphite; phenyldichlorophosphite; Phosphorodichloridous acid, phenyl ester; phosphorodichloridousacid,phenylester; PHENYL PHOSPHORODICHLORIDITE; Dichloridophosphorous acid phenyl es |
Phenylphosphoric acid | 701-64-4 | C6H7O4P | 153.05 | BENZENEPHOSPHORIC ACID; AURORA KA-1620; phenylphosphate; Phosphoricacid,monophenylester; PHENYLPHOSPHORIC ACID; phenyl dihydrogen phosphate; Phenyl acid phosphate; Phenyl hydrogen phosphate |
Phenyl-p-benzoquinone | 363-03-1 | C12H8O2 | 184.19 | Phenyl-p-benzoquinone; Phenyl-p-quinone |
phenylmethanol-d | 14915-25-4 | C7H7DO | 109.15 | |
phenylmethan-d2-ol | 21175-64-4 | C7H6D2O | 110.15 | Benzyl alcohol-alpha,alpha-d2; Dideutero(phenyl)methanol; Dideuterio(phenyl)methanol; Benzyl alcohol-|A,|A-d2 |
Phenylmercuric Nitrate | 8003-05-2 | C6H5HgNO3·C6H5HgOH | 634.40 | |
phenyliodane oxide | 536-80-1 | C6H5IO | 220.01 | Iodosobenzene; Iodosylbenzene |
Phenylalanine,4-acetyl- | 22888-49-9 | C11H13 N O3 | 243.69 | 3-(4-ACETYL-PHENYL)-2-AMINO-PROPIONIC ACID HYDROCHLORIDE; DL-3-(P-ACETYLPHENYL)-ALANINE |
Phenylalanine,2-hydroxy- | 2370-61-8 | C9H11 N O3 | 181.19 | DL-3-(2-HYDROXYPHENYL)ALANINE; DL-2-TYROSINE; D, L-O-TYR; DL-O-TYROSINE; 3-(2-HYDROXYPHENYL)-DL-ALANINE; (+/-)-2-AMINO-3-(2-HYDROXYPHENYL)PROPIONIC ACID; 2-AMINO-3-(2-HYDROXYPHENYL)PROPIONIC ACID; 3-(o-hydroxyphenyl)-alanindl |
Phenylalanine betaine | 56755-22-7 | C12H17NO2 | 207.3 | (2S)-3-Phenyl-2-(trimethylammonio)propanoate |
PHENYL ETHYL TIGLATE | 55719-85-2 | C13H16O2 | 204.26 | 2-Butenoic acid, 2-methyl-, 2-phenylethyl ester, (2E)-, 2-Phenylethyl tiglate, 2-Phenylethyl trans-2,3-dimethylacrylate, Benzylcarbinyl tiglate, Phenethyl 2-methylcrotonate, Phenethyl tiglate, PHENYL ETHYL TIGLATE, Phenylethyl tiglate |
PHENYL ETHYL LACTATE | 10138-63-3 | C11H14O3 | 194.23 | PHENYL ETHYL LACTATE; hydracrylicacid,phenethylester; phenethyl lactate; Propanoic acid, 3-hydroxy-, 2-phenylethyl ester; 3-Hydroxypropanoic acid 2-phenylethyl ester; 2-Hydroxypropionic acid 2-phenylethyl ester |
Phenyl b-D-glucuronide | 17685-05-1 | C12H14O7 | 270.24 | Phenyl b-D-glucopyranosiduronic acid; Phenyl b-D-glucuronic acid monohydrate |
Phenyl b-D-glucopyranoside | 1464-44-4 | C12H16O6 | 256.25 | |
Phenyl b-D-galactopyranoside | 2818-58-8 | C12H16O6 | 256.25 | |
Phenyl a-L-thiorhamnopyranoside | 131724-82-8 | C12H16O4S | 256.32 | |
Phenyl 4-azido-2,3-di-O-benzyl-4,6-dideoxy-b-D-thioglucopyranoside | 369631-91-4 | C26H30N3O3S | 464.6 | |
Phenyl 4-azido-2,3,6-tri-O-benzyl-4-deoxy-b-D-thioglucopyranoside | 236115-67-6 | C33H36N3O4S | 570.72 | |
Phenyl 3,4-di-O-acetyl-2-O-benzyl-a-L-thiofucopyranoside | 183051-73-2 | |||
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-a-D-thiomannopyranoside | 903881-30-1 | C33H32O5S | 540.67 | |
Phenyl 2,3-di-O-benzoyl-b-D-thiogalactopyranoside | 138857-53-1 | |||
Phenyl 2,3,6-tri-O-benzyl-b-D-thioglucopyranoside | 97974-20-4 | C33H34O5S | 542.69 | |
Phenyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside | 2872-72-2 | C20H24O10 | 424.40 | |
Phenoxodiol | 81267-65-4 | C15H12O3 | 240.258 | Dehydroequol; Idronoxil |
Phenolphthalein bisphosphate tetrasodium salt | 68807-90-9 | C20H14Na4O11P2 | 566.21 | Phenolphthalein diphosphate tetrasodium salt |
Phenolphthalein bisphosphate pyridine salt | 267240-23-3 | C25H21NO10P2 | 557.38 | Phenolphthalein diphosphate pyridine salt |
Phenolphthalein b-D-glucuronide sodium salt monohydrate | 6820-54-8 | C26H21O10 Na | 516.43 | PHEG |
Phenolphthalein b-D-glucuronic acid sodium salt | 15265-26-6 | C26H22O10Na | 517.44 | Phenolphthalein mono-b-D-glucosiduronic acid; Phenolphthalein-b-D-glucuronide |
Phenolphthalein | 77-09-8 | C20H14O4 | 318.33 | |
Phenolic resin, rosin modified 2112 | 68152-70-5 | (C15H16O2.C3H8O3.CH2O.W99)x | ||
PHENOL-FORMALDEHYDE RESIN | 9003-35-4 | C7H6O2 | ||
Phenol-2-sulfonic acid | 609-46-1 | C6H6O4S | 174.17444 | o-hydroxybenzenesulphonic acid; Phenol-2-sulfonic acid |
PHENOL-[1-13C] | 29809-11-8 | C6H6O | 95.11 | |
Phenol,4-methyl-2-(1-oxido-2H-benzotriazol-2-yl)- | 54659-85-7 | C13H11 N3 O2 | 36.46094;g/mol | hydrochloricacid; hydrogenchloride; Muriaticacid; 7647-01-0; Chlorohydricacid; Acidechlorhydrique |
Phenol,4-methoxy-3-methyl- | 14786-82-4 | C8H10 O2 | 138.1638;g/mol | 4-methoxy-3-methylphenol; 4-Methoxy-3-methylphenol; 14786-82-4; Phenol,4-methoxy-3-methyl-; 3-methyl-4-methoxyphenol; 4-methoxy-3-methyl-phenol |
Phenol,4-isothiocyanato- | 2131-60-4 | C7H5 N O S | 151.1857 | 4-HYDROXYPHENYLISOTHIOCYANATE; p-Isothiocyanatophenol; Phenol, 4-isothiocyanato- |
Phenol,4-ethenyl-2,6-dimethoxy- | 28343-22-8 | C10H12O3 | 180.20 | 4-Ethenyl-2,6-dimethoxyphenol; 2,6-Dimethoxy-4-ethenylphenol; 2,6-Dimethoxy-4-vinylphenol; 4-Vinyl-2,6-dimethoxyphenol; 4-Vinylsyringol; Canolol; Syringlyethene; Vinylsyringol; Flavis Number:04.061. |
Phenol,4-ethenyl-, polymer with ethenylbenzene | 24979-74-6 | C8 H8 O | 0 | Phenol, 4-ethenyl-, polymer with ethenylbenzene; STYRENE-4-VINYLPHENOL COPOLYMER |
Phenol,4-[(3R)-3-aminobutyl]- | 115548-15-7 | C10H15 N O | 165.2322 | (R)-4-(3-AMINO-BUTYL)-PHENOL; (R)-1-METHYL-3-(P-HYDROXY-PHENYL)-PROPYLAMINE; (R)-2-AMINO-4-(4-HYDROXYPHENYL)BUTANE |
Phenol,4,4'-thiobis[2,6-dimethyl- | 18525-99-0 | C16H18 O2 S | 274.37792 | 4,4'-thiobis[2,6-xylenol]; 4,4'-Thiodi(2,6-dimethylphenol); 4,4'-Thiodi(2,6-xylenol); 4,4'-Thiobis(2,6-dimethylphenol); Einecs 242-401-5 |
Phenol,4,4-(3,3,5-trimethylcyclohexylidene)bis- | 129188-99-4 | |||
Phenol,4-(trimethoxymethyl)- | 27689-95-8 | C10H14 O4 | 198.22 | TRIMETHYL 4-HYDROXYORTHOBENZOATE |
Phenol,4-(1H-pyrazol-3-yl)- | 68535-53-5 | C9H8 N2 O | 160.17300 | |
Phenol,3-bromo-2-chloro- | 863870-87-5 | C6H4 Br Cl O | 207.45 | 3-BROMO-2-CHLOROPHENOL |
Phenol,3-(phenylmethyl)- | 22272-48-6 | C13H12 O | 184.23378 | 3-BENZYLPHENOL |
Phenol,3-(5'-chloro-4-methoxyspiro[1,2-dioxetane-3,2'-tricyclo[3.3.1.13,7]decan]-4-yl)-,1-(dihydrogen phosphate), sodium salt (1:2) | 142849-53-4 | C18H22 Cl O7 P . 2 Na | ||
Phenol,2-methyl-6-nitro- | 13073-29-5 | C7H7 N O3 | 153.14 | o-Cresol, 6-nitro-,; ASISCHEM D50955; 2-METHYL-5-CHLOROPHENOL; 2-NITRO-6-METHYLPHENOL; 2-METHYL-6-NITROPHENOL; 6-NITRO-2-CRESOL |
Phenol,2-fluoro-3-nitro- | 179816-26-3 | C6H4 F N O3 | 157.0992632 | Phenol, 2-fluoro-3-nitro- (9CI) |
Phenol,2,4-dimethyl-6-(1-methylpentadecyl)- | 134701-20-5 | C24H42 O | 346.5897 | phenol,2,4-dimethyl-6-(1-methylpentadecyl)-; IRGANOX 1141; 2,4-DIMETHYL-6-(1-METHYLPENTADECYL)-PHENOL |
Phenol,2-(chloromethyl)-, 1-acetate | 15068-08-3 | C9H9 Cl O2 | 184.62 | 2-(CHLOROMETHYL)PHENYL ACETATE |
Phenol,2-(5-chloro-1-oxido-2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)- | 94102-13-3 | C20H24 Cl N3 O2 | 373.87600 | |
Phenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-2-propen-1-yl)- | 98809-58-6 | C17H17 N3 O | 281.35 | 1-METHALLYL-2-(2-HYDROXY-5-METHYL PHENYL) BENZOTRIAZOLE; 3-METHALLYL-2-HYDROXY-5-METHYLPHENYLBENZOTRIAZOLE; 3-METHALLYL-2-HYDROXY-5-METHYLPHENYL; 4-methyl-6-(2-methyl-2-propenyl)-; Phenol, 2-(2H-benzotriazol-2-yl)- |
Phenol,2-(1-oxido-2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)- | 76539-64-5 | C20H25 N3 O2 | ||
Phenol, dimethyl-,1,1',1''-phosphate | 25155-23-1 | C24H27 O4 P | 410.48 | TRIXYLENYL PHOSPHATE; TRIXYLYL PHOSPHATE; coalitentp; dimethylphenolphosphate(3:1); dimethyl-phenophosphate(3:1); ivviol-3; Phenol,dimethyl-,phosphate(3:1); phosflex179 |
Phenol, 5-(2-aminoethyl)-2-methoxy- | 3213-30-7 | C9H13NO2 | 167.20502;g/mol | 5-(2-aminoethyl)-2-methoxyphenol; 5-(2-Aminoethyl)-2-methoxyphenol; 3213-30-7; 3-Hydroxy-4-methoxyphenethylamine; 4-O-methyldopamine; 5-(2-AMINO-ETHYL)-2-METHOXY-PHENOL |
Phenol, 4-ethynyl- | 2200-91-1 | C8H6 O | 118.14 | 4-ethynylphenol; 4-ethynyl-phenol; Phenol,4-ethynyl-; 2200-91-1; 4-Hydroxyphenylacetylene; Phenol,4-ethenyl-,homopolymer |
Phenol, 4-dodecyl-,branched | 210555-94-5 | C18H30O | 262.4302 | P-LAURYLPHENOL; PARA-DODECYLPHENOL; P-DODECYLPHENOL; PDDP; Dodecylphenol; 4-DODECYLPHENOL |
phenanthrene-9,10-diimine | 5665-52-1 | C14H10N2 | 206.243 g/mol | |
Phenanthrene-1,4-dione | 569-15-3 | C14H8O2 | 208.22 | |
Phenanthrene, 2-methyl- | 2531-84-2 | C15H12 | 192.27 | 2-methyl-phenanthren; 2-METHYLPHENANTHRENE; PHENANTHRENE,2-METHYL- |
Phenanthren-4-methanol | 22863-79-2 | C15H12O | 208.2552 | |
Pheleuin | 169195-23-7 | C15H18N2O | 242.3 | 6-Benzyl-3-(2-methylpropyl)-1H-pyrazin-2-one |
Phebalosin | 6545-99-9 | C15H14O4 | 258.3 | |
PHCCC | 179068-02-1 | C17H14N2O3 | 294.31 | PHCCC; (1aS,7Z,7aS)-7-hydroxyimino-N-phenyl-1,7a-dihydrocyclopropa[b]chromene-1a-carboxamide |
Phaseoloidin | 118555-82-1 | C14H18O9 | 330.29 | 5-Hydroxy-2-(beta-D-glucopyranosyloxy)phenylacetic acid |
Phaseollidin hydrate | 76122-57-1 | C20H22O5 | 342.4 | (6aR-cis)-6a,11a-Dihydro-10-(3-hydroxy-3-methylbutyl)-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol |
Phaseollidin | 37831-70-2 | C20H20O4 | 324.4 | 3,9-Dihydroxy-10-prenylpterocarpan |
PHASEIC ACID | 24394-14-7 | C15H20O5 | 280.31600 | |
Pharacine | 63440-93-7 | C24H24O8 | 440.45 | 3,8,15,20-Tetraoxatricyclo[20.2.2.210,13]octacosa-10,12,22,24,25,27-hexaene-2,9,14,21-tetrone;1,4-Butanediol-terephthaloyl Chloride Cyclic Dimer; Pharacin; PBT Cyclic Dimer; Cyclobis(1,4-butylene terephthalate) |
phanquinone | 84-12-8 | C12H6N2O2 | 210.191 | 4,7-phenanthroline-5,6-dione; phanquinone; phanquone; 4,7-phenanthrolene-5,6-quinone; enthohex; entobex; C-11925; Ciba 11925 |
Phanerosporic acid | 124709-28-0 | C22H36O5 | 380.5 | (-)-Phanerosporic Acid; 2,4-Dihydroxy-6-[(14R)-14-hydroxypentadecyl]benzoic acid |
Phallacidin from Amanita phalloides | 26645-35-2 | C37H50N8O13S | 846.90 | Cyclo(Ala-2-Mercapto-Trp-4,5-Dihydroxy-Leu-Val-erythro-3-Hydroxy-D-Asp-Cys-cis-4-Hydroxy-Pro) |
Phaclofen | 114012-12-3 | C9H13ClNO3P | 249.63 | (RS)-3-Amino-2-(4-chlorophenyl)propylphosphonic acid |
PHA-793887 | 718630-59-2 | C19H31N5O2 | 361.48 | PHA 793887; PHA793887 |
PHA-767491 hydrochloride | 942425-68-5 | C12H12ClN3O | 249.7 | CAY-10572 hydrochloride |
PHA-767491 | 845714-00-3 | C12H11N3O | 213.24 | PHA-767491; PHA767491; PHA 767491. |
PHA-680632 | 398493-79-3 | C28H35N7O2 | 501.62 | PHA-680632; PHA 680632; PHA680632. |
PHA-680626 | 398493-74-8 | C23H26N6O2S | 450.561 | PHA-680626; PHA 680626; PHA680626 |
PHA665752 | 477575-56-7 | C32H34Cl2N4O4S | 641.608 | PHA-665752; PHA 665752 |
PHA 568487 | 527680-57-5 | C16H20N2O3.C4H4O4 | 404.41 | N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-2,3-dihydro-1,4-benzodioxin-6-carboxamide fumarate |
PHA 543613 hydrochloride | 1586767-92-1 | C15H17N3O2·HCl | 307.78 | N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3-c]pyridine-5-carboxamide hydrochloride; N-(1-azabicyclo[2.2.2]octan-3-yl)furo[2,3-c]pyridine-5-carboxamide hydrochloride |
PHA 543613 dihydrochloride | 478148-58-2 | C15H17N3O2.2HCl | 344.24 | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-carboxamide dihydrochloride |
PHA 408 | 503555-55-3 | C29H27ClFN7O2 | 560.02 | 8-[[5-chloro-2-(4-methylpiperazin-1-yl)pyridine-4-carbonyl]amino]-1-(4-fluorophenyl)-4,5-dihydrobenzo[g]indazole-3-carboxamide |
PH-797804 | 586379-66-0 | C22H19BrF2N2O3 | 477.29867 | PH 797804; PH797804 |
PH2P(SIME3) | 24103-44-4 | 0 | PH2P(SIME3) | |
PH11 | 1627843-95-1 | C22H22N6O5 | 450.46 | PH11; PH-11; PH 11; methyl 2-((4-((3,4,5-trimethoxyphenyl)amino)imidazo[1,2-a][1,3,5]triazin-2-yl)amino)benzoate |
PH-064 | 892546-37-1 | C44H58N8O2S2 | 795.11 | (2R)-2-amino-3-[[(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]-3-oxopropyl]disulfanyl]-1-[(8S)-8-(cyclohexylmethyl)-2-phenyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]propan-1-one;Imidazo[1,2-a]pyrazine, 7,7 |
PH-002 | 1311174-68-1 | C27H33N5O4 | 491.58 | Tert-butyl 4-[[4-[[2-(3-methyl-4-oxophthalazin-1-yl)acetyl]amino]phenyl]methyl]piperazine-1-carboxylate |
PH Dane-salt | 69416-61-1 | C13H14KNO5 | 303.35 | |
PH 797804 | 1358027-80-1 | C22H19BrF2N2O3 | 477.3 | |
PH 10 BUFFER | 6106-20-3 | C2HNa3O6 | 190 | carbonicacid,sodiumsalt,hydrate(2:3:2); snowfine; SODIUM HYDROGEN CARBONATE AND SODIUM CARBONATE; SODIUM SEQUICARBONATE; SODIUM SESQUICARBONATE; PH 10 BUFFER; BUFFER, PH 10.00, COLOR CODE BLUE; sodium sesquicarbonate crystalline |
PGS-IN-1 | 102271-49-8 | C19H26O3 | 302.41 | (3E)-3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]oxolan-2-one; alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)gamma-butyrolactone; KME 4; KME-4 |
PGPC | 89947-79-5 | C29H56NO10P | 609.7 | 1-Hexadecanoyl-2-glutaroyl-sn-glycero-3-phosphocholine; 1-Palmitoyl-2-glutaryl phosphatidylcholine; 1-Palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine |
pGpA | 20137-01-3 | C20H23N10O14P2 .3Na | 758.38 | 3'5'-pGpA sodium salt; 3'3'-cGAMP Control |
PGP-4008 | 365565-02-2 | C26H23N3O | 393.5 | N-(1-Benzyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-phenylacetamide |
pGlu-Pro-Arg-MNA | 130835-45-9 | C23H32N8O7 | 532.55 | L-Argininamide, 5-oxo-L-prolyl-L-prolyl-N-(2-methoxy-4-nitrophenyl)- |
PGLa | 102068-15-5 | C88H162N26O22S | 1968.45 | |
PGD2-IN-1 | 885066-67-1 | C23H23Cl2N3O3 | 460.35 | 2-[3-[6-[2-(2,4-dichlorophenyl)ethylamino]-2-methoxypyrimidin-4-yl]phenyl]-2-methylpropanoic acid |
PG-9 maleate | 155649-00-6 | C17H22BrNO2.C4H4O4 | 468.34 | Tropanyl 2-(4-bromophenyl)propionate maleate |
PG545 | 1144492-69-2 | C51H75Na13O60S13 | 2363.748 | PG 545; PG-545 |
PG490-88 | 195883-06-8 | C24H28O9 | 460.479 | Omtriptolide |
pG(2',5')pA | 55779-55-0 | C20H26N10O14P2 | 692.4 | |
PG 931 | 667430-81-1 | C59H85N15O11 | 1180.41 | XDPFRWKPV; (2S,Z)-1-((1E,3S,4Z,6S,7Z,9S,10Z,12S,17E,20S,25aS)-9-((1H-indol-3-yl)methyl)-3-benzyl-6-(3-guanidinopropyl)-1,4,7,10,18-pentahydroxy-20-((Z)-(1-hydroxy-2-((Z)-(1-hydroxyethylidene)amino)hexylidene)amino)-21-oxo-6,9,12,13,14,15,16,19,20,21,23,24 |
PG 01037 dihydrochloride | 675599-62-9 | C26H26Cl2N4O.2HCl | 554.34 | N-[(2E)-4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]-2-buten-1-yl]-4-(2-pyridyl)-benzamide dihydrochloride; PG 01037 dihydrochloride; PG 01037 diHCl; PG 01037; PG01037; PG-01037 |
PG 01 | 853138-65-5 | C28H29N3O2 | 439.55 | N-Methyl-N-[2-[[4-(1-Methylethyl)phenyl]amino]-2-1H-indole-3-acetamide |
PFM 01 | 1558598-41-6 | C14H15NO2S2 | 293.4 | (5Z)-5-[(4-Hydroxyphenyl)methylene]-3-(2-methylpropyl)-2-thioxo-4-thiazolidinone; PFM01; PFM-01; PFM 01 |
PFK-158 | 1462249-75-7 | C18H11F3N2O | 328.29 | PFK 158; PFK158; ACT-PEK-158 |
PFK15 | 4382-63-2 | C17H12N2O | 260.29 | PFK-015 |
PFI-4 | 900305-37-5 | C21H24N4O3 | 380.44 | |
PFI-3 | 1819363-80-8 | C19H19N3O2 | 321.38 | (E)-1-(2-hyd roxyphenyl)-3-[(1R,4R)-2-pyridin-2-yl-2,5-diazabicyclo[2.2.1]heptan-5-yl]prop-2-en-1-one; PF-06687252; PFI-3 compound |
PF-06700841 tosylate | 2140301-96-6 | C18H21F2N7O·C7H8O3S | 561.61 | Brepocitinib tosylate; [(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone tosylate |
PF-06700841 | 1883299-62-4 | C18H21F2N7O | 389.40 | PF-841; Brepocitinib; [(1S)-2,2-difluorocyclopropyl]-[(1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone |
PF-06651600 | 1792180-81-4 | C15H19N5O | 285.351 | 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one |
PF-06650833 | 1817626-54-2 | C18H20FN3O4 | 361.373 | 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide |
PF-06471553 | 1808094-07-6 | C23H25N5O4S | 467.54 | N-(2-cyclobutyl-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)acetyl)isoindoline-5-sulfonamide |
PF-06459988 | 1428774-45-1 | C19H22ClN7O3 | 431.88 | PF 6459988;1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one |
PF-06447475 | 1527473-33-1 | C17H15N5O | 305.33 | PF-06447475 |
PF-06442609 | 1402002-76-9 | C24H24F4N4O3 | 492.47 | 2-((S)-1-(4-fluoro-2-((R)-1,1,1-trifluoropropan-2-yl)phenoxy)propan-2-yl)-7-(4-methyl-1H-imidazol-1-yl)-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-dione |
PF-06424439 | 1469284-78-3 | C22H26ClN7O | 439.94 | PF-06424439; PF06424439; PF 06424439; PF-6424439; PF-6424439; PF 6424439; (R)-(1-(2-(1-(4-chloro-1H-pyrazol-1-yl)cyclopropyl)-3H-imidazo[4,5-b]pyridin-5-yl)piperidin-3-yl)(pyrrolidin-1-yl)methanone |
PF-06282999 | 1435467-37-0 | C13H12ClN3O3S | 325.77 | 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide |
PF-06260414 | 1612755-71-1 | C14H14N4O2S | 302.35 | PF-06260414; PF 06260414; PF06260414; PF6260414; PF-6260414; PF 6260414; (R)-6-(4-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl)isoquinoline-1-carbonitrile |
PF-05241328 | 1387633-03-5 | C19H21ClN4O4S | 436.9179 | 1-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-3-methyl-N-(methylsulfonyl)-1H-indazole-5-carboxamide; 1H-Indazole-5-carboxamide, 1-(5-chloro-6-(2-methylpropoxy)-3-pyridinyl)-3-methyl-N-(methylsulfonyl)-; |
PF-05139962 | 1393712-18-9 | C21H27N5O4S | 445.535 | PF-05139962; PF 05139962; PF05139962. |
PF-05089771 | 1235403-62-9 | C18H12Cl2FN5O3S2 | 500.35 | PF 05089771; 4-(2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(thiazol-4-yl)benzenesulfonamide; SCHEMBL1095065; CHEMBL2325014; ZYSCOUXLBXGGIM-UHFFFAOYSA-N |
PF-05020182 | 1354712-92-7 | C18H30N4O4 | 366.46 | N-[4,6-Dimethoxy-2-(4-methoxy-1-piperidinyl)-5-pyrimidinyl]-3,3-dimethyl-butanamide |
PF-04995274 | 1331782-27-4 | C23H32N2O6 | 432.52 | (R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol; PF-04995274; PF 04995274; PF04995274; PF-4995274; PF 4995274; PF4995274. |
PF-04991532 | 1215197-37-7 | C18H19F3N4O3 | 396.37 | UNII-AJ212MS2O2; CHEMBL2165620; AJ212MS2O2; SCHEMBL1711504; BDBM50394681; 6-[[(2S)-3-cyclopentyl-2-[4-(trifluoromethyl)imidazol-1-yl]propanoyl]amino]pyridine-3-carboxylic acid |
PF-04971729 | 1210344-57-2 | C22H25ClO7 | 436.88 | Ertugliflozin; PF04971729; PF 04971729 |
PF-04942487 | 1046859-34-0 | C20H18Cl2F3N7O2 | 516.31 | PF4942847; PF 4942847; PF-04942847 |
PF-04937319 | 1245603-92-2 | C22H20N6O4 | 432.44 | N,N-dimethyl-5-((2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yl)oxy)pyrimidine-2-carboxamide |
PF-04929113 mesylate | 1173111-67-5 | C26H34F3N5O7S | 617.64 | (1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate mesylate; PF-04929113 mesylate; SNX5422; SNX-5422; SNX 5422; PF4929113; PF-4929113; PF 4929113; PF04929113; PF 04929113; |
PF-04929113 | 908115-27-5 | C25H30F3N5O4 | 521.53 | (1r,4r)-4-((2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)phenyl)amino)cyclohexyl glycinate; SNX5422; SNX-5422; SNX 5422; PF4929113; PF-4929113; PF 4929113; PF04929113; PF 04929113; PF-04929113 |
PF-04880594 | 1111636-35-1 | C19H16F2N8 | 394.39 | PF-04880594; PF04880594; PF 04880594. |
PF-04856264 | 1235397-05-3 | C20H15N5O3S2 | 437.49 | 3-cyano-4-(2-(1-methyl-1H-pyrazol-5-yl)phenoxy)-N-(thiazol-2-yl)benzenesulfonamide |
PF-04691502 | 1013101-36-4 | C22H27N5O4 | 425.489 | 2-amino-8-((1R,4R)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
PF-04620110 | 1109276-89-2 | C21H24N4O4 | 396.44 | N/A |
PF-04457845 | 1020315-31-4 | C23H20F3N5O2 | 455.43 | |
PF-03814735 | 942487-16-3 | C23H25F3N6O2 | 474.48 | PF03814735; PF 03814735 |
PF-03758309 | 898044-15-0 | C25H30N8OS | 490.63 | PF03758309; PF 03758309; PF-3758309; PF3758309; PF 3758309 |
PF-03671148 | 1378524-25-4 | C18H15N5O | 317.352 | PF-03671148; PF03671148; PF 03671148. |
PF-03654746 Tosylate | 1039399-17-1 | C18H24F2N2O.C7H8O3S | 494.59 | Trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(1-pyrrolidinylmethyl)phenyl]-cyclobutanecarboxamide 4-methylbenzenesulfonate; PF-03654746, 4-Methylbenzenesulfonate |
PF-03084014 | 865773-15-5 | C27H41F2N5O | 489.6558 | PF3084014; PF 3084014; PF-03084014; PF03084014; PF 03084014 |
Pf-01247324 | 875051-72-2 | C13H10Cl3N3O | 330.593 | CHEMBL3589894; 6-amino-N-methyl-5-(2,3,5-trichlorophenyl)pyridine-2-carboxamide; 2-Pyridinecarboxamide, 6-amino-N-methyl-5-(2,3,5-trichlorophenyl)-; 6-amino-N-methyl-5-(2,3,5-trichlorophenyl)picolinamide |
PF-00337210 | 854514-88-8 | C26H27N3O5 | 461.51 | PF 00337210; PF00337210; P337210; PF-337210 |
PF 998425 | 1076225-27-8 | C14H14F3NO | 269.26 | 4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile; PF0998425; PF 0998425; PF-0998425 |
PF 9184 | 1221971-47-6 | C21H14Cl2N2O4S | 461.31 | N-(3',4'-Dichloro[1,1'-biphenyl]-4-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
PF 915275 | 857290-04-1 | C18H14N4O2S | 350.39 | N-(6-Amino-2-pyridinyl)-4'-cyano-[1,1'-biphenyl]-4-sulfonamide;N-(6-aminopyridin-2-yl)-4-(4-cyanophenyl)benzenesulfonamide;[1,1'-Bip;4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide |
PF 750 | 959151-50-9 | C22H23N3O | 345.44 | N-Phenyl-4-(3-quinolinylmethyl)-1-piperidinecarboxamide |
PF 6274484 | 1035638-91-5 | C18H14ClFN4O2 | 372.78 | N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-2-propenamide |
PF 5274857 hydrochloride | 1613439-62-5 | C20H25ClN4O3S.HCl | 473.42 | 1-[4-(5'-Chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl-1-piperazinyl]-3-(methylsulfonyl)-1-propanone hydrochloride |
PF 514273 | 851728-60-4 | C21H17Cl2F2N3O2 | 452.28 | 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one |
PF 5006739 | 1293395-67-1 | C22H22FN7O | 419.46 | 4-[4-(4-Fluorophenyl)-1-[1-(3-isoxazolylmethyl)-4-piperidinyl]-1H-imidazol-5-yl]-2-Pyrimidinamine; 4-{4-(4-Fluorophenyl)-1-[1-(1,2-oxazol-3-ylmethyl)piperidin-4-yl]-1H-imidazol-5-yl}pyrimidin-2-amine |
PF 4800567 hydrochloride | 1391052-28-0 | C17H18ClN5O2.HCl | 396.27 | 3-[(3-Chlorophenoxy)methyl]-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine hydrochloride |
PF 4800567 | 1188296-52-7 | C17H18ClN5O2 | 359.81 | 3-[(3-chlorophenoxy)methyl]-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-amine |
PF 4778574 | 1219633-99-4 | C19H22N2O3S2 | 390.52 | N-[(3R,4S)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2H-pyran-4-yl]-2-propanesulfonamide |
PF 4693627 | 1312815-93-2 | C26H29Cl2N3O3 | 502.43 | 1-[5-chloro-6-(4-chlorophenyl)-2-benzoxazolyl]-N-[(1S,3S)-3-(hydroxymethyl)cyclohexyl]-4-piperidinecarboxamide |
PF 429242 dihydrochloride | 2248666-66-0 | C25H35N3O2·2HCl | 482.49 | 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide dihydrochloride |
PF 429242 | 947303-87-9 | C25H35N3O2 | 409.56 | |
PERFLUOROTRI-N-BUTYLAMINE | 86508-42-1 | - | 0 | Perfluorocompounds,C5-18; PF-5050; PERFORMANCE FLUID; PERFLUORO-COMPOUND FC-43; TRI(PERFLUOROBUTYL)AMINE; FLUORINERT(R) FC-43; Fluorinert (TM); FLUORINERT (TM) (FC-43) (R) |
Perfluorotetraglyme | 64028-06-4 | C10F22O5 | 618.0689 | |
PERFLUORO-TERT-BUTYL IODIDE | 4459-18-1 | C4F9I | 345.93 | 1,1,1,3,3,3-Hexafluoro-2-iodo-2-(trifluoromethyl)propane; 2-Iodoperfluoro-2-methylpropane; Nonafluoro-2-iodo-2-methylpropane; Perfluor-tert.-butyljodid; Propane,1,1,1,3,3,3-hexafluoro-2-iodo-2-(trifluoromethyl)-; Propane,hexafluoro-2-iodo-2-(trifluorometh |
PERFLUOROSULFONIC ACID-PTFE COPOLYMER | 66796-30-3 | Rf[OCF(CH3)CF2]OCF2CF2SO3H | 0 | nafion(r)117sol.,~5%inamixt.of; NAFION(R) PERFLUORINATED ION-EXCHANGE RESIN; NAFION(R) PERFLUORINATED RESIN; NAFION(TM) PERFLUORINATED ION-EXCHANGE RESIN; NAFION(TM) 117; NAFION TM NR50; NAFION PERFLUORINATED ION-EXCHANGE RESIN; NAFION(R) 117 |
PERFLUOROOCTANOYL FLUORIDE | 335-66-0 | C8F16O | 416.06 | PENTADECAFLUOROOCTANOYL FLUORIDE; PERFLUOROOCTANOYL FLUORIDE; pentadecafluorooctyl fluoride; Perfluorooctanoyl fluoride 98%; Perfluorooctanoylfluoride98%; ACIDFLUORIDEPERFLUOROOCTANOICACID; PERFLUOROOCTANOICACID,ACIDFLUORIDE; Perfluorocaprylic acid fluori |
Perfluorooctanoic Acid-13C2 | 864071-08-9 | C613C2HF15O2 | 0 | Perfluorooctanoic Acid-13C2; Eftop-3C2 EF 201; NSC 95114-3C; Pentadecafluoro-octanoic Acid-13C2; Perfluoro-1-heptanecarboxylic Acid-13C2; Perfluorocaprylic Acid-13C2; Perfluoroheptanecarboxylic Acid-3C2; NSC 95114-3C2 |
PERFLUOROOCTANEYLAMIMOPROPYL TRIMETHYL AMMONIUM IODIDE | 335-90-0 | C14H16F15IN2O | 640.17000 | |
Perfluorooctanesulfonamide | 754-91-6 | C8H2F17NO2S | 499.14 | 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1-octanesulfonamid; ai3-29759; perfluoroctylsulfonamide; PERFLUOROOCTANESULFONAMIDE; PERFLUOROOCTANESULPHONAMIDE; PERFLUOROOCTANSULFONAMIDE; N-Ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1- oct |
PERFLUORO-N-PENTANE | 678-26-2 | C5F12 | 288.03 | 1,1,1,2,2,3,3,4,4,5,5,5-Dodecafluoropentane; dodecafluoro-pentan; FluorinertFC87; FluorinertPF5050; Pentane, dodecafluoro-; pentane,dodecafluoro-; Perflenapent; perflenapent(INN) |
PERFLUOROMETHOXYPROPIONIC ACID | 377-73-1 | C4 H F7 O3 | 230.03800 | |
Perfluorohexane-1-sulfonic acid | 355-46-4 | C6HF13O3S | 400.1145816 | 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane-1-sulfonicacid; Perfluorohexanesulfonicacid; 355-46-4; 1,1,2,2,3,3,4,4,5,5,6,6,6-Tridecafluorohexane-1-sulfonicacid; tridecafluorohexane-1-sulfonicacid; 1-Hexanesulfonicacid,1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafl |
Perfluorododecyl bromide | 67193-90-2 | C12BrF25 | 698.99 | |
Perfluorodecanesulfonyl fluoride | 307-51-7 | C10F22O2S | 602.14 | perfluorodecanesulfonylfluoride; Perfluorodecanesulphonylfluoride; 307-51-7; Heneicosafluoro-1-decanesulfonylfluoride; 1-Decanesulfonylfluoride,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heneicosafluoro-; AC1Q4HWT |
Perfluorocyclohexane | 355-68-0 | C6F12 | 300.05 | DODECAFLUOROCYCLOHEXANE; PERFLUOROCYCLOHEXANE; 1,1,2,2,3,3,4,4,5,5,6,6-Dodecafluorocyclohexane; cyclohexane,dodecafluoro-; Perfluorocyclohexane 99%; Perfluorocyclohexane99% |
perfluorobutane | 355-25-9 | C4F10 | 238.02700 | |
Perfluoro-4-ethylcyclohexanesulfonicacidpotassiumsalt | 67584-42-3 | |||
PERFLUORO-3,6,9-TRIOXAUNDECANE-1,11-DIOIC ACID | 55621-18-6 | C8H2F12O7 | 438.08 | PERFLUORO-3,6,9-TRIOXAUNDECANE-1,11-DIOIC ACID; Perfluoro-3,6,9-trioxaundecane-1,11-dioc acid; PERFLUORO-3,6,9-TRIOXAUNDECANT-1,11-DIOIC ACID |
Perfluoro-15-crown-5-ether | 97571-69-2 | C10F20O5 | 580.07 | PERFLUORO-15-CROWN-5; PERFLUORO-15-CROWN-5-ETHER; ICOSAFLUORO-15-CROWN-5; PERFLUORO-15-CROWN-5-ETHER 99%; Perfluoro-15-crown-5 95%; Perfluoro-15-crown-595%; Icosafluoro-15-ceown-5 |
PERFLUORO-1,3,5-TRIMETHYLCYCLOHEXANE | 374-76-5 | C9F18 | 450.07 | cyclohexane,1,1,2,3,3,4,5,5,6-nonafluoro-2,4,6-tris(trifluoromethyl)-; cyclohexane,nonafluoro-1,3,5-tris(trifluoromethyl)-; Nonafluoro-1,3,5-tris(trifluoromethyl)cyclohexane; nonafluoro-1,3,5-tris-(trifluoromethyl)-cyclohexane; PERFLUORO-1,3,5-TRIMETHYLCY |
Perfluoro-1,2-dimethylcyclobutane | 2994-71-0 | C6F12 | 300.045 | 1,1,2,2,3,4-HEXAFLUORO-3,4-BIS(TRIFLUOROMETHYL)CYCLOBUTANE; DODECAFLUORODIMETHYLCYCLOBUTANE; PERFLUORO-1,2-DIMETHYLCYCLOBUTANE; PERFLUORODIMETHYLCYCLOBUTANE; 1,1,2,2,3,4-hexafluoro-3,4-bis(trifluoro-methyl)c; 1,1,2,2,3,4-hexafluoro-3,4-bis(trifluoromethyl |
PERFLUORO(ETHYLCYCLOHEXANE) | 335-21-7 | C8F16 | 400.06 | (pentafluoroethyl)undecafluoro-cyclohexan; 1-(1,1,2,2,2-Pentafluoroethyl)-1,2,2,3,3,4,4,5,5,6,6-undecafluorocyclohexane; Cyclohexane, (pentafluoroethyl)undecafluoro-; CYCLOHEXANE, 1-(1,1,2,2,2-PENTAFLUOROETHYL)-1,2,2,3,3,4,4,5,5,6,6-UNDECAFLUORO-; Cyclohe |
Peradoxime | 67254-81-3 | C22H29N3O4 | 399.48 | PERADOXIME; PERADOXINE; 1-[(3-Methoxyphenyl)methylideneamino]oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol; 3-Methoxybenzaldehyde O-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]oxime |
Pentanoic acid,5-amino-, ethyl ester | 26342-05-2 | C7H15 N O2 | 145.1995;g/mol | ethyl5-aminopentanoate;Ethyl5-aminopentanoate;ETHYL5-AMINOVALERATE;Pentanoicacid,5-amino-,ethylester;26342-05-2;5-AMINO-PENTANOICACIDETHYLESTER |
Pentanoic acid,4-methyl-, methyl ester | 2412-80-8 | C7H14 O2 | 130.18 | PENTANOIC ACID, 4-METHYL-, METHYL ESTER; FEMA NUMBER 2721; FEMA 2721; METHYL ISOCAPROATE; METHYL 4-METHYLVALERATE; METHYL 4-METHYLPENTANOATE; 4-methyl-pentanoicacimethylester; 4-Methylvaleric acid, methyl ester |
Pentanoic acid,4-cyano-4-[[(dodecylthio)thioxomethyl]thio]- | 870196-80-8 | C19H33 N O2 S3 | 403.67 | |
PENTANOIC ACID (1-AMINOMETHYL-CYCLOPENTYL)-AMIDE | 912763-48-5 | C11H22N2O | 198.30518 | PENTANOIC ACID (1-AMINOMETHYL-CYCLOPENTYL)-AMIDE |
Pentanedioic acid, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, 1-(1,1-dimethylethyl) 5-ethyl ester,(3R)- | 615556-99-5 | C17H34 O5 Si | 346.53 | (R)-3-HYDROXYGLUTARATE ETHYL TERT-BUTYL TBDMS; TERT-BUTYL ETHYL (R)-3-HYDRO-XYGLUTARATE TBDMS PROTECTED; (R)-TERT-BUTYL ETHYL 3-(TERT-BUTYLDIMETHYLSILOXY)GLUTARATE; (R)-TERT-BUTYL ETHYL 3-(TERT-BUTYLDIMETHYLSILOXY)PENTANEDIOATE |
Pentane-2,4-dione, monopotassium salt | 19393-11-4 | C5H7KO2 | 138.21 | POTASSIUM ACETYLACETONATE; ACETYLACETONE, POTASSIUM DERIVATIVE; pentane-2,4-dione, monopotassium salt; Bis(2,4-pentanedionato) potassium; 2,4-Pentanedionato potassium; 3-Potassiopentane-2,4-dione; 2,4-Pentanedione, ion(1-), potassium; Nsc174286 |
Pentane,3-bromo-3-methyl- | 25346-31-0 | C6H13 Br | 165.07 | 3-bromo-3-methyl-pentan; 3-BROMO-3-METHYLPENTANE; 2-ETHYLBUTYL BROMIDE; Einecs 246-878-0 |
pentane | 68476-43-7 | |||
Pentanamide,2-amino-4-methyl-N-(4-nitrophenyl)-, monohydrochloride, (2S)- (9CI) | 16010-98-3 | C12H17 N3 O3 . Cl H | 287.74 | H-LEU-PNA HCL; L-LEUCYL-P-NITROANILIDE HYDROCHLORIDE; L-LEUCINE P-NITROANILIDE HYDROCHLORIDE; L-Leucine 4-nitroanilide hydrochloride; (S)-2-amino-4-methyl-N-(4-nitrophenyl)pentanamide hydrochloride |
Pentanamide, 2-[[(4-chlorophenyl)sulfonyl]amino]-5,5,5-trifluoro-, (2R)- | 1146699-67-3 | C11H12ClF3N2O3S | 344.73779;g/mol | (2R)-2-[(4-chlorophenyl)sulfonylamino]-5,5,5-trifluoropentanamide; Pentanamide,2-[[(4-chlorophenyl)sulfonyl]amino]-5,5,5-trifluoro-,(2R)-; 1146699-67-3; SCHEMBL310015; AMDXQCHTJWVNGY-SECBINFHSA-N; CS-B0245 |
Pentamidine-d4 2HCl (pentane-1,1,5,5-d4) | 1276197-32-0 | C19H22D4Cl2N4O2 | 417.37 | 4,4'-(Pentamethylenedioxy)dibenzamidine 2HCl; 1,5-Bis(4-amidinophenoxy)pentane |
Pentamidine isethionate salt | 140-64-7 | C19H24N4O2.2(C2H6O4S) | 592.68 | 1,5-BIS(P-AMIDINOPHENOXY)PENTANE BIS(2-HYDROXYETHANESULFONATE SALT);1,5-BIS[P-AMIDINOPHENOXY]PENTANE BIS[2-HYDROXYETHANESULFONATE SALT] ISETHIONATE SALT;4,4'-(PENTAMETHYLENEDIOXY)DIBENZAMIDE BIS(2-HYDROXYETHANESULFONATE);4,4'-(PENTAMETHYLENEDIOXY)DIBENZA |
Pentamidine | 50357-45-4 | C19H24N4O2.2HCl | 413.34 | |
Pentamidine | 100-33-4 | C19H24N4O2 | 340.42 | MP-601205 |
Pentamethyldiethylenetriamine | 3030-47-5 | C9H23N3 | 173.3 | PMDETA; PMDTA; PENTAMETHYLDIETHYLENETRIAMINE; N,N,N',N'',N''-PENTAMETHYLDIETHYLENETRIAMINE; N,N,N',N',N''-PENTAMETHYLDIETHYLENETRIAMINE; n-[2-(dimethylamino)ethyl]-n,n',n'-trimethyl-1,2-ethanediamine; 1,1,4,7,7-pentamethyl-diethylenetriamin; 2,5,8-trimeth |
Pentafluorophenyl isothiocyanate | 35923-79-6 | C7F5NS | 225.14 | Pentafluoroisothiocyanatobenzene; Pentafluorophenyl isothiocyanate |
Pentafluoroethylsulfonamide | 78491-70-0 | C2H2F5NO2S | 199.1 | |
Pentafluoroethanesulfonic acid | 354-88-1 | C2HF5O3S | 200.084556 | Pentafluoroethane sulfonic acid |
Pentafluorobenzyl chloride | 653-35-0 | C7H2ClF5 | 216.54 | PENTAFLUOROBENZYL CHLORIDE; 2,3,4,5,6-PENTAFLUOROBENZYL CHLORIDE; 1-(Chloromethyl)-2,3,4,5,6-pentafluorobenzene; alpha-Chloro-2,3,4,5,6-pentafluorotoluene; (chloromethyl)pentafluorobenzene; à-chloro-2,3,4,5,6-pentafluorotoluene; Pentafluorobenzyl chloride |
Pentaerythritol tetrakis(2-mercaptoacetate) | 10193-99-4 | C13H20O8S4 | 432.55 | PENTAERYTHRITOL TETRAKIS(2-MERCAPTOACETATE); PENTAERYTHRITOL TETRATHIOGLYCOLATE; PENTAERYTHRITOL TETRAKIS(MERCAPTOACETATE); PENTAERYTHRITOL TETRA(MERCAPTOACETATE); ACETIC ACID, MERCAPTO-, 2,2-BIS [[(MERCAPTOACETYL) OXY] METHYL] -1,3-PROPANEDIYL ESTER; ace |
Pentaerythritol octahydrogen tetraphosphate | 7440-78-0 | C5H16O16P4 | 456.066 g/mol | |
Pentaerythritol ester of rosin hydrogenated | 64365-17-9 | C(CH2OCOR)4 | ||
PENTAERYTHRITOL DIMETHACRYLATE | 26846-58-2 | C11H16O6 | 244.24 | 2-propenoicacid,2-methyl-,2,2-bis(hydroxymethyl)-1,3-propanediylester; PENTAERYTHRITOL DIMETHACRYLATE; 2,2-bis(hydroxymethyl)-1,3-propanediyl bismethacrylate; Bismethacrylic acid 2,2-bis(hydroxymethyl)-1,3-propanediyl ester; Dimethacrylic acid 2,2-bis(hyd |
Pentaerythritol dibromide b-D-glucuronide | 1138247-37-6 | C11H18Br2O8 | 438.06 | |
PENTADOXYNOL-200 | 40160-92-7 | |||
Pentadecane, 7-methylene- | 13043-55-5 | C16H32 | 0 | Pentadecane, 7-methylene- |
Pentacyanoammineferroate sodium salt | 14099-05-9 | C5H3FeN6Na3 | 271.93 | SODIUM AMINOPENTACYANOFERROATE; SODIUM PENTACYANOAMINE FERROATE; SODIUM PENTACYANOAMMINEFERROATE; PENTACYANOAMMINEFERROATE SODIUM SALT; TRISODIUM PENTACYANOAMINE FERROATE; TRISODIUM AMMINEPENTACYANOFERROATE; pentacyanoammineferroate(ii) sodium salt; sodiu |
Pentachlorophenyl laurate | 3772-94-9 | C18H23Cl5O2 | 448.64 | Pentachlorophenyllaurate; Mystox; 3772-94-9; MystoxLPL; MystoxLSD; MystoxLSL |
PENTACARBOXY BENZENE | 1585-40-6 | C11H6O10 | 298.17 | BENZENEPENTACARBOXYLIC ACID; 1,2,3,4,5-Benzenepentacarboxylic acid; Pentacarboxy benzene; BENZENEPENTACARBOXYLIC ACID 98+%; benzene-1,2,3,4,5-pentacarboxylic acid |
pentabromotoluene | 87-83-2 | C7H3Br5 | 486.6207 | PENTABROMOTOLUENE; 2,3,4,5,6-PENTABROMOTOLUENE; 1,2,3,4,5-PENTABROMOTOLUENE; 2,3,4,5,6-PENTABROMTOLUOL 99%; 2,3,4,5,6-PENTABROMOTOLUENE 98+%; PENTABROMOMETHYLBENZENE; 1-Methyl-2,3,4,5,6-pentabromobenzene; Flamex 5BT |
Pentabromo(tetrabromophenoxy)benzene | 63936-56-1 | C12HBr9O | 880.27200 | |
Pentaboron sodium octaoxide | 12007-92-0 | B5NaO8 | 205.04 | SODIUM PENTABORATE; pentaboron sodium octaoxide |
Pent-4-enyl-D-glucopyranoside | 125631-33-6 | C11H20O6 | 248.27 | |
PD-119819 | 105277-43-8 | C21H23N3O3 | 365.43 | 4H-1-Benzopyran-4-one,7-[3-[4-(2-pyridinyl)-1-piperazinyl]propoxy]-, hydrochloride (1:2);7-[3-(4-pyridin-2-ylpiperazin-1-yl)propoxy]chromen-4-one;PD119819 |
PD-118717 | 104229-37-0 | C20H24N4O7S | 464.49 | 2H-1-Benzopyran-2-one,7-[3-[4-(2-pyrimidinyl)-1-piperazinyl]propoxy]-;7-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propoxy]chromen-2-one sulfuric acid;PD118717;7-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propoxy)-2H-chromen-2-one sulfate |
PD-118440 | 108351-90-2 | C11H17N3S | 223.33 | 2-Amino-4-[(1-propyl-1,2,5,6-tetrahydropyridin)-3-yl]thiazole;2-Thiazolamine,4-(1,2,5,6-tetrahydro-1-propyl-3-pyridinyl)-;4-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,3-thiazol-2-amine;PD118440 |
PD-117302 | 111728-01-9 | C21H28N2OS | 356.52 | Trans-N-Methyl-N-(2-(1-pyrrolidinyl)cyclohexyl-)benzo-(b)-thiophene-4-acetamide;Benzo(b)thiophene-4-acetamide, N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-;2-(1-Benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;PD117 |
PD-116779 | 102674-89-5 | C19H14O6 | 338.31 | 3,4-Dihydro-2,3,8-trihydroxy-3-methylbenz[a]anthracene-1,7,12(2H)-trione;PD116779;2,3,8-Trihydroxy-3-methyl-3,4-dihydrotetraphene-1,7,12(2H)-trione |
Palladium(II) nitrate | 10102-05-3 | 230.43 | Palladous nitrate; PALLADIUM (II) NITRATE SOLUTION; PALLADIUM(II) NITRATE; PALLADIUM NITRATE; PALLADIUM STANDARD SOLUTION; Nitricacid,palladium(2+)salt | |
p-(1-Methyloctyl)phenol | 17404-66-9 | C15H24O | 220.35 g/mol | P-(1-METHYLOCTYL)PHENOL; 4-(nonan-2-yl)phenol; 17404-66-9; Phenol,4-(1-methyloctyl)-; EINECS241-427-4; 4-nonan-2-ylphenol |
p-(1,1-Dimethylheptyl)phenol | 30784-30-6 | C15H24O | 220.35046 | p-(1,1-Dimethylheptyl)phenol; 30784-30-6; 4-(2-methyloctan-2-yl)phenol; EINECS250-339-5; AC1MI1BP; SCHEMBL678357 |
Ozenoxacin | 245765-41-7 | C21H21N3O3 | 363.4 | 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxoquinoline-3-carboxylic acid |
Oxiracetam | 62613-82-5 | C6H10N2O3 | 158.16 | 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide; 4-Hydroxy-2-oxopyrrolidine-N-acetamide; Hydroxypiracetam; Neuromet |
oxilorphan | 42281-59-4 | C20H27NO2 | 313.438 | Oxilorphan; levo-BC2605; Oxilorfano[INN-Spanish]; Oxilorphane[INN-French]; Oxilorphanum[INN-Latin]; Levo-BC-2605 |
Oxidopamine hydrochloride | 28094-15-7 | C8H12ClNO3 | 205.64 | 5-(2-aminoethyl)benzene-1,2,4-triol;hydrochloride 6 Hydroxydopamine 6-Hydroxydopamine 6-OHDA Hydrobromide, Oxidopamine Hydrochloride, Oxidopamine Oxidopamine Oxidopamine Hydrobromide Oxidopamine Hydrochloride |
Ofloxacin-d8 | 1219170-21-4 | C18H12FN3O4D8·HCl | 369.42 | 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl-d8)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; Ofloxacine-d8 |
Ofloxacin-D3 | 1173147-91-5 | 8-Fluoro-3-methyl-9-(4- methyl-D3-piperazin-1- yl)-6-oxo-2,3-dihydro-6H- 1-oxa-3a-aza-phenalene-5-carboxylic acid | ||
Ofloxacin N-Oxide Acetic Acid Salt (Impurity F) | 104721-52-0 | C18H20FN3O5 . C2H4O2 | 377.38 60.05 | Ofloxacin N-Oxide Acetic Acid Salt;9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Acetic Acid Salt; |
Ofloxacin Impurity E | 82419-52-1 | C17H18FN3O4 | 347.346 | Desmethyl Ofloxacin; 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; Ofloxacin EP Impurity E; |
Ofloxacin Impurity B (Decarboxyl Ofloxacin) | 123155-82-8 | C17H20FN3O2 | 317.37 | Decarboxyl Ofloxacin; 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one; (±)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one; |
Ofloxacin EP Impurity D | 197291-75-1 | C18H20FN3O4 | 361.38 | 9-Piperazino Ofloxacin; 10-Fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; Ofloxacin EP Impurity D; |
Ofloxacin | 82419-36-1 | C18H20FN3O4 | 361.37 | RS-10085 |
Officinalisinin I | 57944-18-0 | C45H76O19 | (3beta,5beta,22alpha)-26-(beta-D-Glucopyranosyloxy)-22-hydroxyfurostan-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside | |
Ofatumumab | 679818-59-8 | C6480H10022N1742O2020S44 | 146100 | |
OF-1 | 919973-83-4 | C17H18BrN3O4S | 440.31 | 4-bromo-N-(2,3-dihydro-6-methoxy-1,3-dimethyl-2-oxo-1H-benzimidazol-5-yl)-2-methyl-benzenesulfonamide; OF-1; OF1; OF 1. |
O-Ethyl thiocarbamate | 625-57-0 | C3H7NOS | 105.15900 | |
Pennyroyal oil (Mentha pulegium) | 8013-99-8 | pennyroyal oil | ||
Pennyroyal oil (Hedeoma pulegioides) | 8007-44-1 | Americanpennyroyal oil; Hedeoma pulegioides oil; Oil of Pennyroyal; Oil ofPennyroyal--American; Oil of hedeoma; Pennyroyal oil | ||
Pennogenin 3-O-beta-chacotrioside | 55916-52-4 | C45H72O17 | 885.1 | Pennogenin triglycoside |
Penitrem A | 12627-35-9 | C37H44ClNO6 | 634.2 | Tremortin A |
Penimepicycline | 4599-60-4 | C29H38N4O9.C16H18N2O5S | 937.02294;g/mol | (4S,4aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]h |
Penigequinolone A | 180045-91-4 | C27H33NO6 | 467.6 | |
Penicolinate A | 1418291-68-5 | C23H30N2O4 | 398.5 | Penicolinate B dimethyl ester; Methyl 5-[9-(6-methoxycarbonylpyridin-3-yl)nonyl]pyridine-2-carboxylate |
Pemetrexed Impurity E Disodium Salt | 937370-10-0 | C20H19N5Na2O6 | 471.38 | (2R)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid sodium |
Pemetrexed Impurity D | 144051-68-3 | C25H28N6O9 | 556.54 | |
Pemetrexed Impurity A | 137281-39-1 | C15H14N4O3 | 298.3 | 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid |
Pemetrexed Impurity 3 | 229470-22-8 | C17H21N5O5 | 375.39 | |
Pemetrexed Impurity 7 (Mixture of Diastereomers) | 193281-00-4 | C20H21N5O7 | 443.41 | Pemetrexed 6-oxo diacid impurity; (2S)-2-[[4-[2-(2-amino-4,6-dioxo-5,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid |
Pemetrexed Impurity | 204257-65-8 | C19H17N5O5 | 395.38 | 4-[2'-(7''Deazaguanine)ethyl]benzoic Acid N-Hydroxysuccinimide Ester |
Pemetrexed Impurity | 869791-42-4 | C21H23N5O6 | 441.45 | N-Methyl Pemetrexed; N-[4-[2-(2-Amino-4,7-dihydro-1-methyl-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid; Pemetrexed EP Impurity A |
Pemetrexed Disodium Heptahydrate | 357166-29-1 | C20H33N5Na2O13 | 597.48 | N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt Heptahydrate; Pemetrexed (sodium salt hydrate); L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-8 oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben |
Pemetrexed Disodium | 357166-30-4 | C20H21N5O6.5/2H2O.2Na | 516.42 | LY-231514 Disodium Hydrate |
Pemetrexed Disodium | 150399-23-8 | C20H19N5Na2O6 | 471.37 | LY-231514 |
Pemetrexed acid oxo impurity | 193265-47-3 | C15H14N4O4 | 314.3 | 4-[2-(2-Amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid |
Pemetrexed | 137281-23-3 | C20H21N5O6 | 427.41 | LY231514; Alimta; LY 231514; LY-231514 |
pembrolizumab | 1374853-91-4 | Anti-PD-1 monoclonal antibody - Merck; Humanised monoclonal IgG4 antibody against PD-1 - Merck; Keytruda; Lambrolizumab; MK-3475; SCH-900475 | ||
Pellitorine | 18836-52-7 | C14H25NO | 223.4 | N-ISOBUTYL(E,E)-2,4-DECADIENAMIDE; (2E,4E)-N-Isobutyl-2,4-decadienamide |
Pelanserin | 2208-51-7 | C21H24N4O2 | 364.44086 | Pelanserin; 3-[3-(4-Phenylpiperazin-1-yl)propyl]quinazoline-2,4(1H,3H)-dione |
Peimisine hydrochloride | 900498-44-4 | C27H41NO3·HCl | 464.08 | |
Peimisine | 19773-24-1 | C27H41NO3 | 427.62 | Ebeiensine |
Peiminine | 18059-10-4 | C27H43NO3 | 429.64 | Verticinone; Raddeanine |
Peimine | 23496-41-5 | C27H45NO3 | 431.65 | Verticine; Dihydroisoimperialine |
Peginterferon alfa-2b | 215647-85-1 | hydrochloricacid; hydrogenchloride; Muriaticacid; 7647-01-0; Chlorohydricacid; Acidechlorhydrique | ||
Pegdinetanib | 906450-24-6 | C468H729N125O139S | 10,362.78 | Pegdinetanib; BMS-844203, CT-322. Brand name: Adnectin; Angiocept |
PEG-7 glyceryl cocoate | 68201-46-7 | |||
PEG-5 TALLOW AMIDE | 8051-61-4 | |||
PEG-5 GLYCERYL TRIISOSTEARATE | 86846-21-1 | |||
PEG-40 SORBITAN LANOLATE | 8036-77-9 | |||
Pefloxacin-D5 | 1228182-51-1 | 1-Ethyl-D5-6-fluoro-7-(4-methyl-piperazin-1-yl)-4- oxo-1,4-dihydro- quinoline-3-carboxylic acid |
||
PEARLATE | 94134-03-9 | C11H20O2 | 184.28 | (Z)-oct-3-en-1-yl propionate, 3-Octen-1-ol, propanoate, (3Z)-, cis-3-Octenyl propionate, Pear propionate, PEARLATE, Z-3-Octenyl Propionate |
PEAR ACETATE | 13049-88-2 | C11H20O2 | 184.28 | 3-Nonen-1-ol, 1-acetate, (3Z)-, cis-3-Nonenyl acetate, PEAR ACETATE, z-3-Nonen-1-yl acetate |
PEAQX tetrasodium salt | 2102348-87-6 | C17H13BrN3Na4O5P | 542.14 | [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium salt; 5-[[[(1S)-1-(4-bromophenyl)ethyl]amino]-phosphonatomethyl]quinoxaline-2,3-diolate tetrasodium salt |
PD318088 | 391210-00-7 | C16H13BrF3IN2O4 | 561.094 | PD318088; PD 318088; PD-318088. |
PD-1-IN-1 | 1673534-76-3 | C12H20N6O7 | 360.32 | (2S,3R)-2-[[(1S)-3-amino-1-[3-[(1R)-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl]carbamoylamino]-3-hydroxybutanoic acid; ZINC616580959 |
PD184161 | 212631-67-9 | C17H13BrClF2IN2O2 | 557.558 | PD184161; PD 184161; PD-184161; PF-1529483, PF-3011370, UK-287074. |
PD180970 | 287204-45-9 | C21H15Cl2FN4O | 429.276 | PD180970; PD180970; PD180970; PF-1515965. |
PD-173955 | 260415-63-2 | C21H16Cl2N4OS | 443.35 | PD173955; PD 173955; PD-173955. |
PD173074 | 219580-11-7 | C28H41N7O3 | 523.682 | PD173074; PD 173074; PD-173074. |
PD-168393 | 194423-15-9 | C17H13BrN4O | 369.222 | 4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline; PD168393; PD 168393; PD-168393 |
PD166866 | 192705-79-6 | C20H24N6O3 | 396.451 | PD166866; PD-166866; PD 166866 |
PD166326 | 185039-91-2 | C21H16Cl2N4O2 | 427.285 | PD166326; PD-166326; PD 166326. |
PD-161570 | 192705-80-9 | C26H35Cl2N7O | 532.51 | N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea; PD-161570; PD 161570; PD161570. |
PD158780 | 171179-06-9 | C14H12BrN5 | 330.18 | PD-158780 |
PD153035 HCl | 183322-45-4 | C16H14BrN3O2.HCl | 396.67 | SU-5271 (AG1517) HCl ,ZM 252868 HCl |
PD-153035 | 153436-54-5 | C16H14BrN3O2 | 360.211 | AG 1517; NSC 669364; PD 153035; SU 5271; WHI-P 79. |
PD153035 | 175178-82-2 | C16H14ClN3O2 | 315.757 | |
PD-140376 | 149027-97-4 | C33H40N4O5 | 572.71 | PD-140376; PD 140376; AC1L52KZ; 3-((4-Aminophenyl)methyl)-N-(alpha-methyl-N-((tricyclo(3.3.1.1)dec-2-yloxy)carbonyl)-D-tryptophyl)-beta-alanine; OR223333 |
PD-138312 | 107334-06-5 | C19H23FN4O3 | 374.41 | PD138312;7-(3-(2-Aminopropan-2-yl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;7-(3-(1-Amino-1-methylethyl)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
PD128907 HCl | 112960-16-4 | C14H19NO3.HCl | 285.77 | N/A |
PD-128763 | 129075-56-5 | C10H11NO | 161.204 | PD-128763; PD 128763; PD128763. |
PD-123319 TFA salt | 136676-91-0 | C35H34F6N4O7 | 736.66 (anhydrous basis) | (S)-1-(4-(dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2); PD-123319; PD 123319; PD123319; PD-123319 TFA; PD 123319 ditrifluoroacetate |
PD123319 | 130663-39-7 | C31H32N4O3 | 508.61 | (6S)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic Acid; (S)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxy |
PD-120697 | 108351-91-3 | C11H15N3S | 221.32 | 4-(1,2,5,6-Tetrahydro-1-allyl-3-pyridinyl)-2-thiazolamine;2-Thiazolamine, 4-[1,2,5,6-tetrahydro-1-(2-propen-1-yl)-3-pyridinyl]-;4-(1-Prop-2-enyl-3,6-dihydro-2H-pyridin-5-yl)-1,3-thiazol-2-amine;PD120697;4-(1-Allyl-1,2,5,6-tetrahydropyridin-3-yl)thiazol-2- |
PD-116152 | 101708-64-9 | C16H12N2O6 | 328.28 | 6-Formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid methyl ester;PD116152;Methyl 6-formyl-4,7,9-trihydroxy-8-methylphenazine-1-carboxylate |
PD-113413 | 103733-50-2 | C23H24N2O4 | 392.45 | 2H-Pyrazino(1,2-b)isoquinoline-2-acetic acid, 1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-, (3S-(2(R*),3alpha,11abeta))-;(2S)-2-[(3S,11aS)-3-methyl-1,4-dioxo-3,6,11,11a-tetrahydropyrazino[1,2-b]isoquinolin-2-yl]-4-phenylbutanoic acid |
PD-1/PD-L1 Inhibitor 3 | 1629654-95-0 | C89H126N24O18S | 1852.17 | Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 3 |
PD-1/PD-L1 inhibitor 2 | 1675203-84-5 | C25H29N3O3 | 419.52 | |
PD-1/PD-L1 Inhibitor 1 | 1675201-83-8 | C29H33NO5 | 475.58 | (2S)-1-[[2,6-dimethoxy-4-[(2-methyl-3-phenylphenyl)methoxy]phenyl]methyl]piperidine-2-carboxylic acid PD1-PDL1 inhibitor 1 CHEMBL3582252 (S)-1-(2,6-dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid 1675201-83-8 |
PD089828 | 179343-17-0 | C18H18Cl2N6O | 405.283 | PD089828; PD-089828; PD 089828 |
PD0407824 | 622864-54-4 | C20H12N2O3 | 328.327 | PD0407824; PD-0407824; PD 0407824; PD407824; PD-407824; PD 407824 |
PD0325901 | 391210-10-9 | C16H14F3IN2O4 | 482.198 | PD 0325901; PD 325901. |
PD0176078 | 248922-46-5 | C23H30F2N2O | 388.49 | (2S)-N-[4,4-bis(4-fluorophenyl)butyl]-4-methyl-2-(methylamino)pentanamide; PD176078 |
PD0166285 | 185039-89-8 | C26H27Cl2N5O2 | 512.435 | PD0166285; PD 0166285; PD-0166285; PD166285; PD 166285; PD-166285 |
PD 90780 | 77422-99-2 | C19H14N4O4 | 362.34 | 7-(Benzoylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid |
PD 81723 | 132861-87-1 | C14H12F3NOS | 299.31 | (2-Amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone; PD 81723; PD81723; NCGC00025124-01; CPD000468734; SAM001247067; PD-81,723; Methanone |
PD 404182 | 72596-74-8 | C11H11N3S | 217.29 | 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine |
PD 334581 | 548756-68-9 | C20H19F3IN5O2 | 545.3 | N-[5-[3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl]-1,3,4-oxadiazol-2-yl]-4-morpholineethanamine |
PD 198306 | 212631-61-3 | C18H16F3IN2O2 | 476.23 | N-(Cyclopropylmethoxy)-3,4,5-trifluoro-2-[(4-iodo-2-methylphenyl)amino]-benzamide |
PD 174265 | 216163-53-0 | C17H15BrN4O | 371.2 | 4-[(3-Bromophenyl)amino]-6-propionylamidoquinazoline; N-[4-(3-bromoanilino)quinazolin-6-yl]propanamide |
PD 173212 | 217171-01-2 | C38H53N3O3 | 599.85 | N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide |
PD 169316 | 152121-53-4 | C20H13FN4O2 | 360.348 | |
PD 168568 dihydrochloride | 210688-56-5 | C22H27N3O.2HCl | 422.39 | 3-[2-[4-(3,4-dimethylphenyl)-1-piperazinyl]ethyl]-2,3-dihydro-1H-isoindol-1-one dihydrochloride |
PD 168368 | 204066-82-0 | C31H34N6O4 | 554.6 | (2S)-3-(1H-indol-3-yl)-2-methyl-2-[(4-nitrophenyl)carbamoylamino]-N-[(1-pyridin-2-ylcyclohexyl)methyl]propanamide |
PD 168077 maleate | 630117-19-0 | C20H22N4O.C4H4O4 | 450.49 | N-(Methyl-4-(2-cyanophenyl)piperazinyl-3-methylbenzamide maleate |
PD 166793 | 199850-67-4 | C17H18BrNO4S | 412.3 | N-[(4'-Bromo[1,1'-biphenyl]-4-yl)sulfonyl]-L-valine; PD-166793; PD 166793; PD166793; PD-166793-0000 |
PD 166285 dihydrochloride | 212391-63-4 | C26H27Cl2N5O2.2HCl | 585.35 | 6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride |
PD 160170 | 181468-88-2 | C18H17N3O4S | 371.41 | 6-[[2-(1-Methylethyl)phenyl]]sulfonyl-5-nitro-8-quinolinamine |
PD 151746 | 179461-52-0 | C11H8FNO2S | 237.25 | |
PD 150606 | 179528-45-1 | C9H7IO2S | 306.12 | (Z)-3-(4-Iodophenyl)-2-mercapto-2-propenoic acid; PD 150606; PD-150606; PD150606 |
PD 146176 | 4079-26-9 | C15H11NS | 237.32 | 6,11-Dihydro[1]benzothiopyrano[4,3-b]indole; PD 146176; PD-146176; PD146176; NSC 168807; NSC-168807; NSC168807 |
PD 145305 | 90536-15-5 | C9H10O2S | 182.2 | 3-phenyl-2-sulfanylpropanoic acid; Benzylthioglykolsaure |
PD 144418 oxalate | 154130-99-1 | C18H22N2O.C2H2O4 | 372.42 | 1,2,3,6-Tetrahydro-5-[3-(4-methylphenyl)-5-isoxazolyl]-1-propylpyridine oxalate |
PD 142505-0028 | 161774-09-0 | C18H20N2O6 | 360.36 | CTK4D0956; 1-Azabicyclo[2.2.1]heptan-3-one,O-[3-(3-methoxyphenyl)-2-propyn-1-yl]oxime |
PD 140248 | 147208-55-7 | C21H19F3N4O3 | 432.39 | PD-140248; PD 140248; 7-(3-(1-Aminoethyl)-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1,8-Naphthyridine-3-carboxylic acid, 7-(3-(1-aminoethyl-1-pyrrolidinyl))-1-(2,4-difluorophenyl)-6-fluoro-1,4-d |
PD 138142 | 142642-31-7 | C25H35NO5S | 461.62 | 2,6-diisopropylphenyl (2,6-diisopropylphenoxy)carbonylsulfamate |
Ostarine(MK-2866) | 1202044-20-9 | C19H10D4F3N3O3 | 393.35300 | |
OSS-128167 | 887686-02-4 | C19H14N2O6 | 366.32 | STK292625; 5-[3-(furan-2-amido)benzamido]-2-hydroxybenzoic acid; 5-{3-[(Furan-2-carbonyl)-amino]-benzoylamino}-2-hydroxy-benzoic acid |
Oleuroside | 116383-31-4 | C25H32O13 | 540.5 | |
Oleuropeinic acid | 96382-90-0 | C25H30O15 | 570.5 | |
Oleuropein | 32619-42-4 | C25H32O13 | 540.5 | 2-(3,4-dihydroxyphenyl)ethyl [2S-(2alpha,3E,4beta)]-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate; |
Oleuropeic acid 8-O-glucoside | 865887-46-3 | C16H26O8 | 346.4 | (4S)-4-[1-(beta-D-Glucopyranosyloxy)-1-methylethyl]-1-cyclohexene-1-carboxylic acid |
Oleuropeic acid | 5027-76-9 | C10H16O3 | 84.235 | Oleuropeicacid; 1-Cyclohexene-1-carboxylicacid, 4-(1-hydroxy-1-methylethyl)-, (4S)-; (4s)-4-(2-hydroxypropan-2-yl)cyclohex-1-ene-1-carboxylic acid |
OLETH-5 | 5353-27-5 | C28H56O6 | 488.74064;g/mol | 2-[2-[2-[2-[2-[(Z)-octadec-9-enoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol; OLETH-5; 5353-27-5; (Z)-3,6,9,12,15-Pentaoxa-24-tritriacontene-1-ol |
Norwogonin | 4443-09-8 | C15H10O5 | 270.2 | 5,7,8-Trihydroxyflavone; 5,7,8-Trihydroxy-2-phenyl-4H-chromen-4-one |
Norviburtinal | 85051-41-8 | C9H6O2 | 146.15 | Cyclopenta[c]pyran-7-carboxaldehyde |
NORVERAPAMIL | 67018-85-3 | C26H36N2O4 | 440.58 | NORVERAPAMIL; 5-[(3,4-dimethoxyphenethyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-; D591; 2-(3,4-Dimethoxyphenyl)-2-isopropyl-5-(3,4-di |
Norvancomycin hydrochloride | 213997-73-0 | C65H74Cl3N9O24 | 1471.69 | Desmethyl-vancomycin hydrochloride |
Norvaline, 4-oxo- (9CI) | 4439-83-2 | C5H9NO3 | 131.12986 | (S)-2-Amino-4-oxopentanoicacid;4439-83-2;Norvaline,4-oxo-;Norvaline,4-oxo-(9CI);2-amino-4-oxo-pentanoicacid;Norvaline,4-oxo- |
N-Methyl-o-phenylenediamine dihydrochloride | 25148-68-9 | |||
N-Methylol acrylamide | 924-42-5 | C4H7NO2 | 101.1 | 2-Propenamide,N-(hydroxymethyl)-; Acrylamide, N-(hydroxymethyl)-; Monomethylolacrylamide; n-(hydroxymethyl)-2-propenamid; n-(hydroxymethyl)-acrylamid; NCI-C60333; NM-AMD; N-Methanolacrylamide |
N-Methylnuciferine | 754919-24-9 | C20H24NO2 | 310.4 | (R)-5,6,6a,7-Tetrahydro-1,2-dimethoxy-6,6-dimethyl-4H-dibenzo[de,g]quinolinium |
N-Methyl Zonisamide | 68292-02-4 | C9H10N2O3S | 226.26 | N-Methyl-1,2-benzisoxazole-3-methanesulfonamide |
N-methyl Protoporphyrin IX | 79236-56-9 | C35H36N4O4 | 576.7 | NMPP; N-methyl PPIX; 7,12-Diethenyl-3,8,13,17,23-pentamethyl-21H,23H-porphine-2,18-dipropanoic acid; 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17,22-pentamethyl-23H-porphyrin-2-yl]propanoic acid |
N-methyl Paroxetine | 110429-36-2 | C20H22FNO3 | 343.39 | N-Methylparoxetine; Paroxetine-Related Compound F; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methylpiperidine |
N-Methyl Omeprazole (Mixture of Isomers) | 89352-76-1 | C18H21N3O3S | 359.45 | 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole; 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole; |
N-Methyl Nicotinamide | 114-33-0 | C7H8N2O | 136.15 | N-methylpyridine-3-carboxamide; |
N-Methyl Moxifloxacin | 721970-37-2 | C22H26FN3O4 | 415.47 | 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-1-methyloctahydro-6H-pyrrolo[3,4-b]pyridine-6-yl]-4-oxo-3-quinolinecarboxylic acid; |
PD 136450 | 139067-52-0 | C35H40N4O6 | 612.72 | Cam-1189;(E)-4-((2-(2-(((adamantan-2-yloxy)carbonyl)amino)-3-(1H-indol-3-yl)-2-methylpropanamido)-1-phenylethyl)amino)-4-oxobut-2-enoic acid |
PD 135390 | 150351-31-8 | C37H61N5O7S2 | 752.04 | PD-135390; PD135390; PD 135390; 5-((2S)-N-(1-(allylthio)-2-amino-2-oxoethyl)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropylhexanamide |
PD 135158 | 130325-35-8 | C35H44N4O6 | 616.76 | 4-[[(1R)-2-[[(2S)-3-(1H-indol-3-yl)-2-methyl-2-[(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxycarbonylamino]propanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoicacid;130325-35-8;CTK8E9978;RT-014954 |
PD 135158 | 130285-87-9 | C35H44N4O6 | 616.76 | 4-[[(1R)-2-[[(2R)-3-(1H-Indol-3-yl)-2-methyl-1-oxo-2-[[[[(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy]carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid |
PD 134922 | 150351-30-7 | C37H61N5O7S | 719.98 | PD 134922; PD-134922; AC1L3V1C; DTXSID30164523; AM008268; (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-5-[[(2S)-2-[[(2S)-2-(morpholin-4-ylsulfonylamino)-3-phenylpropanoyl]amino]pent-4-enoyl]amino]-2-propan-2-ylhexanamide |
PD 132002 | 134452-04-3 | C31H50N4O9S | 654.81 | (2R)-methyl 3-amino-2-((2S)-N-((2S,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)-3-oxopropanoate |
PD 131628 | 127967-03-7 | C16H17FN4O3 | 332.33 | (S)-7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
PD 130908 | 131505-02-7 | C8H14Br2N4O2 | 358.03 | N-(2-bromoethyl)-3-(2-nitro-1H-imidazol-1-yl)propan-1-amine hydrobromide |
PD 130883 | 123685-36-9 | C18H15N5O3 | 349.34 | CHEMBL62769;123685-36-9;2-Amino-6-(((4-nitrophenyl)-2-propynylamino)methyl)-4(3H)quinazolinone;4(3H)-Quinazolinone,2-amino-6-[[(4-nitrophenyl)-2-propyn-1-ylamino]methyl]-;ACMC-20mqpf;PD130883 |
PD 128907 | 123594-64-9 | C14H19NO3 | 249.31 | 4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol; 2H,5H-[1]Benzopyrano[4,3-b]-1,4-oxazin-9-ol,3,4,4a,10b-tetrahydro-4-propyl-, (4aS,10bS)-rel-; 3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol |
PD 127443 | 121502-05-4 | C20H28N2O | 312.45 | (E)-2,6-di-tert-butyl-4-(2-(5-methyl-1H-pyrazol-3-yl)vinyl)phenol |
PD 125967 | 128139-14-0 | C51H67N5O4 | 814.12 | 5-(3-(1H-imidazol-4-yl)-2-(3-(naphthalen-1-yl)-2-(naphthalen-1-ylmethyl)propanamido)propanamido)-6-cyclohexyl-4-hydroxy-2-isobutyl-N-(2-methylbutyl)hexanamide |
PD 125754 | 124339-32-8 | C42H65N5O7 | 752.00 | tert-butyl ((2S,3S)-6-(((2S,3S)-5-(((S)-1-((3-(aminomethyl)benzyl)amino)-4-methyl-1-oxopentan-2-yl)amino)-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl)amino)-3-hydroxy-6-oxo-1-phenylhexan-2-yl)carbamate |
PD 123177 | 114785-12-5 | C29H28N4O3 | 480.56 | Exp 655,1-[(4-amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid |
PD 122860 | 122576-86-7 | C23H20F3N3O4S | 491.48 | ethyl 5-cyano-6-methyl-2-((pyridin-4-ylsulfonyl)methyl)-4-(2-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylate |
PD 121373 | 113457-06-0 | C21H27N5OS | 397.54 | 5-((2-aminoethyl)amino)-2-(2-(diethylamino)ethyl)-2H-thiochromeno[4,3,2-cd]indazol-9-ol,Sedoxantrone |
PD 118057 | 313674-97-4 | C21H17Cl2NO2 | 386.27 | 2-[[4-[2-(3,4-Dichlorophenyl)ethyl]phenyl]amino]benzoic acid; PD-118057; PD118057; PD 118057 |
PD 102807 | 23062-91-1 | C23H24N2O4 | 392.45 | 3,6a,11,14-Tetrahydro-9-methoxy-2-methyl-(12H)-isoquino[1,2-b]pyrrolo[3,2-f][1,3]benzoxazine-1-carboxylic acid, ethyl ester |
PD 099560 | 155758-74-0 | C18H16O4 | 296.32 | 4-Hydroxy-3-(3-phenoxypropyl)-2H-1-benzopyran-2-one; PD-099560; PD099560; 3PhOPr-4OHBzpyran2one |
PD 0332991 hydrochloride | 571189-11-2 | C24H29N7O2.2HCl | 520.45 | Palbociclib 2HCl; Palbociclib dihydrochloride; Palbociclib hydrochloride; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one dihydrochloride |
PD 0220245 | 640736-79-4 | C24H26Cl2N4S2.2HCl | 578.45 | N-[6,7-dichloro-3-(5-thiophen-2-ylthiophen-2-yl)quinoxalin-2-yl]-N',N'-diethylbutane-1,4-diamine dihydrochloride |
p-Cresyl valerate | 10415-86-8 | C12H16O2 | 192.25424;g/mol | 4-Methylphenylvalerate; p-Cresylvalerate; 10415-86-8; Pentanoicacid,4-methylphenylester; AO-548/41714256; p-tolylpentanoate |
p-Coumaroyl-b-D-glucose | 7139-64-2 | C15H18O8 | 326.30 | 1-O-(4-Hydroxycinnamoyl)-b-D-glucose; 1-O-(4-Coumaroyl)-b-D-glucose |
p-Coumaric acid ethyl ester | 7362-39-2 | C11H12O3 | 192.2 | (E)-Ethyl 3-(4-hydroxyphenyl)acrylate |
PCNA I1 | 444930-42-1 | C17H14N2O2S | 310.37 | N-(3-Methylthiophene-2-carboxylic acid)-N'-[(1-hydroxy-2-naphthalenyl)methylene]hydrazide |
PCI-34051 | 950762-95-5 | C17H16N2O3 | 296.326 | PCI-34051; PCI 34051; PCI34051. |
PCI-32765 Racemate | 936563-87-0 | C25H24N6O2 | 440.5 | Ibrutinib Racemate |
PCI-27483 | 871266-63-6 | C26H24N6O9S | 596.6 | PCI27483; PCI 27483; (2S)-2-[[2-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetyl]amino]butanedioic acid |
PCI 29732 | 330786-25-9 | C22H21N5O | 371.44 | PCI29732; PCI-29732 |
p-Chlorobenzotrichloride | 5216-25-1 | C7H4Cl4 | 229.92 | |
p-Chloroaniline HCl | 20265-96-7 | C6H7NCl2 | 164.03 | 1-amino-4-chlorobenzenehydrochloride; 4-chloroaniliniumchloride; 4-chloro-benzenaminhydrochloride; 4-chlorophenylaminehydrochloride; Aniline, p-chloro-, hydrochloride; aniline,p-chloro-,hydrochloride; Benzenamine, 4-chloro-, hydrochloride; benzenamine,4-c |
PCDTBT | 958261-50-2 | Poly[N-9-heptadecanyl-2,7-carbazole-alt-5,5-(4,7-di-2-thienyl-2,1,3-benzothiadiazole)], Poly[[9-(1-octylnonyl)-9H-carbazole-2,7-diyl]-2,5-thiophenediyl-2,1,3-benzothiadiazole-4 | ||
PCBM | 160848-22-6 | |||
PCB No 118 | 31508-00-6 | C12H5Cl5 | 326.43 | PCB No 118; 2,3',4,4',5-Pentachlorobiphenyl |
p-Carboxylic acid benzamide | 6051-43-0 | C8H7NO3 | 165.14600 | |
PCA 4248 | 123875-01-4 | C19H23NO4S | 361.46 | 1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid methyl 2-(phenylthio)ethyl ester |
PC786 | 1902114-15-1 | C41H38FN5O4S | 715.83 | N-(2-fluoro-6-methylphenyl)-6-[4-[[5-methyl-2-(7-oxa-2-azaspiro[3.5]nonan-2-yl)pyridine-3-carbonyl]amino]benzoyl]-4,5-dihydrothieno[3,2-d][1]benzazepine-2-carboxamide |
PC-766B | 108375-77-5 | C43H68O12 | 777.0 | |
PC-046 | 1202401-59-9 | C22H18N2O3 | 358.390 | |
PBTZ169 | 1377239-83-2 | C20H23F3N4O3S | 456.48 | 2-(4-(cyclohexylmethyl)piperazin-1-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one |
PBS 57 | 898531-99-2 | C50H96N2O9 | 869.31 | (15Z)-N-[(1S,2S,3R)-1-[[[6-(Acetylamino)-6-deoxy-a-D-galactopyranosyl]oxy]methyl]-2,3-dihydroxyheptadecyl]-15-tetracosenamide |
p-Bromofluorobenzene-d4 | 50592-31-9 | C6BrD4F | 179.02 | 4-Bromofluorobenzene-d4; 1-Bromo-4-fluorobenzene-d4; SCHEMBL3069929; DTXSID50460115 |
p-Bromocyclohexylbenzene | 25109-28-8 | C10H12Cl2N2O2 | 263.12 | 1-bromo-4-cyclohexylbenzene; 1-Bromo-4-cyclohexylbenzene; 25109-28-8; P-BROMOCYCLOHEXYLBENZENE; 1-brom-4-cyclohexylbenzol; ST50408829 |
PbPc | 15187-16-3 | |||
PBP 10 | 794466-43-6 | C84H126N24O15 | 1712.1 | |
PBOX-15 | 354759-10-7 | C28H19NO3 | 417.13 | 5-(naphthalen-1-yl)naphtho[2,3-b]pyrrolo[1,2-d][1,4]oxazepin-4-yl acetate; |
PBIT | 2514-30-9 | C14H11NOS | 241.31 | 2-(4-Methylphenyl)-1,2-benzisothiazol-3(2H)-one |
PBAN-560 (degassed) | 25265-19-4 | |||
Pazinaclone | 103255-66-9 | C25H23ClN4O4 | 478.93 | 2-(7-chloro-1,8-naphthyridin-2-yl)-3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxoethyl]-3h-isoindol-1-one; 2-(7-Chloro-1,8-naphthyridin-2-yl)-3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxoethyl]-3H-isoindol-1-one; 8-[[2-(7-Chloro-1,8-naphthyridin-2-y1 |
Paxiphylline E | 1092555-03-7 | C23H29NO5 | 399.5 | Daphnilongeranine A N-oxide; Methyl (1S,2S,3R,5R,6S,8R,10S)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.11,5.02,10.03,8.017,20]henicosa-13(20),17-diene-18-carboxylate 8-oxide |
Paxiphylline D | 1092555-02-6 | C23H29NO4 | 383.5 | Methyl (1R,2S,3R,5R,6S,8R,10S)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.11,5.02,10.03,8.016,19]icosa-13(19),16-diene-17-carboxylate 8-oxide |
Paxilline | 57186-25-1 | C27H33NO4 | 435.6 | |
Pavinetant | 941690-55-7 | C26H25N3O3S | 459.6 | AZD 2624; AZD 4901;MLE-4901; 3-(methanesulfonamido)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |
Paucinervin A | 1243249-16-2 | C24H26O7 | 426.465 | 2,7,9-trihydroxy-1-methoxy-3,8-bis(3-methylbut-2-enyl)benzo[b][1,4]benzodioxepin-6-one |
Epothilon B | 152044-54-7 | C27H41NO6S | 507.68 | Patupilone; (-)-Epothilone B |
Patent Blue VF | 129-17-9 | C27H31N2NaO6S2 | 566.66 | 1085blue; 4,4'-di(diethylamino)-4',6'-disulphotriphenylmethanolanhydride,sodiumsalt; abcolpatentbluevf; acidbrightazurez; acidbrilliantbluevf; acidbrilliantbluez; acidbrilliantskybluez; acidleatherbluev |
Patent blue V sodium salt | 20262-76-4 | 582.66 | Acid blue 3 sodium salt, Food Blue 5 sodium salt | |
PATENT BLUE V | 3536-49-0 | C54H62CaN4O14S4 | 1159.43 | M-HYDROXYTETRAETHYLDIAMINOTRIPHENYLCARBINOL ANHYDRIDE DISULFONIC ACID CALCIUM SALT; PATENT BLUE; PATENT BLUE V; PATENT BLUE VIOLET CALCIUM SALT; XYLENE BLUE V; acidalcarminev; bleupatentev; bluezn3 |
Patchouli alcohol | 5986-55-0 | C15H26O | 222.36 | 1,6-Methanonaphthalen-1(2H)-ol, octahydro-4,8a,9,9-tetramethyl-, (1alpha,4beta,4aalpha,6beta,8aalpha)-; 1,6-Methanonaphthalen-1(2H)-ol, octahydro-4,8a,9,9-tetramethyl-, [1R-(1alpha,4beta,4aalpha,6beta,8aalpha)]-; 1,6-Methanonaphthalen-1(2H)-ol,octahydro-4 |
Passion Flower Extract | 8057-62-3 | |||
Paspalinine | 63722-91-8 | C27H31NO4 | 433.54 | 4H-3,15a-Epoxy-1-benzoxepino(6',7':6,7)indeno(1,2-b)indol-4-one, 2,3,5b,6,7,7a,8,13,13b,13c,14,15-dodecahydro-5b-hydroxy-2,2,13b,13c-tetramethyl-, (3R-(3alpha,5balpha,7abeta,13balpha,13cbeta,15aalpha))- |
Pasireotide L-aspartate salt | 396091-77-3 | C62H73N11O13 | 1180.31 | cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-) L-aspartate salt |
Pasireotide diaspartate | 820232-50-6 | C58H66N10O9·2C4H7NO4 | 1313.41 | SOM230 |
Pasireotide | 396091-73-9 | C58H66N10O9 | 1047.227 | Pasireotide; SOM230; SOM-203; Signifor |
Pasiniazid | 2066-89-9 | C13H14N4O4 | 290.28 | 4-amino-2-hydroxybenzoic acid;pyridine-4-carbohydrazide Fintosid isoniazide 4-aminosalicylate pasiniazide |
Pashanone | 42438-78-8 | C17H16O5 | 300.3 | 2',6'-DIHYDROXY-3',4'-DIMETHOXYCHALCONE; DIHYDROXY-3',4'-DIMETHOXYCHALCONE, 2',6'-; (E)-1-(2,6-DIHYDROXY-3,4-DIMETHOXY-PHENYL)-3-PHENYL-PROPENONE; (E)-1-(2,6-Dihydroxy-3,4-dimethoxy-phenyl)-3-; (E)-1-(2,6-Dihydroxy-3,4-dimethoxyphenyl)-3-phenyl-2-propen-1 |
Parylene F | 1785-64-4 | C16H8F8 | 352.22 | Dimer,Parylene F; 5,6,11,12,13,14,15,16-Octafluorotricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene; Parylene F Dimer |
Parvodicin complex | 187888-13-7 | C83H88Cl2N8O29 (for C1) | 1732.5 | A 40926 complex |
Parvifuran | 69470-93-5 | C16H14O3 | 254.28 | 5-Hydroxy-6-methoxy-3-methyl-2-phenylbenzofuran;6-methoxy-3-methyl-2-phenyl-1-benzofuran-5-ol |
Parvifolixanthone B | 906794-57-8 | C24H26O6 | 410.466 | 1,5,6-Trihydroxy-3-methoxy-4,7-bis(3-methyl-2-butenyl)-9H-xanthene-9-one |
Parvifolixanthone A | 906794-56-7 | C28H32O6 | 464.558 | 1,3,5,6-Tetrahydroxy-2,4,7-tris(3-methyl-2-butenyl)-9H-xanthene-9-one |
parvaquone | 4042-30-2 | C16H16O3 | 256.29644 | parvaquone; 2-Cyclohexyl-3-hydroxy-1,4-naphthalenedione; 2-Cyclohexyl-3-hydroxy-1,4-naphthoquinone; 3-cyclohexyl-4-hydroxy-1,2-naphthoquinone; 3-cyclohexyl-4-hydroxy-naphthalene-1,2-dione; 3-cyclohexyl-4-hydroxynaphthalene-1,2-dione |
Parthenolide | 20554-84-1 | C15H20O3 | 248.32 | |
Parstatin (mouse) | 1065756-01-5 | C189H326N58O57S3 | 4419.19 | MGPRRLLIVALGLSLCGPLLSSRVPMSQPESERTDATVNPR |
Parstatin (human) | 1065755-99-8 | C191H330N64O53S3 | 4467.29 | MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPR |
PARSOL SLX | 207574-74-1 | 0 | DIMETHICO-DIETHYLBENZALMALONATE; PARSOL SLX; POLYSILICONE-15; Siloxanes and Silicones, di-Me, 1-4-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propenylphenoxymethylethenyl Me, 3-4-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propenylphenoxy-1-propenyl Me, Me hydrogen; BENZ | |
Pardoprunox hydrochloride | 269718-83-4 | C12H16ClN3O2 | 269.73 | 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one;hydrochloride 2(3H)-benzoxazolone, 7-(4-methyl-1-piperazinyl)-monohydrochloride pardoprunox SLV-308 SME-308 |
Pardoprunox | 269718-84-5 | C12H15N3O2 | 233.27 | 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one 2(3H)-benzoxazolone, 7-(4-methyl-1-piperazinyl)-monohydrochloride pardoprunox SLV-308 SME-308 |
Parconazole | 61400-59-7 | C17H16Cl2N2O3 | ||
Parbendazole-d3 (deuterated) | 1613439-58-9 | (5-Butyl-1H-benzoimi- dazol-2-yl)-carbamic acid methyl-D3 ester | ||
Parbendazole | 14255-87-9 | C13H17N3O2 | 247.29 | methyl N-(6-butyl-1H-benzimidazol-2-yl)carbamate; N-(6-Butyl-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester; 5-Butyl-2-(carbomethoxyamino)benzimidazole; Helatac; Helmatac; Methyl (5-butyl-1H-benzimidazol-2-yl)carbamate; Methyl 5(6)-butyl-2-benzimidazolec |
Paraxanthine-d3 | 65566-70-3 | C7H5D3N4O2 | 183.18 | 3,7-Dihydro-1-methyl-7-(methyl-d3)-1H-purine-2,6-dione |
Paracetamol Impurity G | 34523-34-7 | C8H9NO2 | 151.17 | 1-(4-Hydroxyphenyl)ethanone Oxime; 1-(4-Hydroxyphenyl)-1-ethanone Oxime; 1-(4-Hydroxyphenyl)ethanone Oxime; |
Paracetamol Impurity C | 3964-54-3 | C8H8ClNO2 | 185.61 | N-(4-Hydroxyphenyl)propanamide; 4'-Hydroxypropionanilid; N-(4-Hydroxyphenyl)propanamide; Parapropamol; Parapropanol; |
Paracetamol Impurity B | 1693-37-4 | C9H11NO2 | 165.19 | N-(4-Hydroxyphenyl)propanamide; 4'-Hydroxypropionanilid; N-(4-Hydroxyphenyl)propanamide; |
Paracetamol Impurity A | 614-80-2 | C8H9NO2 | 151.17 | N-(2-Hydroxyphenyl)acetamide; 2'-Hydroxyacetanilide; 2-(Acetylamino)phenol; 2-(N-Acetylamino)phenol; 2-Acetaminophenol; 2-Hydroxyacetanilide; o-(Acetylamino)phenol; NSC 3989; USP Acetaminophen Related Compound C |
PARACELSIN | 88526-44-7 | |||
para-(2-Thenoyl) hydratropic acid | 40828-46-4 | C14H12O3S | 260.31 | |
Panulisib | 1356033-60-7 | C27H20F3N9 | 527.515 | AK151761; AK 151761; AK-151761; AGN-PC-0BMUW9; S9WA04F921 |
Pangelin | 33783-80-1 | C16H14O5 | 286.28 | R-(+)-Pangelin |
PANGAMIC ACID | 11006-56-7 | C14H27NO8 | 337.37 | PANGAMIC ACID; VITAMIN B15; VITAMIN B15, PANGAMIC ACID |
Pandamarilactonine B | 303008-81-3 | C18H23NO4 | 317.385 | (5S)-5beta-[(2R)-1-[4-[(2Z)-4-Methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl]-2beta-pyrrolidinyl]-3-methyl-2,5-dihydrofuran-2-one; (5Z)-3-methyl-5-(4-{(2R)-2-[(2S)-4-methyl-5-oxo-2,5-dihydro-2-fur Anyl]-1-pyrrolidinyl}butylidene)-2(5H)-furanone |
Pandamarilactonine A | 303008-80-2 | C18H23NO4 | 317.385 | (5Z)-3-methyl-5-[4-[(2R)-2-[(2R)-4-methyl-5-oxo-2H-furan-2-yl]pyrrolidin-1-yl]butylidene]furan-2-one |
Pancuronium bromide | 15500-66-0 | C35H60N2O4.2Br | 732.67 | |
Pancrelipase | 53608-75-6 | |||
Pancreatic Polypeptide (human) | 75976-10-2 | C185H287N53O54S2 | 4181.7 | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY |
Pancixanthone A | 174232-30-5 | C18H16O5 | 312.321 | 1,3,5-trihydroxy-4-(2-methylbut-3-en-2-yl)xanthen-9-one |
Panaxynol | 81203-57-8 | C17H24O | 244.37 | Falcarinol; (+)-Falcarinol; (S)-Falcarinol |
Panaxyne | 122855-49-6 | C14H20O2 | 220.3 | tetradec-13-en-1,3-diyne-6,7-diol |
Panaxydol | 72800-72-7 | C17H24O2 | 260.38 | (3R)-8-[(2R,3S)-3-heptyloxiran-2-yl]oct-1-en-4,6-diyn-3-ol |
Panaxydiol | 63910-76-9 | C17H24O2 | 260.37 | 1,8-heptadecadiene-4,6-diyne-3,10-diol |
Panaxcerol C | 63180-02-9 | C45H74O10 | 774.53 | |
Panaxadiol | 19666-76-3 | C30H52O3 | 460.73 | (3S,5R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol panaxadiol panaxadiol, (3beta,12beta)-isomer |
Panasenoside | 31512-06-8 | C27H30O16 | 610.52 | Kaempferol 3-O-beta-D-glucosylgalactoside |
PAMP-20 (human) | 150238-87-2 | C112H178N36O27 | 2460.87 | |
PAMP-12 (human, porcine) | 196305-05-2 | C77H119N25O14 | 1618.95 | |
Pamoic acid disodium salt | 6640-22-8 | C23H14Na2O6 | 432.33 | 4,4'-Methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) disodium salt |
Pamiparib | 1446261-44-4 | C16H15FN4O | 298.31 | BGB-290 |
p-Aminosalicylic acid sodium salt dihydrate | 6018-19-5 | C7H7NO3.2H2O.Na | 211.15 | |
p-Aminophenol sulfate | 15658-52-3 | C6H7NO4S | 189.1903 | |
p-Aminobenzyl bromide | 63516-03-0 | C7H8 Br N | 0 | p-Aminobenzylbromide; 4-(bromomethyl)-Benzenamine |
p-Aminoazobenzene HCl | 3457-98-5 | C12H11N3 | 233.69678 | 4-(phenylazo)benzenaminemonohydrochloride; 4-(phenylazo)-benzenaminmonohydrochloride; AminoazobenzeneSalt; Benzenamine,4-(phenylazo)-,monohydrochloride; c.i.solventyellow1,monohydrochloride; p-(phenylazo)-anilinhydrochloride; 4-(phenylazo)anilinium chlori |
Pamidronate Disodium | 57248-88-1 | C3H9NNa2O7P2 | 279.03 | |
Pamaquine | 635-05-2 | C23H16O6.C19H29N3O | 703.823 g/mol | |
Pamapimod-d4 | 1246814-57-2 | C19H16F2N4O4D4 | 410.42 | Ro 4402257-d4; R 1503-d4; 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one-d4 |
Pamapimod | 449811-01-2 | C19H20F2N4O4 | 406.39 | 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one; R 1503; R-1503; R1503; Ro 4402257; Ro4402257; Ro-4402257 |
Pamabrome | 155-88-9 | C24H30BrN7O3 | ||
Pam2CSK4 | 868247-72-7 | C65H126N10O12S | 1271.83 | CHEMBL2179400; BDBM50399457; AKOS024458268; 868247-72-7 |
Palytoxin from palythoa | 77734-91-9 | C129H223N3O54 | 2680.1386 | PTX; PALYTOXIN; (C52-55-HEMIACETAL) PALYTOXIN; palytoxin from palythoa tuberculosa; PALYTOXIN FROM PALYTHOA 98%; Palytoxinfrompalythoa |
PALYTOXIN | 77734-92-0 | C129H223N3O54 | 0 | PTX; PALYTOXIN; (C52-55-HEMIACETAL) PALYTOXIN; PALYTOXIN (PTX) >97% (C52-55-HEMIACETAL) PA |
Palustrol | 5986-49-2 | C15H26O | ||
Palmitoyl-L-carnitine chloride | 18877-64-0 | C23H46NO4·Cl | 436.07 | Hexadecanoyl-L-carnitine; L-Hexadecanoylcarnitine; L-Palmitoylcarnitine; [(2R)-3-carboxy-2-hexadecanoyloxypropyl]-trimethylazanium chloride |
Palmitoylisopropylamide | 189939-61-5 | C19H39NO | 297.52 | N-(1-Methylethyl)-hexadecanamide; PIA |
Palmitoylethanolamide | 544-31-0 | C18H37NO2 | 299.5 | N-(2-Hydroxyethyl)hexadecanamide; Palmidrol; PEA |
Palmitoyl-D-carnitine chloride | 28330-02-1 | C23H46NO4·Cl | 436.07 | Hexadecanoyl-D-carnitine; D-Hexadecanoylcarnitine; D-Palmitoylcarnitine; [(2S)-3-carboxy-2-hexadecanoyloxypropyl]-trimethylazanium chloride |
Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH | 117858-54-5 | C59H111N3O9S | 1038.59 | S-[2,3-BIS(PALMITOYLOXY)-(2RS)-PROPYL]-N-PALMITOYL-(R)-CYS-ALA-GLY-OH; PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-ALA-GLY-OH; PAM3-CYS-ALA-GLY-OH; N-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine |
Palmitoylcarnitine | 1935-18-8 | 0 | [3-Carboxylato-2-(palmitoyloxy)propyl]trimethylaminium; CPD-419 | |
Palmitoyl tripeptide-5 triflate | 623172-56-5 | C37H67F6N5O9 | 839.959 | (S)-6-Amino-2-((S)-2-((S)-6-amino-2-palmitamidohexanamido)-3-methylbutanamido)hexanoic acid compound with 2,2,2-trifluoroacetic acid (1:2); Palmitoyl tripeptide-5 bistrifluoracetate salt |
Palmitoyl Tripeptide-38 | 1447824-23-8 | Palmitoyl Tripeptide 38; matrixyl synthe'6 | ||
Palmitoyl tripeptide-1 | 147732-56-7 | C30H54N6O5 | 578.799 | L-Lysine, N-(1-oxohexadecyl)glycyl-L-histidyl-; Palmitoyl-glycyl-histidyl-lysine; palmitoyl oligopeptide; Pal-GHK |
Palmitoyl tetrapeptide-7 | 221227-05-0 | C34H62N8O7 | 694.919 | (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid |
Palmitoyl serotonin | 212707-51-2 | C26H42N2O2 | 414.6 | N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]hexadecanamide; Palmitoylserotonin |
Palmitoyl pentapeptide-4 | 214047-00-4 | C39H75N7O10 | 802.068 | N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl-L-serine |
PALMITOYL GLUTAMIC ACID | 38079-66-2 | C21H39NO5 | 385.53806 | |
Palmitoyl 3-carbacyclic phosphatidic acid | 476310-22-2 | C20H39O5P | 390.5 | 3-ccPA 16:0 |
Palmitone | 502-73-8 | C31H62O | 450.836 | 16-Hentriacontanone; Dipentadecyl ketone; Hentriacontan-16-one; Pentadecyl ketone |
Palmitoleoyl 3-carbacyclic phosphatidic acid | 910228-13-6 | C20H37O5P | 388.5 | 3-carbacyclic PA; 3-ccPA 16:1 |
PALMITOLEIC ACID | 373-49-9 | C16H30O2 | 254.41 | CIS-9-HEXADECENOIC ACID; DELTA 9 CIS HEXADECENOIC ACID; C16:1 (CIS-9) ACID; 9-HEXADECENOIC ACID; RARECHEM AL BE 0686; PALMITOLEIC ACID; (Z)-9-hexadecenoic acid; (Z)-Palmitoleic acid |
Palmitic acid glycidyl-ester-D5 | 1794941-80-2 | Hexadecanoic acid oxiranylmethyl-D5 ester; Glycidyl Palmitate-d5 | ||
Palmitic acid | 57-10-3 | C16H32O2 | 256.43 | Hexadecanoic Acid, PALMITIC ACID (NATURAL) |
Palmitelaidic Acid | 10030-73-6 | C16H30O2 | 254.41 | hexadec-9-enoic acid; hexadec-9-enoic acid; 9-Hexadecenoic acid, (9Z)- |
Palmatrubine | 16176-68-4 | C20H20NO4 | Dibenzo[a,g]quinolizinium,5,6-dihydro-9-hydroxy-2,3,10-trimethoxy- | |
Palmatine hydrochloride | 10605-02-4 | C21H22ClNO4 | 387.86 | Palmatine chloride; 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium chloride |
Palmatine | 3486-67-7 | C21H22NO4 | 352.4 | 7,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-berbiniu; 7,8,13,13a-tetrahydro-2,3,9,10-tetramethoxyberbinium; berbericinine; g)quinolizinium,5,6-dihydro-2,3,9,10-tetramethoxy-dibenzo(; o,o-dimethyldemethyleneberberine; palmatin; PALMATINE; 2,3,9,10-TETRAMET |
Palm Oil | 8002-75-3 | |||
Palladium, di-m-bromobis[tris(1,1-dimethylethyl)phosphine]di-,(Pd-Pd) | 185812-86-6 | C24H54 Br2 P2 Pd2 | 777.28 | DI-BROMOBIS(TRI-T-BUTYLPHOSPHINO)DIPALLADIUM (I); PALLADIUM (I) TRI-TERT-BUTYLPHOSPHINE BROMIDE; PALLADIUM (I) TRI-TERT-BUTYLPHOSPHINE BROMIDE, DIMER; Bromo(tri-tert-butylphosphine)palladium(I)dimer; DI--BROMOBIS(TRI-TERT-BUTYLPHOSPHINO)DIPALLADIUM(I); Di |
Palladium(II) Chloride | 7647-10-1 | PdCl2 | 177.31 | |
Palladium dioxide | 12036-04-3 | O2Pd | 138.42 | PALLADIUM DIOXIDE; Pddarkredorblackcrystallinesolid; Einecs 234-836-4; Palladium oxide (pdo2) |
Palladium difluoride | 13444-96-7 | F2Pd | 144.42 | PALLADIUM DIFLUORIDE; PALLADIUM FLUORIDE; PALLADIUM DIFLUORIDE 99.9%; Palladium(II)difluoride; Einecs 236-589-8; Palladium fluoride (pdf2) |
Palladium diacetate | 3375-31-3 | Pd.(C2H3O2)2 | 224.51 | ACETIC ACID PALLADIUM(II) SALT; PALLADIUM ACETATE; PALLADIUM(+2)ACETATE; PALLADIUM DIACETATE; PALLADIUM(II) ACETATE; PALLADIUM(II) ACETATE IN IONIC LIQUID ON SILICA |
Palitantin | 15265-28-8 | C14H22O4 | 254.32 | NSC 246119; (±)-Palitantin; (2R,3R,5S,6R)-5-[(1E,3E)-hepta-1,3-dienyl]-2,3-dihydroxy-6-(hydroxymethyl)cyclohexan-1-one |
Paliperidone Palmitate | 199739-10-1 | C39H57FN4O4 | 664.91 | 9-Hydroxyrisperidone Palmitate; Invega Sustenna; RO 92670; Hexadecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl Ester |
Paliperidone Impurity O HCl | 84163-13-3 | C12H13FN2O.HCl | 256.71 | Paliperidone USP RC B; Paliperidone Amine Impurity ; Risperidone EP Impurity M ; 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride |
Paliperidone Impurity H | 1388021-47-3 | C23H28F2N4O3 | 446.5 | Paliperidone Z-Oxime; 3-[2-[4-[(Z)-(2,4-Difluorophenyl)(hydroxyimino) methyl]piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
Paliperidone Impurity G | 1388021-46-2 | C23H28F2N4O3 | 446.5 | Paliperidone E-Oxime; 3-[2-[4-[(E)-(2,4-Difluorophenyl)(hydroxyimino) methyl]piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
Paliperidone Impurity F | 1380413-60-4 | C23H28N4O3 | 408.5 | Paliperidone Desfluoro Impurity; 3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
Paliperidone Impurity D | 1006685-69-3 | C24H27FN4O5 | 470.5 | 2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl 4-(6-fluorobenzo[d]isoxazol-3-yl)piperidine-1-carboxylate |
Paliperidone Impurity 7 | 1415488-05-9 | C27H45ClN2O3 | 481.12 | |
Paliperidone Impurity 5 | 1138463-56-5 | C11H13ClN2O2 | 240.69 | 3-(2-Chloroethyl)-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione |
Paliperidone Impurity 4 | 152542-03-5 | C23H28FN3O4 | 429.5 | Paliperidone 2-Hydroxybenzoyl Impurity; 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one ;Paliperidone Impurity 4 |
Paliperidone Impurity 3 | 95742-20-4 | C11H15ClN2O | 226.71 | |
Paliperidone Impurity 2 | 849903-79-3 | C11H16N2O2 | 208.26 | Paliperidone USP RC A; Paliperidone Ethyl Impurity ; 3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-one hydrochloride |
Paliperidone Impurity 1 | 260273-82-3 | C11H11ClN2O2 | 238.68 | 3-(2-Chloro ethyl )-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one HCl; Paliperidone Tetradehydro Chloroethyl Impurity |
Paliperidone | 144598-75-4 | C23H27FN4O3 | 426.48 | 9-Hydroxyrisperidone; Invega; Paliperidona; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; Invega; Paliperidone; R 76477; RO 76477 |
Palifosfamide tromethamine | 1070409-31-2 | C8H22Cl2N3O5P | 342.15 | 2-Amino-2-(hydroxymethyl)propane-1,3-diol;Bis(2-chloroethylamino)phosphinic acid;ZIO201;ZIO-201;NSC297900;NSC-297900;N,N'-Bis(2-chloroethyl)phosphorodiamidic acid |
Palifosfamide | 31645-39-3 | C4H11Cl2N2O2P | 221.018 | Isophosphamide mustard; Isophosphoramide mustard; IPAM; bis(2-chloroethylamino)phosphinic acid |
Palifermin | 162394-19-6 | 16411.0324 | palifermin; 24-163-Keratinocyte growth factor (human); Kepivance; 24-163 Fibroblast growth factor 7 (human); Unii-qms40680K6 | |
PALDA | 136181-87-8 | C24H41NO3 | 391.59 | N-[2-(3,4-Dihydroxyphenyl)ethyl]hexadecanamide |
Palbociclib-d8 | 1628752-83-9 | C24H21N7O2D8 | 455.59 | 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one-d8; PD 0332991-d8; PD 332991-d8 |
PADN | 865435-20-7 | |||
Padmatin | 80453-44-7 | C16H14O7 | 318.3 | Dihydrorhamnetin |
Padimate | 21245-01-2 | C14H21NO2 | 235.33 | |
padeliporfin | 759457-82-4 | C37H41N5O9PdS | 916.43 | WST11; Stakel; palladium-bacteriopheophorbide monolysine taurine |
Padanamide A | 1314881-80-5 | C31H47N7O9 | 661.8 | (3S)-N-[(2S,3S,4S)-5-[[(3S)-1-carbamoyl-2-oxopyrrolidin-3-yl]amino]-3-hydroxy-4-methyl-5-oxo-1-phenylpentan-2-yl]-2-[(2R,3R)-3-hydroxy-2-[(2-methoxyacetyl)amino]-4-methylpentanoyl]diazinane-3-carboxamide |
Pactimibe | 189198-30-9 | C25H40N2O3 | 416.60 | 2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindo l-5-yl]acetic acid; pactimibe; 7-[(2,2-Dimethyl-1-oxopropyl)amino]-2,3-dihydro-4,6-dimethyl-1-octyl-1H-indole-5-acetic acid |
Pacritinib | 937272-79-2 | C28H32N4O3 | 472.589 | SB1518; SB-1518 |
PACOCF3 | 141022-99-3 | C17H31F3O | 308.43 | 1,1,1-Trifluoro-2-heptadecanone |
PACMA 31 | 1401089-31-3 | C21H22N2O6S | 430.47 | N-(2,4-Dimethoxyphenyl)-N-(1-oxo-2-propyn-1-yl)-2-(2-thienyl)glycylglycine ethyl ester |
Paclobutrazol Impurity 2 | 66345-53-7 | C15H20ClN3O | 293.8 | 1H-1,2,4-Triazole-1-ethanol,b-[(4-chlorophenyl)methyl]-a-(1,1-dimethylethyl)-,[R-(R*,S*)]- (9CI) |
Paclobutrazol | 76738-62-0 | C15H20ClN3O | 293.79 | |
Paclitaxel-d5 | 1261254-56-1 | C47H46NO14D5 | 858.96 | Genetaxyl-d5; Abraxane-d5; Yewtaxan-d5; Genaxol-d5; Pacliex-d5 |
Paclitaxel side chian 2 | 155371-59-8 | C20H31NO4Si | 423.626 | PACLITAXEL SIDE CHAIN 2; PACLITAXEL SIDE CHIAN 2 |
Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity | 932042-85-8 | C47H53NO15 | 871.94 | b-(Benzoylamino)-a-hydroxybenzenepropanoic acid (a-R,b-S)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen- |
Paclitaxel Impurity O | 219783-77-4 | C49H53NO14 | 879.97 | N-Cinnamoyl N-Debenzoyl Paclitaxel |
Paclitaxel Impurity F | 153083-53-5 | C47H59NO14 | 861.99 | |
Paclitaxel Impurity E | 105454-04-4 | C47H51NO14 | 853.91 | 7-epi-Taxol; Epitaxol; Paclitaxel EP Impurity E |
Paclitaxel EP Impurity C | 153415-45-3 | C46H57NO14 | 847.97 | N-Debenzoyl-N-hexanoylpaclitaxel; (-)-Taxuyunnanine; Taxol C; Taxuyunnanine; Taxuyunnanine A |
Pachysamine M | 1253202-75-3 | C28H44N2O2 | 440.672 | |
Pachypodol | 33708-72-4 | C18H16O7 | 344.3 | 4',5-dihydroxy-3,3',7-trimethoxyflavone; |
Pachybasin | 2549-78-2 | C15H10O3 | 238.24 | 1-Hydroxy-3-methylanthraquinone; 1-hydroxy-3-methylanthracene-9,10-dione |
PACAP 6-38 | 143748-18-9 | C182H300N56O45S | 4024.74 | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK; L-phenylalanyl-L-threonyl-L-alpha-aspartyl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L- |
PACAP 6-27 | 136134-68-4 | C121H193N33O31S | 2638.1 | Pituitary Adenylate Cyclase-activating Peptide (6-27) |
PACAP 1-38 | 137061-48-4 | C203H331N63O53S | 4534.26 | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK; L-histidyl-L-seryl-L-alpha-aspartyl-glycyl-L-isoleucyl-L |
PAC-1 | 315183-21-2 | C23H28N4O2 | 392.503 | PAC 1; PAC1 |
pabulenol | 33889-70-2 | C16H14O5 | 286.28 | 4-[[(S)-2-Hydroxy-3-methyl-3-butenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one |
Pabociclib Impurity B Hydrochloride | 1883672-48-7 | C29H38ClN7O4 | 584.11 | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate hydrochloride |
Pabociclib Impurity B | 1651214-74-2 | C29H37N7O4 | 547.66 | tert-butyl 4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate |
PA-824 | 187235-37-6 | C14H12F3N3O5 | 359.26 | PA824; PA-824; PA 824; Pretomanid. |
p-(tert-Butyldimethylsiloxy)styrene | 84494-81-5 | C14H22OSi | 234.41 | p-(tert-Butyldimethylsiloxy)styrene; p-(tert-Butyl)phenethyltrichlorosilane |
p-(phenylthio)benzaldehyde | 1208-88-4 | C13H10OS | 214.287 | ART-CHEM-BB B022078; 4-(PHENYLTHIO)BENZALDEHYDE; 4-PHENYLSULFANYL-BENZALDEHYDE; AKOS B022078; p-(phenylthio)benzaldehyde; 4-(Phenythio)benzaldehde |
p-(Methoxymethyl)anisole | 1515-81-7 | C9H12O2 | 152.19 g/mol | 1-methoxy-4-(methoxymethyl)benzene; 1515-81-7; p-(Methoxymethyl)anisole; Benzene,1-methoxy-4-(methoxymethyl)-; p,|A-dimethoxytoluene; 4-(Methoxymethyl)anisole |
P-(DIACETOXYIODO)-TOLUENE | 16308-16-0 | C11H13IO4 | 336.12 | P-(DIACETOXYIODO)-TOLUENE; AURORA KA-4364; 4-Tolyliodine Diacetate; Zinc03957862 |
p-(3,4-dihydro-2,2,4-trimethyl-2H-1-benzopyran-4-yl)phenol | 472-41-3 | C18H20O2 | 268.3502 | p-(3,4-dihydro-2,2,4-trimethyl-2H-1-benzopyran-4-yl)phenol; 4-(3,4-DIHYDRO-2,2,4-TRIMETHYL-2H-1-BENZOPYRAN-4-YL)PHENOL; Chroman I; 2,2,4-Trimethyl-4-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran; 2,2,4-Trimethyl-4-(4-hydroxyphenyl)chroman; 2,2,4-Trimethyl |
Ozarelix | 295350-45-7 | C72H96ClN17O14 | 1459.115 | Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-N-Me-Tyr-D-Hci-Nle-Arg-Pro-D-Ala-NH2 |
Ozanimod | 1306760-87-1 | C23H24N4O3 | 404.47 | RPC1063; RPC-1063; 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile |
Ozagrel sodium | 130952-46-4 | C13H12N2O2.Na | 264.71 | SODIUM OZAGREL;4-(1h-imidazol-1-ylmethyl)cinnamic acid sodium salt;OZAGREL SODIUM CP;OzagrelSodiumC13H11N2Nao2 |
Ozagrel sodium | 189224-26-8 | C13H11N2O2·Na | 250.23 | KCT-0809; Cataclot; Xanbo; (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate sodium |
Ozagrel hydrochloride | 74003-18-2 | C13H12N2O2.HCl | 264.71 | (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid hydrochloride |
Ozagrel HCl | 78712-43-3 | C13H13ClN2O2 | 264.71 | Ro 15-1788 |
Ozagrel | 82571-53-7 | C13H12N2O2 | 228.25 | OKY046;2-Propenoic acid,3-[4-(1H-imidazol-1- ylmethyl)phenyl]-,(2E)-;(E)-p-(Imidazol-1-ylmethyl)cinnamic acid;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid;(E)-3-[P-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid |
oxyvanadium phthaloCyanine | 13930-88-6 | C32H16N8OV | 579.47 | VANADYL(IV)-PHTHALOCYANINE; VANADYL PHTHALOCYANINE; VANADIUM(IV) OXIDE PHTHALOCYANINE; VOPC; 31h-phthalocyaninato(2-)-n29,n39,n31,n32]-oxo[29(sp-5-12)-vanadiu; PHTHALOCYANINE, VANADYL |
Oxytocin acetate | 6233-83-6 | C45H70N12O14S2 | 1067.24 | (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicos |
Oxytetracycline Impurity C | 6542-44-5 | C22H23NO10 | 461.43 | 2-Acetyl-2-Decarbamoyl Doxycycline; (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,11(4H,5H)-dione |
Oxytetracycline Impurity A | 14206-58-7 | C22H24N2O9 | 460.4 | 4-Epioxytetracycline |
Oxytetracycline hydrochloride | 2058-46-0 | C22H24N2O9.HCl | 496.90 | Biosolvomycin; Engemycin; Oxamycen; Terramycin hydrochloride; Bisolvomycin; Dalimycin; Unimycin |
Oxytetracycline dihydrate | 6153-64-6 | C22H24N2O9.2H2O | 496.46 | |
Oxytetracycline | 79-57-2 | C22H24N2O9 | 460.43 | |
Oxysophoridine | 54809-74-4 | C15H24N2O2 | 264.36 | Oxymatrine; Matrine N-oxide; Ammothamnine |
Oxysophocarpine | 26904-64-3 | C15H22N2O2 | 262.35 | |
oxyphencyclimine | 125-53-1 | C20H28N2O3 | 344.46 | Caridan;Naridan;Zamanil;C07851;(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;125-52-0 (hydrochloride) |
Oxyphenbutazone-d9 | 1189693-23-9 | C19H11N2O3D9 | 333.44 | 4-(Butyl-d9)-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione; 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-(butyl-d9)pyrazolidine; Butapirone-d9; Californit-d9; Crovaril-d9; p-Hydroxyphenylbutazone-d9; Visubutina-d9 |
Oxyphenbutazone | 129-20-4 | C19H20N2O3 | 324.38 | 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione; oxyphenbutazone; Oxiphenbutazone; Oxyphenylbutazone; Oxifenylbutazon; Oxazolidin |
Oxypeucedaninhydrate | 2643-85-8 | C16H16O6 | 304.29 | (+)-4-[(R)-2,3-Dihydroxy-3-methylbutoxy]-7H-furo[3,2-g][1]benzopyran-7-one; Hydroxypeucedanin hydrate; Prangol; Prangolarin hydrate; Aviprin |
Oxypeucedanin hydrate | 133164-11-1 | C16H16O6 | 304.29 | (S)-(-)-Oxypeucedan hydrate |
oxypeucedanin | 737-52-0 | C16H14O5 | Oxypeucedarin; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((3,3-dimethyloxiranyl)methoxy)-; 4-[(3,3-dimethyloxiran-2-yl)methoxy]-7H-furo[3,2-g]chromen-7-one; 5-[(3,3-dimethyloxiran-2-yl)methoxy]-7H-furo[3,2-g]chromen-7-one | |
Oxyntomodulin (porcine, bovine) | 62340-29-8 | C192H295N59O60S | 4421.86 | |
Oxymorphone D3 | 145225-02-1 | C18H18D3NO4 | 318.36 | (4S,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-(trideuteriomethyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride Roxicodone-d3 Stupenone-d3 Dinarkon-d3 Endone-d3 Thecodine-d3 Base Dihydrone-d3 Hydrochloride Dihydrooxyco |
Oxomemazine Impurity 2 HCl | 31412-48-3 | C6H14ClN.2HCl | 208.56 | |
Oxomemazine Impurity 1 (HCl) (salt) | 67952-96-9 | C8H20N2.2HCl | 217.18 | 1,3-Bis(dimethylaminomethyl)-2-methylpropane |
Oxomemazine Impurity | 5495-65-8 | C6H14ClN.HCl | 172.1 | 3-Chloro-N,N-Dimethyl-1-Butanamine HCl |
Oxomemazine HCl | 4784-40-1 | C18H22N2O2S.HCl | 366.91 | 3-(5,5-dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine hydrochloride (1:1) |
Oxolinic acid-D5 | 1189890-98-9 | 5-Ethyl-D5-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5- g]quinoline-7-carboxylic acid |
||
Oxolinic acid | 14698-29-4 | C13H11NO5 | 261.23 | 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid oxolinic acid 14698-29-4 Nidantin Dioxacin Emyrenil Prodoxal Prodoxol Gramurin Oxolinic Oksaren Ossian Uroxol Utibid Starner Ultibid Oxoboi Pietil Acido oxolinico Acide oxolin |
Oxirane-2,2,3-d3,3-(chloromethyl-d2)- | 69533-54-6 | C3Cl D5 O | 97.56 | EPICHLOROHYDRIN-D5; EPICHLOROHYDRIN-D5, 98 ATOM % D; Oxirane-d3, (chloromethyl-d2)-; Epichlorohydrin-d5, 97 atom % D (Stablilized with hydroquinone) |
Oxirane,methyl-,polymers,polymer with oxirane,ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) | 52624-57-4 | |||
Oxirane,2-[(2,2,3,3-tetrafluoropropoxy)methyl]- | 19932-26-4 | C6H8 F4 O2 | 188.12 | 3-(2,2,3,3-TETRAFLUOROPROPOXY)-1,2-EPOXYPROPANE; 3-(2,2,3,3-TETRAFLUOROPROPOXY)-1,2-PROPENOXIDE; 3-(2,2,2,3-TETRAFLUOROPROPOXY)-1,2-PROPENOXIDE; 2-(4,4,5,5-TETRAFLUORO-2-OXAPENTYL)OXIRANE; GLYCIDYL 2,2,3,3-TETRAFLUOROPROPYL ETHER; DAIKIN E-5244 |
Oxirane,2-(chloromethyl-d2)- | 83385-55-1 | C3H3 Cl D2 O | 94.54 | EPICHLOROHYDRIN-1,1-D2; Epichlorohydrin-1,1-d2, 97 atom % D (Stablilized with hydroquinone) |
Oxirane,2-(chloromethyl)-, homopolymer | 24969-06-0 | C3 H5 Cl O | 0 | Epoxy resin; EPICHLOROHYDRIN RESIN; POLYEPICHLOROHYDRIN; POLYEPICHLOROHYDRIN AVERAGE MW CA 700000 (GPC); (Chloromethyl)oxirane,homopolymer; (chloromethyl)-oxiranhomopolymer; Epichlorohydrinhomopolymer; Oxirane,(chloromethyl)-,homopolymer |
Oxirane,2-(2-bromoethyl)-, (2S)- | 61847-07-2 | C4H7 Br O | 151 | OXIRANE, (2-BROMOETHYL)-, (S); (S)-4-BROMO-1,2-EPOXYBUTANE; S(-)-4-BROMO-1,2-EPOXYBUTANE; (S)-(2-BROMOETHYL)OXIRANE; S(-)-(2-BROMOETHYL)OXIRANE |
Oxirane, methyl-, polymer with oxirane, mono(3-(1,3,3,3-tetramethyl-1-((trimethylsilyl)oxy)disiloxanyl)propyl) ether | 134180-76-0 | C15H38O5Si3 | 382.7157 | Oxirane, methyl-, polymer with oxirane, mono3-1,3,3,3-tetramethyl-1-(trimethylsilyl)oxydisiloxanylpropyl ether; heptamethyltrisiloxane, ethoxylate,propoxylate allyl ether |
Oxirane, 2-propyl-,(2R)- | 139406-51-2 | C5H10 O | 86.13 | (R)-1,2-EPOXYPENTANE |
Oxirane, 2-ethenyl- | 930-22-3 | C4H6 O | 70.10 | (R,S)-2-Vinyl-oxirane; 1,2-Epoxy-3-butylene; 1,2-epoxybutene; 1,2-Epoxybutene-3; 1,2-Oxido-3-butene; 1,3-Butadiene monooxide; 1,3-Butadiene oxide; 1,3-butadieneoxide |
Oxirane, (1-methoxyethyl)- (9CI) | 143587-91-1 | C5H10 O2 | 102.1317;g/mol | 2-(1-methoxyethyl)oxirane; Oxirane,2-(1-methoxyethyl)-; OXIRANE,(1-METHOXYETHYL)-(9CI); 143587-91-1; ACMC-1C67X; SCHEMBL6443137 |
oxiran-2-ylmethyl nitrate | 6659-62-7 | C3H5NO4 | 119.076 g/mol | |
oxiran-2-ylmethyl 2-ethyl-2,5-dimethylhexanoate | 26761-45-5 | C13H24O3 | 228.33 | 2,3-Epoxypropyl neodecanoate; Glycidyl ester of versatic acid; Glycidyl neodecanoate |
Oxiracetam Related Compound 3 | 62833-66-3 | C6H8N2O2 | 140.14 | |
Oxiracetam Impurity D | 870695-39-9 | C8H13NO4 | 187.2 | |
Oxiracetam Impurity C | 85614-52-4 | C7H11NO4 | 173.17 | methyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate; Methyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate; Methyl 4-hydroxy-2-oxopyrrolidine-1-acetate; AK102154 |
Oxiracetam Impurity B | 77191-37-8 | C6H9NO4 | 159.14 | 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetic acid; 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetic acid; 4-HYDROXY-2-OXO-1-PYRROLIDINEACETIC ACID; BRN 5333573; (+-)-4-Hydroxy-2-oxo-1-pyrrolidineacetic acid |
Oxiracetam Impurity A | 68108-18-9 | C4H7NO2 | 101.11 | (S)-4-Hydroxy-2-pyrrolidinone |
Oxidase, reducednicotinamide adenine dinucleotide | 9032-21-7 | 0 | NICOTINAMIDE-ADENINE DINUCLEOTIDE OXIDASE; NADH OXIDASE; NADH OXIDASE, BACILLUS LICHENIFORMIS; NADH Oxidase, Bacillus lichenformis; NADH Oxidase from Bacillus licheniformis | |
Oxidase, D-amino acid | 9000-88-8 | C9H20N2O2 | 0 | EC 1.4.3.3; D-AMINO ACID OXIDASE TV; D-AMINO ACID:OXYGEN OXIDOREDUCTASE; D-AMINO ACID : OXYGEN OXIDOREDUCTASE (DEAMINATING); D-AMINO ACID OXIDASE; D-AMINO ACID OXIDASE, CARRIER-FIXED; D-AMINO ACID OXIDASE, IMMOBILIZED; D-AAO |
OXi-4503 sodium | 288847-34-7 | C18H22Na4O12P2 | 584.23 | sodium (Z)-3-methoxy-6-(3,4,5-trimethoxystyryl)-1,2-phenylene bis(phosphate); OXi4503; OXi-4503; OXi 4503; OXi-4503 sodium, CA1P; Combretastatin A-1 phosphate. |
OXi-4503 | 288847-35-8 | C18H22O12P2 | 492.31 | OXi4503; OXi 4503; CA1P; tetrasodium [3-methoxy-2-phosphonatooxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] phosphate |
Oxfendazole-D3 | 1228182-54-4 | (5-Benzenesulfinyl-1H- benzoimidazol-2-yl)- carbamic acid methyl-D ester; Fenbendazole sulfoxide-D3 | ||
Oxfendazole | 53716-50-0 | C15H13N3O3S | 315.35 | RS-8858 |
Oxethazaine | 126-27-2 | C28H41N3O3 | 467.65 | OXETHAZAINE;OXETHAZINE;OXETACAINE;2,2'-((2-hydroxyethyl)imino)bis(n-(1,1-dimethyl-2-phenylethyl)-n-methylaceta;2,2'-((2-hydroxyethyl)imino)bis(n-(alpha,alpha-dimethylphenethyl)-n-acetamid;2,2'-((2-hydroxyethyl)imino)bis(n-(alpha,alpha-dimethylphenethyl)- |
Oxepinac | 55689-65-1 | C16H12O4 | 268.267 | |
Oxeladin Citrate | 52432-72-1 | C20H33NO3.C6H8O7 | 527.61 | 2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate;2-hydroxypropane-1,2,3-tricarboxylic acid; |
Oxeladin | 468-61-1 | C20H33NO3 | 335.488 | Oxeladina; Oxeladine; Oxeladinum; 2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate |
Oxcarbazepine-d4 | 1020719-71-4 | C15H8N2O2D4 | 256.3 | 10,11-Dihdyro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide-d4; Aurene-d4; GP 47680-d4 |
Oxcarbazepine Related Compound A | 1346601-76-0 | C16H12N2O3 | 280.29 | N-Formyl-10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide; N-Formyl Oxcarbazepine |
Oxcarbazepine N-Sulfate | 1159977-54-4 | C15H12N2O5S | 332.33 | N-[(10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepin-5-yl)carbonyl]sulfamic Acid; |
Oxcarbazepine Impurity (10-Keto-iminodibenzyl) | 21737-58-6 | C14H11NO | 209.25 | 5,11-Dihydro-10H-dibenz[b,f]azepin-10-one; USP Oxcarbazepine Related Compound E; Dibenzazepinone |
Dibenzazepine-10,11-dione | 19579-83-0 | C14H9NO2 | 223.23 | 5H-Dibenz[b,f]azepine-10,11-dione; Dibenzazepine-10,11-dione; Dibenzazepinodione |
Oxcarbazepine EP Impurity G | 15882-79-8 | C17H17NO | 251.33 | |
Oxcarbazepine EP Impurity F | 28721-08-6 | C16H12ClNO2 | 285.73 | |
Oxcarbazepine enol-sulfate | 104746-00-1 | C15H12N2O5S | 332.34 | 10-(Sulfooxy)-5H-dibenz[b,f]azepine-5-carboxamide |
Oxcarbazepine | 28721-07-5 | C15H12N2O2 | 252.27 | GP47680; GP 47680; GP-47680 |
Oxazolo[5,4-c]pyridine,4,5,6,7-tetrahydro-2-methyl- | 886371-60-4 | C7H10 N2 O | 138.16700 | |
Oxazolidinone Dimer Impurity | 914777-33-6 | C21H20F2O3 | 358.39 | 1,9-bis(4-fluorophenyl)nonane-1,5,9-trione ; 1,9-Di-(4-fluorophenyl)-1,5,9-trioxononane. |
Oxazolidine-4-carboxylic acid hydrochloride | 162285-30-5 | C4H7 N O3 . Cl H | 153.56422;g/mol | 1,3-oxazolidine-4-carboxylicacid;hydrochloride;OXAZOLIDINE-4-CARBOXYLICACIDHYDROCHLORIDE;162285-30-5;C4H8ClNO3;CTK7J0696 |
Oxazole-5-carbonitrile | 68776-61-4 | C4H2N2O | 94.07 | OXAZOLE-5-CARBONITRILE |
OTX008 | 286936-40-1 | C52H72N8O8 | 937.18 | Acetamide, 2,2',2'',2'''-[pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetrayltetrakis(oxy)]tetrakis[N-[2-(dimethylamino)ethyl]-.; OTX-008; OTX 008; OTX008; PTX008; PTX-008; PTX 008; cali |
OTSSP167 hydrochloride | 1431698-10-0 | C25H29Cl3N4O2 | 523.88 | 4-[7-acetyl-8-[[4-[(dimethylamino)methyl]cyclohexyl]amino]-1H-1,5-naphthyridin-2-ylidene]-2,6-dichlorocyclohexa-2,5-dien-1-one;hydrochloride OTSSP167 (hydrochloride) UNII-65P731R507 65P731R507 OTSSP167 HCL OTS-167 monohydrochloride HY-15512A AKOS02 |
OTSSP167 | 1431697-89-0 | C25H28Cl2N4O2 | 487.425 | 1-(6-(3,5-dichloro-4-hydroxyphenyl)-4-(((1r,4r)-4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)ethanone; OTSSP167 free base; OTSSP 167; OTSSP-167; OTS167; OTS-167; OTS 167 |
OTS-964 | 1338545-07-5 | C23H25ClN2O2S | 428.97 | OTS964 |
OTS964 | 1338542-14-5 | C23H24N2O2S | 392.5 | OTS-964; OTS 964; 9-[4-[(2R)-1-(dimethylamino)propan-2-yl]phenyl]-8-hydroxy-6-methyl-5H-thieno[2,3-c]quinolin-4-one |
Osthenone | 112789-90-9 | C14H12O4 | 244.246 | 7-Methoxy-8-[(E)-3-oxobut-1-enyl]chromen-2-one |
Osthenol | 484-14-0 | C14H14O3 | 230.3 | 7-hydroxy-8-prenylcoumarin |
Orthohydroxyatorvastatin | 214217-86-4 | C33H35FN2O6 | 574.649 | O-Hydroxyatorvastatin; 2-Hydroxy Atorvastatin; (3R,5R)-7-(2-(4-fluorophenyl)-4-(2-hydroxyphenylcarbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
Ortho-Hydroxy Atorvastatin Lactone | 163217-74-1 | C33H33FN2O5 | 556.64 | 2-Hydroxy Atorvastatin Lactone(EP); Atorvastatin 2-Hydroxy Lactone; 5-(4-Fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; O-Hydroxy Atorvastatin Lactone |
ortho-Hydroxy Atorvastatin Calcium Salt | 214217-86-6 | C66H68CaF2N4O12 | 1187.36 | 2-hydroxy Atorvastatin Calcium salt; Sodium (3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-phenyl-1Hp-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
ortho-Hydroxy Atorvastatin Calcium Salt | 265989-46-6 | C66H68CaF2N4O12 | 1187.36 | 2-hydroxy Atorvastatin Calcium salt; Sodium (3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-phenyl-1Hp-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
ortho-Gliclazide | 1076198-18-9 | C15H21N3O3S | 323.42 | Gliclazide impurity F; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-2-methylbenzenesulfonamide; 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-o-tolylsulphonylurea |
Ornidazole Epoxide | 16773-52-7 | C7H9N3O3 | 183.17 | 2-Methyl-5-nitro-1-(2-oxiranylmethyl)-1H-imidazole; 1-(2,3-Epoxypropyl)-2-methyl-5-nitro-imidazole; 1-(2,3-Epoxypropyl)-2-methyl-5-nitroimidazole; |
Ornidazole Diol | 62580-80-7 | C7H11N3O4 | 201.18 | 3-Deschloro-3-hydroxy Ornidazole; 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-propanediol; |
Ornidazole | 16773-42-5 | C7H10ClN3O3 | 219.63 | Ro7-0207, NSC 95075; Ro 7-0207, NSC95075; Ro-7-0207, NSC-95075 |
Ormetoprim | 6981-18-6 | C14H18N4O2 | 274.32 | 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine |
Ormeloxifene | 78994-24-8 | C30H35NO3 | 457.60400 | |
Ormaplatin | 62816-98-2 | C6H14Cl4N2Pt | 451.083 | Ormaplatin; tetraplatin |
ORM-15341 | 1297537-33-7 | C19H17ClN6O2 | 396.83 | UNII-9EPS75QMTL; ORM-15341; 9EPS75QMTL; SCHEMBL1815556; GMBPVBVTPBWIKC-NSHDSACASA-N; CS-5191 |
Orlistat-d3 | 1356930-46-5 | C29H50NO5D3 | 498.77 | N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester-d3; (-)-Tetrahydrolipstatin-d3; Ro 18-0647/002-d3; Tetrahydrolipstatin-d3; Xenical-d3 |
Orlistat USP Related Compound E | 1072902-75-0 | C29H53NO5 | 495.75 | L-Isoleucine Orlistat; N-Formyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester; |
Orlistat USP Related Compound B (Diisopropyl Hydrazine-1, 2-Dicarboxylate) | 19740-72-8 | C8H16N2O4 | 204.23 | Bicarbamic Acid Diisopropyl Ester; 1,2-Hydrazinedicarboxylic Acid 1,2-Bis(1-methylethyl) Ester; 1,2-Hydrazinedicarboxylic Acid Bis(1-methylethyl) Ester; Bis(1-methylethyl) hydrazine-1,2-dicarboxylate; |
Orlistat Related Compound D | 130793-27-0 | C29H53NO5 | 495.75 | N-Formyl-L-leucine (3S,4R,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester; Orlistat USP Related Compound D |
Orlistat Related Compound [(S)-3-Hexyl-5,6-dihydro-6-undecyl-2H-pyran-2-one] | 130676-64-1 | C22H40O2 | 336.56 | (S)-3-Hexyl-5,6-dihydro-6-undecyl-2H-pyran-2-one; |
Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid) | 130793-28-1 | C29H55NO6 | 513.76 | (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid; |
Orlistat Impurity M1 | 130676-66-3 | C29H55NO6 | 513.76 | (2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid; N-Formyl-L-leucine(1S)-1-[(2S,3S)-3-carboxy-2-hydroxynonyl]dodecyl Ester; 5-(Formamido-4-methylpentanoyloxy)-2-hexyl-3-hydroxyhexadecanoic Acid; Orlistat Impurity M1; |
Orlistat Impurity 2 | 130676-63-0 | C28H53NO3 | 451.74 | N-Formyl-L-leucine [S-(E)]-1-(2-Nonenyl)dodecyl Ester; |
Orlistat Dimer Impurity | 881900-54-5 | C57H106N2O9 | 963.49 | O5-(N-Formyl-L-leucyl)-(2S,3S,5S)-2-hexyl-3,5-dihydroxyhexadecanoyl-L-leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester; |
Orexin B (human) | 205640-91-1 | C123H212N44O35S | 2899.36 | |
Orexin 2 Receptor Agonist | 1796565-52-0 | C32H34N4O5S | 586.707 | CHEMBL3623075; N-[2-[3-[[5-[3-(dimethylcarbamoyl)phenyl]-2-methoxyphenyl]sulfonylamino]anilino]ethyl]-3-methylbenzamide; GTPL9305; SCHEMBL18138813 |
Oregonin | 55303-93-0 | C24H30O10 | 478.494 | (5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyheptan-3-one |
Ordopidine | 871351-60-9 | C14H20FNO2S | 285.38 | ACR 325; 1-Ethyl-4-(2-fluoro-3-(methylsulfonyl)phenyl)piperidine |
Orciprenaline | 586-06-1 | C11H17NO3 | 211.26 | Metaproterenol;Alupent;Metaprel;5-[1-Hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;Astmopent;1-(3,5-dihydroxyphenyl)-2-isopropylaminoethanol;1,3-Benzenediol, 5-1-hydroxy-2-(1-methylethyl)aminoethyl-;3,5-Dihydroxy-a-[(isopropylamino)methyl]benzyl alco |
Orcinol Gentiobioside | 164991-86-0 | C19H28O12 | Anacardoside | |
Orbifloxacin | 113617-63-3 | C19H20F3N3O3 | 395.38 | N/A |
Oracet blue B | 12769-16-3 | C21H16N2O2 | 328.36 | LABOTEST-BB LT00847534; ORACET BLUE; ORACET BLUE B; ORACET BLUE B FOR MICROSCOPY; C.I. Solvent Blue 19; 1-Anilino-4-(methylamino)anthraquinone, Disperse blue 24, Solvent blue 19 |
Optovin | 348575-88-2 | C15H13N3OS2 | 315.41 | |
Optical brightener BA (C.I.28/113) | 4193-55-9 | C40H42N12O10S2.2Na | 960.95 | 2,2'-(1,2-Ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]benzenesulfonicacid,disodiumsalt; 3,5-triazin-2-yl]amino]--6-(phenylamino)-disodiumsalt; 4,4'-bis((4-anilino-6-bis(2-hydroxyethyl)amino-s-2'-stilbenedisulfon |
ONO-7300243 | 638132-34-0 | C28H31NO5 | 461.55 | 2-[4-[[(3,5-dimethoxy-4-methylbenzoyl)-(3-phenylpropyl)amino]methyl]phenyl]acetic acid; ONO-7300243; ONO 7300243; ONO7300243 |
ONO-5334 | 868273-90-9 | C21H34N4O4S | 438.59 | N-((S)-3-(2-((R,Z)-3,4-dimethylthiazolidin-2-ylidene)hydrazinyl)-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl)cycloheptanecarboxamide |
ONO-4059 analogue | 1351635-67-0 | C25H24N6O3 | 456.5 | ONO-WG-307 |
ONO-4059 (hydrochloride) | 1439901-97-9 | C25H23ClN6O3 | 490.95 | (R)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one hydrochloride; ONO-4059 HCl; ONO4059; ONO 4059; ONO-4059; GS 4059; GS-4059; GS4059; ONO-WG-307; Tirabrutinib |
ONO-4059 | 1351636-18-4 | C25H22N6O3 | 454.48 | (R)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; ONO-4059; ONO4059; ONO 4059; ONO-4059; GS 4059; GS-4059; GS4059; ONO-WG-307; Tirabrutinib |
ONO-4057 | 134578-96-4 | C27H34O7 | 470.56 | Ono-LB-457; (E)-5-(2-(2-carboxyethyl)-3-((6-(4-methoxyphenyl)hex-5-en-1-yl)oxy)phenoxy)pentanoic acid |
Ono-4007 sodium salt | 152646-95-2 | C50H78NNaO12S | 940.21 | Sodium 2-deoxy-3-O-(9-phenylnonanoyl)-2-({(3S)-3-[(9-phenylnonanoyl)oxy]tetradecanoyl}amino)-4-O-sulfonato-D-glucose; Ono4007 sodium; Ono 4007 sodium |
ONO3708 | 102191-05-9 | C23H37NO4 | 391.55 | Ono-3708;5-Heptenoic acid, 7-((1S,2S,3S,5R)-3-(((2R)-cyclopentylhydroxyacetyl)amino)-6,6-dimethylbicyclo(3.1.1)hept-2-yl)-, (5Z)-;(Z)-7-[(1R,3S,4S,5S)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethyl-4-bicyclo[3.1.1]heptanyl]hept-5-enoic acid |
ONO-2050297 | 1637756-67-2 | C30H32N2O7 | 532.59 | ONO-2050297; ONO 2050297; ONO2050297; (S)-4-(3-carboxypropyl)-8-(4-(4-phenylbutoxy)benzamido)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylic acid |
ONO-1301 | 176391-41-6 | C27H26N2O4 | 428.48 | Ono1301; Ono-1301; Ono 1301; 7,8-Dihydro-5-[(E)-[[-(3-pyridyl)benzylidene]aminooxy]ethyl]-1-naphthyloxy]acetic acid |
Ono-1082 | 111111-04-7 | C30H49NO7 | 535.72 | N-(7-((1R,2R,3R)-2-((1E,3S)-3-((1S,3S)-3-Butylcyclopentyl)-3-hydroxy-1-propenyl)-3-hydroxy-5-oxocyclopentyl)-1,6-dioxoheptyl)-L-leucine;(2S)-2-[[7-[(2R,3R)-2-[(E,3S)-3-(3-butylcyclopentyl)-3-hydroxyprop-1-enyl]-3-hydroxy-5-oxocyclopentyl]-6-oxoheptanoyl]a |
ONO EI-601 | 155023-59-9 | C15H14N2O6S | 350.35 | Ono-EI-601; Ono EI-601; AC1MHG4J; N-(2-(p-Hydroxyphenylsulfonylamino)benzoyl)glycine; N-(2-(((4-Hydroxyphenyl)sulfonyl)amino)benzoyl)glycine |
Omeprazole Sulfide-D3 | 922730-98-1 | C17H16D3N3O2S | 332.44 | 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole-d3; 2-[[(3,5-Dimethyl-4-methoxy-2-pyridyl)methyl]thio]-5-methoxybenzimidazole-d3; Pyrmetazole-d3; Ufiprazole-d3 |
Olinone | 1770789-37-1 | C17H21N3O2 | 299.37 | Olinone; SCHEMBL16771423; N-[4-(1-Oxo-1,2,3,4-Tetrahydro-5h-Pyrido[4,3-B]indol-5-Yl)butyl]acetamide |
OLIGOTHYMIDYLIC ACID D(PT)4 SODIUM | 159964-43-9 | C40H54N8NaO29P4 | 1257.777777;g/mol | [2-[[hydroxy-[2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl][5-(5-methyl-2,4 |
Oligomycin E | 110231-34-0 | C45H72O13 | 821.1 | 26-hydroxy-28-oxooligomycin A. |
Oligomycin D | 1404-59-7 | C44H72O11 | 777.0 | Rutamycin, 26-demethyloligomycin A, A 272, RR 32705, Rutamycin A |
Oligomycin C | 11052-72-5 | C45H74O10 | 775.1 | 12-Deoxyoligomycin A |
Oligomycin B | 11050-94-5 | C45H72O12 | 805.1 | |
Oligomycin A | 579-13-5 | C45H74O11 | 791.06 | MCH 32 |
Oligomycin | 1404-19-9 | C45H74O11 | 791.06 | RK3325000 |
Oligo(2-(2-ethyoxy)ethoxyethylguanidium chloride) | 374572-91-5 | (C6H16N2O2)x.(CH5N3)x.x(HCl) | 0 | 2,2'-[1,2-Ethanediylbis(oxy)]bisethanamine polymer with guanidine monohydrochloride; Oligo(2-(2-ethyoxy)ethoxyethylguanidium chloride) |
Oleyloxyethyl phosphorylcholine | 84601-19-4 | C25H52NO5P | 477.7 | 2-Oleyloxyethyl 2-trimethylammonioethyl phosphate; 2-[(Z)-octadec-9-enoxy]ethyl 2-(trimethylazaniumyl)ethyl phosphate |
Oleylethanolamide | 111-58-0 | C20H39NO2 | 325.53 | (9Z)-N-(2-Hydroxyethyl)-9-octadecenamide |
oleylamine | 1838-19-3 | C18H37N | 267.497 | |
Oleyl trifluoromethyl ketone | 177987-23-4 | C19H33F3O | 334.5 | Heptadecyl trifluoromethyl ketone; OTK; (Z)-1,1,1-Trifluoro-nonadec-10-en-2-one |
Oleyl palmitylamide | 16260-09-6 | C34H67NO | 505.909 | (Z)-N-octadec-9-enylhexadecan-1-amide; OLEYL PALMITAMIDE; Hexadecanamide, N-(9Z)-9-octadecenyl-; OLEYLPALMITOAMIDE; (Z)-N-Octadec-9-enylhexadecan-1-amid; (z)-hexadecanamid; N-9-octadecenyl-, (Z)-Hexadecanamide; (Z)-N-9-OCTADECENYLHEXADECANAMIDE |
Oleyl oleate | 3687-45-4 | C36H68O2 | 532.92 | Oleic acid oleyl ester |
Oleyl methanesulfonate | 35709-09-2 | C19H38O3S | 346.57 | methanesulfonate,(z)-9-octadecen-1-o; OLEYL METHANE SULFATE; METHANESULFONIC ACID OLEYL ESTER; CIS-9-OCTADECENYL METHANESULFONATE; oleyl methanesulphonate; oleyl mesylate; (Z)-9-Octadecen-1-ol methanesulfonate |
Oleyl bis-(2-hydroxyethyl) amine | 25307-17-9 | C22H45NO2 | 355.5982 | 2,2'-(octadec-9-enylimino)bisethanol; Ethanol, 2,2-(9-octadecenylimino)bis-; ARMOSTAT710; 2,2'-(9-octadecenylimino)bis-Ethanol; bis(2-hydroxyethyl)oleylamine |
Oleyl bis-(2-hydroxyethyl) methyl ammonium chloride | 18448-65-2 | C23H48ClNO2 | 406.08572 | bis(hydroxyethyl)methyloleylammonium chloride; Oleylbis(2-hydroxyethyl)methylammoniumchloride; 9-Octadecen-1-aminium, N,N-bis(2-hydroxyethyl)-N-methyl-, chloride, (9Z)-; (Z)-N,N-BIS(2-HYDROXYETHYL)-N-METHYL-9-OCTADECEN-1-AMINIUM CHLORIDE; N,N-Bis-(2-hydro |
Oleyl anilide | 5429-85-6 | C24H39NO | 357.6 | OA; Oleic acid anilide; Cis-9-octadecenanilide; (Z)-N-phenyloctadec-9-enamide |
Oleyl amine ethoxylate (3-50EO) | 68155-39-5 | C18H37NO | 283.4925 | Oleyl amine ethoxylate (3-50EO); Oleyl amine ethoxylate ether (5EO) |
OLETH-2 | 5274-65-7 | C22H44O3 | 356.58296;g/mol | 2-[2-[(Z)-octadec-9-enoxy]ethoxy]ethanol; UNII-7L6R1SQ6M0; 7L6R1SQ6M0; 5274-65-7; Genapol2; Oleth-2 |
Olean-12-en-28-oicacid,22-(acetyloxy)-3-hydroxy-21-[[(2Z,4E)-6-methyl-1-oxo-2,4-octadienyl]oxy]-, (3b,21b,22a)- (9CI) | 29038-41-3 | C41H62 O7 | ||
Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)- | 102519-34-6 | C30H48O5 | 488.7 | |
Oleamide | 301-02-0 | C18H35NO | 281.48 | cis-9-Octadecenamide |
OLDA | 105955-11-1 | C26H43NO3 | 417.63 | (9Z)-N-[2-(3,4-Dihydroxyphenyl)ethyl]-9-octadecenamide |
Olcegepant hydrochloride | 586368-06-1 | C38H47Br2N9O5.HCl | 906.11 | N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide;hydrochloride; Olcegepant (hydrochloride); Olcegepant hydrochlo |
Olcegepant | 204697-65-4 | C38H47Br2N9O5 | 869.65 | N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide Olcegepant Olcegepant [INN] BIBN-4096BS BIBN 4096 BS CHEMB |
olaratumab | 1024603-93-7 | C6554H10076N1736O2048S40 | 147200 | |
Olaquindox-D4 | 1189487-82-8 | 3-Methyl-quinoxaline-2- carboxylic acid (2- hydroxy-ethyl-D4)-amide 1,4-dioxide | ||
Olaquindox | 23696-28-8 | C12H13N3O4 | 263.25 | N-(2-HYDROXYETHYL)-3-METHYL-2-QUINOXALINECARBOXAMIDE 1,4-DIOXIDE;OLAGUINDOX; OLAQUINDOX;2-(n-(2-hydroxyethyl)karbamoyl)-3-methylchinoxalin-1,4-dioxid; 2-quinoxalinecarboxamide,n-(2-hydroxyethyl)-3-methyl-,1,4-dioxide;bayernox;bayonox; bisergon |
o-Flutamide | 151262-93-0 | C11H11F3N2O3 | 276.22 | 2-Methyl-N-[2-nitro-5-(trifluoromethyl)phenyl]propanamide; NSC 674689; Flutamide EP Impurity F |
ODQ | 41443-28-1 | C9H5N3O2 | 187.16 | 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one |
Odorine | 72755-20-5 | C18H24N2O2 | 300.4 | (S)-2-Methyl-N-[(2R)-1-[(E)-1-oxo-3-phenyl-2-propenyl]pyrrolidin-2-yl]butanamide; |
Odoriflavene | 101153-41-7 | C17H16O5 | 300.31 | 7,2'-Dihydroxy-3',4'-dimethoxyisoflav-3-ene |
Odoratisol A | 891182-93-7 | C21H24O5 | 356.418 | 2,6-dimethoxy-4-[(2S,3S)-7-methoxy-3-methyl-5-[(E)-prop-1-enyl]-2,3-dihydro-1-benzofuran-2-yl]phenol |
ODM-201 | 1297538-32-9 | C19H19ClN6O2 | 389.85 | ODM-201; ODM 201; ODM201. |
odiparcil | 137215-12-4 | C15H16O6S | 324.35 | GSK-424323;4-methyl-7-(((2R,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-thiopyran-2-yl)oxy)-2H-chromen-2-one |
O-diacetyldaurisoline | 132139-17-4 | C41H46N2O8 | 694.82 | O,O-bisacetyldaurisoline |
O-Desmorpholinopropyl Gefitinib | 184475-71-6 | C15H11ClFN3O2 | 319.72 | O-Desmorpholinopropyl Gefitinib; FAAH-IN-2; FAAH IN 2 |
O-Desmethyl-N,N-didesmethyl venlafaxine HCl | 135308-76-8 | C14H21NO2.HCl | 271.79 | D,L-N,N-Didesmethyl-O-desmethyl Venlafaxine Hydrochloride; 4-[2-Amino-1-(1-hydroxycyclohexyl)ethyl]phenol Hydrochloride |
Octylacrylamide/acrylates/butylaminoethyl methacrylate copolymer | 70801-07-9 | C36H64N2O10 | ||
Octyl stearate | 109-36-4 | C26H52O2 | 396.6899 | OCTYL STEARATE; OCTADECANOIC ACID OCTYL ESTER; OCTYL OCTADECANOATE |
Octanoic acid-1,2,3,4-13C4 | 159118-65-7 | C8H16O2 | 148.18 | Caprylic acid-1,2,3,4-13C4 |
Octanoic acid,7-hydroxy- | 17173-14-7 | C8H16 O3 | 160.21 | 7-hydroxyoctanoicacid;7-Hydroxyoctanoicacid;7-hydroxy-octanoicacid;7-hydroxyoctans;Octanoicacid,7-hydroxy-;17173-14-7 |
Octanoic acid,3-hydroxy-, methyl ester | 7367-87-5 | C9H18 O3 | 174.2374 | |
Octanesulfonic acid | 3944-72-7 | C8H18O3S | 194.29 | 1-octanesulfonic acid solution; 1-OCTANE SULFONIC ACID; OCTANESULFONIC ACID; octanesulphonic acid; 1-OCTANESULPHONICACID; Octane-1-sulfonic acid |
Octanedioic acid,1,8-diethyl ester | 2050-23-9 | C12H22 O4 | 230.3 | HEXANE-1,6-DICARBOXYLIC ACID DIETHYL ESTER; ETHYL SUBERATE; DIETHYL OCTANEDIOATE; DIETHYL SUBERATE; SUBERIC ACID DIETHYL ESTER; OCTANEDIOIC ACID DIETHYL ESTER |
Octanedioic acid calcium salt (1:1) | 27796-71-0 | C8H12CaO4 | 212.26 | Octanedioic acid calcium salt (1:1) |
Octanedial | 638-54-0 | C8H14O2 | 142.196 g/mol | |
Octane, 1-methoxy- | 929-56-6 | C9H20 O | 144.25 | 1-METHOXYOCTANE; Ether, methyl octyl; Methyl octyl ether; Methyloctylether; n-Octyl methyl ether; Octyl methyl ether |
OCTANAL DIMETHYL ACETAL | 10022-28-3 | C10H22O2 | 174.28 | 1,1-Dimethoxyoctane, Aldehyde C-8 dimethyl acetal, OCTANAL DIMETHYL ACETAL, Octanal DMA, Octane, 1,1-dimethoxy- |
Octanal 2,4-dinitrophenylhydrazone | 1726-77-8 | C14H20N4O4 | 308.33 | Octanal2,4-dinitrophenylhydrazone; 1726-77-8; NSC402247; AC1NSMMX; AC1Q1ZLP; Octylaldehyde-2,4-DNPH |
Octamethyltrisiloxane | 107-51-7 | C8H24O2Si3 | 236.53146;g/mol | OCTAMETHYLTRISILOXANE; 107-51-7; DIMETHICONE; Dimethicones; Dimeticone; Trisiloxane,octamethyl- |
oCtakis(trimethylsiloxy)silsesquioxane | 51777-38-9 | C24H72O20Si16 | 1130.18 | OCTAKIS(TRIMETHYLSILOXY)SILSESQUIOXANE; Octakis[(trimethylsilyl)oxy]-pentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane; Q8M8; Octakis(trimethylsiloxy)silsesquioxane,min.94%; Octakis(trimethylsiloxy)silsesquioxane, min. 94% |
Octakis(6-deoxy-6-amino)-gamma-cyclodextrin octahydrochloride | 156297-62-0 | C48H96O32N8Cl8 | 1580.9 | |
Octahydroindolizine | 13618-93-4 | C8H15N | 125.211 g/mol | OCTAHYDROINDOLIZINE; Indolizidine; 13618-93-4; Indolizine,octahydro-; .delta.-Coniceine; 1-Azabicyclo[4.3.0]nonane |
Octahydrocurcumin | 36062-07-4 | C21H28O6 | 376.44 | Hexahydrobisdemethoxycurcumin |
octahydro-4,7-methano-1H-indenedimethanol | 26160-83-8 | C12H20O2 | 196.286 | octahydro-4,7-methano-1H-indenedimethanol; TCDALCOHOLDM; dimethyloltricyclo(5.2.1.0(2,6))decane; hexahydro-4,7-methanoindandimethanol; hexahydro-7-methanoindandimethanol |
Octahydro-4,7-methano-1H-indenedimethanamine | 68889-71-4 | C12H22N2 | ||
OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID | 80828-13-3 | C9H15NO2 | 169.22 | OCTAHYDRO-INDOLE-2-CARBOXYLIC ACID; OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID; (S) OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID; H-OIC-OH; (2S,3ALPHA-S,7ALPHA-S)-OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID; (2S,3AS,7AS)-2-CARBOXYOCTAHYDROINDOLE; Octahydro-1H-2-carboxylic |
octahydro[1,2,4,5]tetrazino[1,2-a][1,2,4,5]tetrazine | 1743-13-1 | C4H12N6 | 144.181 | octahydro[1,2,4,5]tetrazino[1,2-a][1,2,4,5]tetrazine; Tetraformaltrisazine; TETRAFORMYLTRISAZINE |
Octafluorotetrahydrofuran | 773-14-8 | C4F8O | 216.027 | |
Octafluoropentyl acrylate | 376-84-1 | C8H6F8O2 | 286.12 | DAIKIN R-5410; ACRYLIC ACID 1H,1H,5H-OCTAFLUOROPENTYL ESTER; 1H,1H,5H-OCTAFLUOROPENTYL ACRYLATE; 2,2,3,3,4,4,5,5-OCTAFLUOROPENTYL ACRYLATE; 2-Propenoic acid, 2,2,3,3,4,4,5,5-octafluoropentyl ester; acrylicacid2,2,3,3,4,4,5,5-octafluoro-pentylester |
Octafluoropentane-2,3-dione | 74728-95-3 | C5F8O2 | 244.04 | octafluoro-2,3-pentadione; OCTAFLUORO-2,3-PENTANEDIONE; OCTAFLUOROPENTANE-2,3-DIONE; Octafluoropentadione; Octafluoropentane-2,3-dione 97%; Octafluoropentane-2,3-dione97% |
Octafluorocyclopentene | 559-40-0 | C5F8 | 212.04 | Octafluorocyclopentene; Perfluorocyclopentene |
Octadecyl vinyl ether, polymer | 9003-96-7 | (C20H40O)n | 296.53100 | Octadecyl vinyl ether, polymer; Poly(vinyl stearyl ether) |
Octadecyl p-coumarate | 72943-88-5 | C27H44O3 | 416.646 | 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E)- |
Octadecyl caffeate | 69573-60-0 | C27H44O4 | 432.636 | Octadecyl (2E)-3-(3,4-dihydroxyphenyl)acrylate |
Octadecyl bis-(2-hydroxyethyl) methyl ammonium chloride | 3010-24-0 | C23H50ClNO2 | 408.1016;g/mol | bis(2-hydroxyethyl)-methyl-octadecylazanium; chloride; 1-Octadecanaminium,N,N-bis(2-hydroxyethyl)-N-methyl-,chloride; 3010-24-0; 1-Octadecanaminium,N,N-bis(2-hydroxyethyl)-N-methyl-,chloride(1:1); AC1Q1SPX |
Octadecyl amine ethoxylate ether (5,10,15,20, 25,60 EO) | 26635-92-7 | C26H55NO4 | 0 | Octadecyl amine ethoxylate ether (5,10,15,20, 25,60 EO); N,N'-bis-(Polyoxyethylene)stearylamine; Stearyl amine ethoxylate ether (5,10,15,20, 25,60 EO); Stearyl amine ethoxylate ether (5EO) |
Octadecyl 4-chlorobenzenesulfonate | 34184-41-3 | C24H41ClO3S | 445.10 | Octadecyl p-chlorobenzenesulfonate |
Octadecyl 3-mercaptopropionate | 31778-15-1 | C21H42O2S | 358.62 | 3-MERCAPTOPROPIONIC ACID OCTADECYL ESTER; STEARYL MERCAPTOPROPIONATE; OCTADECYL 3-MERCAPTOPROPIONATE; Stearyl 3-mercaptopropionate; 3-mercapto-propanoic acid octadecyl ester; Octadecyl 3-Mercaptopropionate (contains ca. 12% Hexadecyl 3-Mercaptopropionate) |
Octadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 135198-09-3 | C32H57NO9 | 599.8 | |
Oclacitinib Maleate | 1640292-55-2 | C15H23N5O2S.C4H4O4 | 453.51 | (Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide; PF-03394197 |
Oclacitinib maleate | 1208319-27-0 | C19H27N5O6S | 453.51 | (Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide; Oclacitinib (maleate) |
Oclacitinib | 1208319-26-9 | C15H23N5O2S | 337.442 | PF-03394197; JAKI; N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide |
NCX1022 | 571186-50-0 | C29H35NO9 | 541.59 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3-(nitrooxymethyl)benzoate |
NCX 4040 | 287118-97-2 | C16H13NO7 | 331.28 | 2-(Acetyloxy)benzoic acid 4-[(nitrooxy)methyl]phenyl ester |
NCT-503 | 1916571-90-8 | C20H23F3N4S | 408.48 | N-(4,6-dimethylpyridin-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]piperazine-1-carbothioamide |
NCT-502 | 1542213-00-2 | C18H20F3N5S | 395.4 | NCT 502; NCT502; N-(4,6-Dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamide |
NCT-501 | 1802088-50-1 | C21H32N6O3 | 416.52 | NCT501; NCT 501 |
Notexine Np | 37223-96-4 | 13574 | ||
N-Methyl-d3-piperazine | 1093380-08-5 | 103.18100 | ||
N-Methyl-d3-glycine-2,2-d2 HCl | 1219794-62-3 | 130.59 | Sarcosine-d5 HCl; N-Methylaminoacetic Acid-d5 HCl; H-Sar-OH-d5 HCl; N-Me-Gly-OH-d5 HCl; 2,2-dideuterio-2-(trideuteriomethylamino)acetic acid hydrochloride | |
N-Methyl-d3-glycine HCl | 347840-04-4 | 128.57 | Sarcosine-d3 HCl; N-Methylaminoacetic Acid-d3 HCl; H-Sar-OH-d3 HCl; N-Me-Gly-OH-d3 HCl; 2-(trideuteriomethylamino)acetic acid hydrochloride | |
N-Methyl-b-D-glucopyranosylamine (hydrochloride or other salt) | 114761-39-6 | C7H15NO5 HCl | 229.7 | |
N-Methylanabasine | 24380-92-5 | C11H16N2 | 176.261 | (-)-1-Methylanabasine; (-)-3-[(2S)-1-Methyl-2-piperidinyl]pyridine; [S-(-)]-Methylanabasine; 1-Methylanabasine; (S)-3-(1-Methyl-2-piperidinyl)pyridine; Pyridine, 3-(1-methyl-2-piperidinyl)-, (S)- |
NCB-0846 | 1792999-26-8 | C21H21N5O2 | 375.42 | 4-[2-(3H-benzimidazol-5-ylamino)quinazolin-8-yl]oxycyclohexan-1-ol |
N-Carboxymethylurea | 462-60-2 | C3H6N2O3 | 118.09 | Hydantoic acid; Carbamoylglycine; Glycoluric acid; N-Carbamylglycine; 2-(carbamoylamino)acetic acid |
N-Carboxymethyl-N'-(b-aminoethyl)piperazine | 87980-97-0 | C8 H17 N3 O2 | 187.23900 | |
N-CARBOXYGLYCINE DISODIUM SALT | 35783-03-0 | C3H3NNa2O4 | 163.04 | disodium; 2-(carboxylatoamino)acetate; N-Carboxyglycinedisodiumsalt; 35783-03-0; disodium2-(carboxylatoamino)acetate; N-carboxyglycinedisodium |
N-Carbobenzyloxy-L-valinyl-ganciclovir | 194154-40-0 | C22H28N6O7 | 488.50 | CBz-Valganciclovir; N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester; 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-3-hydroxy-1-propyl N-(benzyloxycarbonyl)-L-valinate; Cbz-Valine ganciclovi |
Ocinaplon | 96604-21-6 | C17H11N5O | 301.3 | 2-Pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]methanone |
Ocimene quintoxide | 7416-35-5 | C10H18O | 154.25 | (± )-2,2-Dimethyl-5-(1-methyl-1-propenyl)tetrahydrofuran |
Ochratoxin C | 4865-85-4 | C22H22ClNO6 | 431.9 | |
Ochratoxin B | 4825-86-9 | C20H19NO6 | 369.4 | |
Ochnaflavone | 50276-96-5 | C30H18O10 | 538.46 | 7-O-beta-D-gluco-pyranoside |
o-Chlorophenylacetyl chloride | 51512-09-5 | C8H6Cl2O | 189.03864 | 2-Chlorophenylacetyl chloride; 2-chlorobenzeneacetyl chloride; 2-Chlorophenylacetyl chloride,97%; 2-Chlorophenylacetyl chloride2-Chlorobenzeneacetyl chloride |
O-CHLOROPHENOLINDOPHENOL | 2582-41-4 | C12H8ClNO2 | 233.65 | O-CHLOROPHENOLINDOPHENOL |
o-Chlorobenzalmalononitrile | 2698-41-1 | C10H5ClN2 | 188.61300 | |
o-Chlorobenzaldehyde Oxime | 698-16-8 | C7H6ClNO | 155.58 | ALPHA-CHLOROBENZALDOXIME; -Chlorobenzaldehydeoxime; N-Hydroxybenzenecarboximidoylchloride; -Chlorobenzaldoxime; BenzohydroximoylChloride; o-Chlorobenzaldoxime; A-CHLOROBENZALDOXIME; Chlorophenylmethanone oxime |
Ocean Blue, SE | 215868-33-0 | C14H7F2NO7 | 339.2 | Pacific Blue succinimidyl ester; pacific blue N-hydroxysuccinimidyl ester; 3-Carboxy-6,8-difluoro-7-hydroxycoumaryl succinimidyl ester; (2,5-dioxopyrrolidin-1-yl) 6,8-difluoro-7-hydroxy-2-oxochromene-3-carboxylate |
OB 24 hydrochloride | 939825-12-4 | C15H17BrN2O2.HCl | 373.67 | 1-[[2-[2-(4-Bromophenyl)ethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazole hydrochloride |
O-Arachidonoyl ethanolamine hydrochloride | 443129-35-9 | C22H37NO2·HCl | 384 | O-AEA hydrochloride; Arachidonic acid-(2-aminoethyl)-ester hydrochloride; Virodhamine hydrochloride; 2-aminoethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate hydrochloride |
O,S-DIISOBUTYL METHYLPHOSPHONOTHIOATE | 100860-55-7 | C9H21O2PS | 224.3 | O,S-DIISOBUTYL METHYLPHOSPHONOTHIOATE; O,S-BIS(ISOBUTYL)METHYLPHOSPHONOTHIOATE |
o,o'-DioCtadecylpentaerythritol bis(phosphite) | 3806-34-6 | C41H82O6P2 | 733.03 | 3,9-BIS(OCTADECYLOXY)-2,4,8,10-TETRAOXA-3,9-DIPHOSPHASPIRO[5.5]UNDECANE; O,O'-Dioctadecylpentaerythritol bis(phosphite); 3,9-bis(octadecyloxy)-2,4,8,10-tetraoxa-3,9-dipho; 4,8,10-Tetraoxa-3,9-diphosphaspiro[5,5]undecane,3,9-bis(octadecyloxy)-2; 8,10-tetra |
O,O-Dimethyl dithiophosphate | 756-80-9 | C2H7O2PS2 | 158.17 | O,O-Dimethyl dithiophosphate; Di(methyl)dithiophosphoric acid |
O,O-Didesmethyl Omeprazole Sulfide | 176219-12-8 | C15H15N3O2S | 301.37 | 2-[[(4-Hydroxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazol-5-ol; |
O,O'-dibromobibenzyl | 59485-34-6 | C14H12Br2 | 340.053 g/mol | 1-bromo-2-[2-(2-bromophenyl)ethyl]benzene; Bibenzyl,2,2'-dibromo-; o,o'-Dibromobibenzyl; 59485-34-6; 61163-13-1; NSC140278 |
O,O'-Bis(2-aminopropyl)polypropyleneglycol | 9046-10-0 | (C3H6O)multC6H16N2O | 192.301 | O,O'-BIS(2-AMINOPROPYL)POLYPROPYLENEGLYCOL; O,O'-BIS(2-AMINOPROPYL)POLYPROPYLENE GLYCOL 300; POLY(PROPYLENE OXIDE), DIAMINE TERMINATED; POLYPROPYLENE GLYCOL 300 BIS(2-AMINOPROPYL ETHER); POLYPROPYLENE GLYCOL 130 BIS(2-AMINOPROPYL ETHER); POLY(PROPYLENE GL |
O,O'-BIS(2-AMINOETHYL)OCTADECAETHYLENE GLYCOL | 892154-56-2 | C40H84N2O19 | 0 | |
O,O,S-trimethyl phosphorothioate | 152-20-5 | C3H9O3PS | 156.14100 | |
O,o,o-triethylphosphorothioate | 126-68-1 | C6H15O3PS | 198.220261 | (C2H5O)3PS; Ethyl phosphorothioate ((EtO)3PS); O,O,O-Triethyl thiophosphate; O,O,O-Triethylester kyseliny thiofosforecne; o,o,o-triethylesterkyselinythiofosforecne; O,O,O-Triethylthiofosfat; O,O,O-triethylthiophosphate; Phosphine sulfide, triethoxy- |
O,N-carboxymethylchitosan | 107043-88-9 | |||
o-(p-hydroxybenzoyl)benzoic acid, compound with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1) | 31139-87-4 | 517.66 | TIPEPIDINE HIBENZATE; asverinh; ethylpiperidine(1:1); o-(p-hydroxybenzoyl)-benzoicacicompd.with3-(di-2-thienylmethylene)-1-m; o-(p-hydroxybenzoyl)benzoic acid, compound with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1); TIPEDINE HIBENZATE | |
O-(N-Butylfluorescein)-O-{3-[6-O-(D,L-1-ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene)-D,L-myo-inositol]}phosphate, Lithium Salt | 1792191-32-2 | C40H46LiO14P | 788.7 | |
O-(D-Glucopyranosylidene)amino N-phenylcarbamate | 104012-84-2 | C13H16N2O7 | 312.28 | PUGLU |
O-(4-Fluoro-benzyl)-hydroxylamine hydrochloride | 51572-89-5 | C7H9ClFNO | 0 | 4-[(Aminooxy)methyl]fluorobenzene |
O-(4-aminooxybutyl)hydroxylamine | 66080-74-8 | C4H12N2O2 | 120.15 g/mol | |
O-(3-Phenyl-propyl)-hydroxylamine | 73941-30-7 | C9H13NO | 151.20562 | O-(3-Phenyl-propyl)-hydroxylamine; O-(3-Phenyl-propyl)-hydroxylamine,hydrochloride; Hydroxylamine, o-(3-phenylpropyl)-, hydrochloride |
NONAFLUORO-3,6-DIOXAHEPTANOYL CHLORIDE | 261503-81-5 | C5ClF9O3 | 314.49 | NONAFLUORO-3,6-DIOXAHEPTANOYL CHLORIDE |
Nonadecanoic acid,methyl ester | 1731-94-8 | C20H40 O2 | 312.53 | NONADECANOIC ACID METHYL ESTER; N-NONADECANOIC ACID METHYL ESTER; 1N-NONADECANOIC ACID METHYL ESTER; METHYL N-NONADECANOATE; METHYL NONADECANOATE; C19:0 METHYL ESTER |
Nonadecanoic acid N-methylamide | 6212-93-7 | C20H41NO | 311.55 | |
NMS-E973 | 1253584-84-7 | C22H22N4O7 | 454.43 | |
NMS-873 | 1418013-75-8 | C27H28N4O3S2 | 520.666 | |
NMS-859 | 1449236-96-7 | C15H12ClN3O3S | 349.79 | NMS-859 |
NMS-1286937 | 1034616-18-6 | C24H27F3N8O3 | 532.528 | NMS1286937; NMS-P937 |
N-MPPP Hydrochloride | 207452-97-9 | C21H26N2O.HCl | 358.91 | N-Methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]phenylacetamide hydrochloride |
N-Monodesmethyl Rizatriptan | 144034-84-4 | C14H17N5 | 255.33 | N-Methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; |
N-MONODESMETHYL PROMETHAZINE | 37707-23-6 | C16H18N2S | 270.39 | N-MONODESMETHYL PROMETHAZINE; N-desmethylpromethazine |
N-Methyltyramine hydrochloride | 13062-76-5 | C9H13NO.HCl | 187.67 | 4-[2-(Methylamino)ethyl]phenol hydrochloride; N-Methyl tyramine hydrochloride |
N-Methyltetrahydrofuran-3-amine hydrochloride | 917882-94-1 | C5H11NO.HCL | 137.60800 | N-Methyltetrahydrofuran-3-amine hydrochloride; Methyl-(tetrahydro-furan-3-yl)-amine; Methyl-(tetrahydro-furan-3-yl)-amine hydrochloride |
N-Ethoxycarbonyl Ciprofloxacin | 93594-29-7 | C20H22FN3O5 | 403.41 | 7-[4-(Ethoxycarbonyl)-1-piperazinyl]-1-cyclopropyl-6-fluoro-3-carboxy-1,4-dihydro-4-oxoquinoline; 1-Cyclopropyl-7-[4-(ethoxycarbonyl)-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; |
Netarsudil Mesylate | 1422144-42-0 | C30H35N3O9S2 | 645.742 | |
Netarsudil hydrochloride | 1253952-02-1 | C28H29Cl2N3O3 | 526.458 | AR-13324 hydrochloride; Netarsudil dihydrochloride; [4-[(2S)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate dihydrochloride |
Nestoron | 7759-35-5 | C23H30O4 | 370.48 | ST-1435; ST1435; ST1435; Elcometrine; Nestorone; segesterone acetate; 17-Hydroxy-16-methylene-19-norpregn-4-ene-3,20-dione acetate; Elcometrine; 16-Methylene-17-hydroxy-19-norpregn-4-ene-3,20-dione acetate; Segesterone acetate; [(8R,9S,10R,13S,14S,17R)-17 |
NESS 0327 | 494844-07-4 | C24H23Cl3N4O | 489.8 | |
N-Boc-3,4-dehydro-D-proline | 58617-29-1 | C10H15NO4 | 213.232 | N-Boc-3,4-dehydro-D-proline |
N-BOC-3-(iodomethyl)-2-oxa-8-azaspiro[4.5]decane | 1250998-93-6 | C14H24INO3 | 0 | N-BOC-3-(iodomethyl)-2-oxa-8-azaspiro[4.5]decane |
N-BOC-3-(4-CYANOPHENYL)OXAZIRIDINE | 150884-56-3 | C13H14N2O3 | 246.26 | N-BOC-3-(4-CYANOPHENYL)OXAZIRIDINE; N-BOC-3-(4-CYANOPHENYL)OXAZIRIDINE, 98+% |
N-Boc-2-Cyclohexyl-DL-glycine | 35264-05-2 | C13H23NO4 | 257.32 | N-Boc-2-Cyclohexyl-DL-glycine |
O-(2-Acetamido-3,4,6-tri-O-acetyl-D-glucopyranosylidene)amino N-phenyl carbamate | 132063-04-8 | C21H25N3O10 | 479.44 | 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-N-[(phenylaminocarbonyl)oxy]-D-gluconimidic acid-1,5-lactone |
Nylon 6/6 | 32131-17-2 | C36H66N6O6X2 | 678.95 | Poly[imino(1,6-dioxo-1,6-hexanediyl)imino-1,6-hexanediyl]; HEXAMETHYLENE ADIPAMIDE POLYMER; POLY(N,N'-HEXAMETHYLENEADIPINEDIAMIDE); POLY(HEXAMETHYLENE DODECANEDIAMIDE); POLY(HEXAMETHYLENE ADIPAMIDE); NYLON 6/6; NYLON 6/6 POLYHEXAMETHYLENE ADIPAMIDE; NYLON |
nylon 12 | 24937-16-4 | (C12H23NO)mult | 591.95 | Poly[imino(1-oxo-1,12-dodecanediyl)]; NYLON 12; POLYLAURYLLACTAM; 610 NYLON610; Polyamide p-12 |
Nylidrin hydrochloride | 849-55-8 | C19H26NO2Cl | 335.87 | 1-p-Hydroxyphenyl-2-(1'-methyl-3'-phenylpropylamino)-1-propanolhydrochloride;Arlidin hydrochloride;Buphenine hydrochloride;Dilatol hydrochloride;p-Hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-benzylalcohohyd;Suprifenpsb hydrochloride;4-[1-hydro |
Nybomycin | 30408-30-1 | C16H14N2O4 | 298.3 | NSC 613948 |
Nyasol | 96895-25-9 | C17H16O2 | 252.31 | Cis-Hinokiresinol |
Nyasicol 1,2-acetonide | 1432057-64-1 | C20H20O6 | 356.4 | 4-(3-((4R,5R)-5-(3,4-dihydroxyphenyl)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-1-yn-1-yl)benzene-1,2-diol |
Nyasicol | 111518-95-7 | C17H16O6 | 316.3 | 4,4'-[(4S,5R)-4,5-Dihydroxy-1-pentyne-1,5-diyl]bis-1,2-benzenediol |
NXD30001 | 1223580-83-3 | |||
NW457 | 1373761-12-6 | C25H32N2O7 | 472.53 | |
NVS-PAK1-1 | 1783816-74-9 | C23H25ClF3N5O | 479.93 | (3S)-3-[[8-chloro-11-(2,2-difluoroethyl)-3-fluorobenzo[b][1,4]benzodiazepin-6-yl]amino]-N-propan-2-ylpyrrolidine-1-carboxamide |
NVS-CRF38 | 1207258-55-6 | C19H21N5O2 | 351.4 | NVS-CRF 38; NVS-CRF-38 |
NVS-CECR2-1 | 1992047-61-6 | C27H37N5O2S | 495.68 | N-Cyclopropyl-2-(propylsulfonyl)-6-(1-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-indol-5-yl)pyrimidin-4-amine |
NUCLEOSIDE PHOSPHORYLASE | 9030-21-1 | C5H6ClN3 | 0 | PNP; NUCLEOSIDE PHOSPHORYLASE; PURINE NUCLEOSIDE: ORTHOPHOSPHATE RIBOSYLTRANSFERASE; PURINE NUCLEOSIDE PHOSPHORYLASE; EC 2.4.2.1; Phosphorylase, purine nucleoside; NUCLEOSIDE PHOSPHORYLASE FROM HUMAN*BLOO D; Purine nucleoside phosphorylase, Purine nuc |
Deoxyribonucleic acid sodium salt | 9007-49-2 | C15H31N3O13P2 | 523.38 | DNA-Na |
Nuclear Fast Red Sodium Salt | 6409-77-4 | C14H8NNaO7S | 357.27100 | |
Nuciferine | 475-83-2 | C19H21NO2 | 295.375 | (-)-nucipherine;(r)-1,2-dimethoxyaporphine;1,2-dimethoxy-6a-beta-aporphin;5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-g)quinolin(r)-4h-dibenzo(d;l-5,6-dimethoxyaporphine |
N-tetradecanoyl-alanine | 71448-29-8 | C17H33NO3 | 299.45 | N-TETRADECANOYL-ALANINE; N-Tetradecanoyl-L-alanine |
n-Tetradecanamide | 638-58-4 | C14H29NO | 227.39 | TETRADECANAMIDE; MYRISTAMIDE; MYRISTICAMIDE; N-TETRADECANAMIDE; Myristic acid amide; tetradecanoicacidamide; Tetradecylamide |
N-TERT-OCTYLACRYLAMIDE | 4223-03-4 | C11H21NO | 183.29 | TERTIARY-OCTYL ACRYLAMIDE; N-TERT-OCTYLACRYLAMIDE; T-OCTYLACRYLAMIDE; TOA; 2-Propenamide,N-(1,1,3,3-tetramethylbutyl)-; Acrylamide, N-(1,1,3,3-tetramethylbutyl)- |
N-tert-Butyl--phenylnitrone | 3376-24-7 | C11H15NO | 177.24 | N-Benzylidene-tert-butylamine N-oxide, PBN, Phenyl N-t-butylnitrone |
N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine | 198474-61-2 | C18H27NO4S.C12H23N | 534.80 | N-ALPHA-T-BOC-S-4-METHYLBENZYL-L-PENICILLAMINE DICYCLOHEXAMMONIUM SALT; N-ALPHA-T-BUTOXYCARBONYL-S-P-METHYLBENZYL-L-PENICILLAMINE; BOC-S-4-METHYLBENZYL-L-PENICILLAMINE; BOC(S-4-METHYLBENZYL)-L-PENICILLAMINE DICYCLOHEXYLAMINE SALT; BOC-S-4-METHYLBENZYL-L-P |
N-tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine | 227000-59-1 | C22H31NO | 325.49 | 2,2,5-Trimethyl-3-(1-phenylethoxy)-4-phenyl-3-azahexane, Alkoxyamine NMP initiator |
N-Tert-Butyldibenzylamine | 30923-82-1 | C18H23N | 253.38 | t-butyldibenzylamine |
N-tert-Butylcarbonyl-piperazine | 155295-47-9 | C9H18N2O | 170.252 | N-tert-Butylcarbonyl-piperazine; 1-Pivaloyl-piperazine, 1-(2,2-dimethylpropanoyl)piperazine |
N-tert-butylbenzothiazole-2-sulphenamide | 95-31-8 | C11H14N2S2 | 238.37 | 2-(tert-Butylaminothio)benzothiazole; 2-[(tert-Butylamino)sulfanyl]-1,3-benzothiazole; 2-Benzothiazolesulfenamide, N-tert-butyl-; Accel bns; accelbns; accelerator(ns); AcceleratorNS; Akrochem BBTS |
N-tert-Butylbenzenesulfinimidoyl chloride | 49591-20-0 | C10H14ClNS | 215.74 | N-tert-Butylbenzenesulfinimidoyl chloride; N-tert-Butylbenzenesulfinimidoyl chloride [oxidizing Reagent] |
N-tert-butyl-2-methylpropan-2-amine | 21981-37-3 | C8H19N | 129.243 g/mol | |
N-tert-Butyl-2-chlorobenzamide | 70657-65-7 | C11H14ClNO | 0 | N-tert-Butyl-2-chlorobenzamide |
N-Tallowalkyl-1,3-diaminopropane | 61791-55-7 | 2C5H14N2 | 204.3592 | N-Tallowalkyl-1,3-diaminopropane; N-Tallow-1,3-propyl diamine |
N-Tallow dipropylene triamine | 61791-57-9 | |||
NT-157 | 1384426-12-3 | C16H14BrNO5S | 410.98 | NT157; AK174915; AKOS025404921; CS-5531; (4E)-2-bromo-6-hydroxy-4-[(Z)-3-sulfanyl-3-[(3,4,5-trihydroxyphenyl)methylamino]prop-2-enylidene]cyclohexa-2,5-dien-1-one |
NT113 | 1398833-56-1 | C27H25ClFN5O2 | 505.98 | NT-004; NT-113; NT-125;(E)-N-(7-(((1R,5S,6s)-3-oxabicyclo[3.1.0]hexan-6-yl)ethynyl)-4-((3-chloro-4-fluorophenyl)amino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide |
N-Sulfo-glucosamine Potassium salt | 31284-96-5 | C6H12KNO8S | 297.33 | |
N-Sulfinylacetamide | 16767-75-2 | C2H3NO2S | 105.12 | N-SULFINYLACETAMIDE |
N-Succinyl-L-tyrosine | 374816-32-7 | C13H15NO6 | 0 | N-(3-Carboxy-1-oxopropyl)-L-tyrosine; N-Succinyl-L-tyrosine |
N-Succinyl-5-aminoimidazole-4-carboxamide ribose 5'-phosphate dibarium salt | 6057-44-9 | C13H15Ba2N4O12P | 724.91 | SAICAR Dibarium salt; N-[(5-Amino-1-b-D-ribofuranosylimidazol-4-yl)carbonyl]-L-aspartic acid |
N-Succinimidyl N-(2,4-dinitrophenyl)-6-aminocaproate | 82321-04-8 | C16H18N4O8 | 394.34 | DNP-X, SE |
N-Succinimidyl 4-(4-maleimidophenyl)butyrate | 79886-55-8 | C18H16N2O6 | 356.33 | N-SUCCINIMIDYL 4-(P-MALEIMIDOPHENYL)BUTYRATE; N-SUCCINIMIDYL 4-(4-MALEIMIDOPHENYL)BUTYRATE; SMPB; SUCCINIMIDYL 4-[P-MALEIMIDOPHENYL]BUTYRATE; SUCCINIMIDYL 4-(4-MALEIMIDOPHENYL)BUTYRATE; 4-(P-MALEIMIDOPHENYL)BUTYRIC ACID N-HYDROXYSUCCINIMIDE ESTER; 4-(P-MA |
NSC134754 | 75041-32-6 | C27H34N2O2 | 418.58 | NZ28;(S)-3-ethyl-9,10-dimethoxy-2-(((R)-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline |
NSC12 | 102586-30-1 | C24H34F6O3 | 484.52 | 21-(Hydroxy(bistrifluoromethyl)methyl)pregnane-3,20-diol;Pregn-5-ene-3,20-diol, 21-(2-hydroxy-1,1,1,3,3,3-hexafluoro-2-propyl)-;LS-118618;4,4,4-Trifluoro-1-[(8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cycl |
NSC 95397 | 93718-83-3 | C14H14O4S2 | 310.38 | 2,3-bis[(2-Hydroxyethyl)thiol]-1,4-naphthoquinone; NSC-95397; NSC95397; NSC 95397 |
NSC 87877 | 56932-43-5 | C19H13N3O7S2·2Na | 503.42 | Disodium 8-hydroxy-7-[(6-sulphonato-2-naphthyl)azo]quinoline-5-sulphonate |
NSC 756093 | 1629908-92-4 | C20H19NO4 | 337.37 | AOB6494; 4,9-Dihydro-4-(2-hydroxyethyl)-6-methoxy-9-phenylfuro[3,4-b]quinolin-1(3H)-one |
NSC 693868 | 40254-90-8 | C9H7N5 | 185.19 | 1H-Pyrazolo[3,4-b]quinoxalin-3-amine |
NSC 66811 | 6964-62-1 | C23H20N2O | 340.42 | 2-Methyl-7-[Phenyl(phenylamino)methyl]-8-quinolinol |
NSC 668036 | 144678-63-7 | C21H36N2O9 | 460.52 | N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl-(2S)-2-hydroxy-3-methylbutanoyl-L-alanine-(1S)-1-carboxy-2-methylpropyl ester |
NSC 663284 | 383907-43-5 | C15H16ClN3O3 | 321.76 | 6-chloro-7-(2-morpholin-4-ylethylamino)quinoline-5,8-dione; NSC 663284; NSC-663284; NSC663284 |
NSC 660028 | 153230-81-0 | C27H27NO6 | 461.51 | NSC660028; NSC-660028; NSC 660028; 2,6-dimethoxy-4-((5S,5aS,8aR,9R)-9-(phenylamino)-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)phenol |
NSC 636819 | 1618672-71-1 | C22H12Cl4N2O4 | 510.15 | 1,5-Bis[(1E)-2-(3,4-dichlorophenyl)ethenyl]-2,4-dinitrobenzene |
NSC 632839 hydrochloride | 157654-67-6 | C21H21NO.HCl | 339.86 | 3,5-Bis[(4-methylphenyl)methylene]-4-piperidone hydrochloride |
NSC 625987 | 141992-47-4 | C15H13NO2S | 271.33 | 1,4-Dimethoxy-9(10H)-acridinethione |
NSC 624206 | 13116-77-3 | C19H32ClNS2.HCl | 410.51 | N-[2-[[(4-Chlorophenyl)methyl]dithio]ethyl]-1-decanamine hydrochloride |
NSC 617145 | 203115-63-3 | C13H10Cl4N2O4 | 400.04 | 1,1'-(2,2-Dimethyl-1,3-propanediyl)bis[3,4-dichloro-1H-pyrrole-2,5-dione |
NSC 42834 | 195371-52-9 | C23H24N2O | 344.45 | Z3; 1-Butanone, 2-methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]- |
NSC 3852 | 3565-26-2 | C9H6N2O2 | 174.16 | 5-Nitroso-8-quinolinol |
NSC 33994 | 82058-16-0 | C28H42N2O2 | 438.65 | E-4,4'-(1,2-Diethyl-1,2-ethenediyl)bis[2-[(diethylamino)methyl]phenol |
NSC 319726 | 71555-25-4 | C11H14N4S | 234.32 | NSC-26386 |
NSC 23925 | 858474-14-3 | C22H24N2O2·2HCl | 421.4 | (2-(4-methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol dihydrochloride |
NSC 23766 trihydrochloride | 1177865-17-6 | C24H38Cl3N7 | 530.967 | N6-(2-((5-(Diethylamino)pentan-2-yl)amino)-6-methylpyrimidin-4-yl)-2-methylquinoline-4,6-diamine Trihydrochloride |
NSC 23766 | 733767-34-5 | C24H35N7 | 421.58 | |
NSC 23005 sodium | 1796596-46-7 | C13H16NNaO4S | 305.33 | sodium 4-(N-cyclohexylsulfamoyl)benzoate |
NSC 228155 | 113104-25-9 | C11H6N4O4S | 290.25 | NSC228155; NSC-228155; 7-nitro-4-(1-oxidopyridin-1-ium-2-yl)sulfanyl-2,1,3-benzoxadiazole |
NSC 210902 | 51726-83-1 | C14H9NO3 | 239.2 | 4-oxo-1,4-dihydrobenzo[h]quinoline-3-carboxylic acid |
NSC 207895 | 58131-57-0 | C11H13N5O4 | 279.25 | XI-006 |
NSC 185058 | 39122-38-8 | C11H9N3S | 215.3 | N-(pyridin-2-yl)pyridine-2-carbothioamide |
NSC 146109 hydrochloride | 59474-01-0 | C17H16N2S.HCl | 316.85 | (10-Methyl-9-anthracenyl) methyl carbamimidothioic acid ester hydrochloride |
NSC 109555 ditosylate | 66748-43-4 | C19H24N10O.2C7H8O3S | 752.86 | 4,4'-diacetyldiphenylurea bis(guanylhydrazone) ditosylate |
NSC 109555 dimesylate | 15427-93-7 | C19H24N10O·2CH3SO3H | 600.7 | DDUG; NCI C04808; Carbanilide, 4,4'-diacetyl-, 4,4'-bis(amidinohydrazone), dimethanesulfonate |
NS-638 | 150493-34-8 | C15H11ClF3N3 | 325.72 | 1-[(4-chlorophenyl)methyl]-5-(trifluoromethyl)benzimidazol-2-amine; 2-amino-1-(4-chlorobenzyl)-5-trifluoromethylbenzimidazole; NS 638; NS-638 |
NS6180 | 353262-04-1 | C16H12F3NOS | 323.33 | NS6180; NS-6180; NS 6180. |
NS309 | 18711-16-5 | C8H4Cl2N2O2 | 231.04 | 6,7-dichloro-3-(hydroxyamino)indol-2-one 6,7-dichloro-1H-indole-2,3-dione 3-oxime NS 309 NS-309 NS309 cpd |
NS-304 | 475086-01-2 | C26H32N4O4S | 496.6 | Selexipag; ACT-293987; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; |
NS-2359 | 195875-68-4 | C16H21Cl2NO | 558.675 | (1S,3S,4R,5R)-3-(3,4-dichlorophenyl)-4-(methoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane; GSK 372475; GSK-372475; GSK372475; NS 2359; NS2359; NS-2359 |
NS-2214 | 171655-92-8 | C16H22Cl2N2O5S | 425.32 | Brasofensine sulfate; BMS 204756; BMS-204756; NS 2214; NS2214; NS-2214; (E)-1-[(1R,3S,4R,5R)-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-4-yl]-N-methoxymethanimine;sulfuric acid |
NS-1209 | 245063-59-6 | C24H28N4O7S | 516.57 | 2-[[5-[4-(dimethylsulfamoyl)phenyl]-8-methyl-2-oxo-7,9-dihydro-6H-pyrrolo[3,2-h]isoquinolin-3-yl]amino]oxy-4-hydroxybutanoic acid; NS-1209; NS 1209; NS1209; 245063-59-6; SPD-502; SPD502; SPD 502 |
NS-018 hydrochloride | 1239358-85-0 | C21H21ClFN7 | 425.89 | NS018 hydrochloride; NS 018 hydrochloride |
NS-018 | 1239358-86-1 | C21H20FN7 | 389.43 | NS-018; UNII-56R994WX4L; 56R994WX4L; GTPL7839; SCHEMBL14954406; UQTPDWDAYHAZNT-AWEZNQCLSA-N |
NS 9283 | 913830-15-6 | C14H8N4O | 248.24 | 3-[3-(3-Pyridinyl)-1,2,4-oxadiazol-5-yl]benzonitrile |
NS 8593 hydrochloride | 875755-24-1 | C17H17N3.HCl | 299.8 | N-[(1R)-1,2,3,4-Tetrahydro-1-naphthalenyl]-1H-benzimidazol-2-amine hydrochloride |
n-Propyl lactate | 616-09-1 | C6H12O3 | 132.15 | ISOPROPYL-S(-)-2-HYDROXY-PROPIONATE; ISOPROPYL (S)-(-)-LACTATE; ISOPROPYL-(S)-LACTATE; ISOPROPYL ESTER OF NATURAL L(+)- LACTIC ACID; ISOPROPYL LACTATE; (-)-ISOPROPYL L-LACTATE; LACTIC ACID N-PROPYL ESTER; L(+) LACTIC ACID, ISOPROPYL ESTER |
n-Propyl Dioxepin | 4469-34-5 | C8H14O2 | 142.198 | 2-Propyl-4,7-dihydro-1,3-dioxepine |
N-Propyl b-lactoside | 98302-29-5 | C15H28O11 | 384.38 | n-Propyl 4-O-b-D-galactopyranosyl-b-D-glucopyranoside; b-D-Gal-(1,4)-b-D-Glc-1-OPr |
N-Propionylglycine-2,2-d2 | 1256842-51-9 | CH3CH2CONHCD2COOH | 133.14 | Propionylaminoacetic Acid-d2; 2,2-dideuterio-2-(propanoylamino)acetic acid |
N-Propionyl-D-glucosamine | 15475-14-6 | C9H17NO6 | 235.23 | |
N-Propionyl Mesalazine-d3 | 1330265-97-8 | C10H8NO4D3 | 212.22 | 2-Hydroxy-5-[(1-oxopropyl)amino]benzoic-d3 Acid; N-Propionyl-d3 Mesalamine; N-Propionyl 5-Aminosalicylic Acid-d3 |
N-Propionyl Mesalazine | 93968-80-0 | C10H11NO4 | 209.2 | 2-Hydroxy-5-[(1-oxopropyl)amino]benzoic Acid; N-Propionyl Mesalamine; N-Propionyl 5-Aminosalicylic Acid |
N-Propanoyl mannosamine | 79624-37-6 | C9H17NO6 | 235.23 | 2-Deoxy-2-[(1-oxopropyl)amino]-D-mannose |
NPPB | 107254-86-4 | C16H16N2O4 | 300.31 | 5-Nitro-2-(3-phenylpropylamino)benzoic acid |
NPOM-Caged-dT CEP | 942218-71-5 | C50H58N5O13P | 967.99 | |
N-Phthaloyl-Phe-OH | 5123-55-7 | C17H13NO4 | 295.29 | |
N-Phthalimide L-glutaminc acid | 340-90-9 | |||
N-Phenylglycine potassium salt | 19525-59-8 | C8H8KNO2 | 189.25 | L-Phenylglycinepotassiumsalt(ethyl); n-phenyl-glycinmonopotassiumsalt; potassiumn-phenylglycinate; N-PHENYLGLYCINE POTASSIUM SALT; L-PHENYL GLYCINE, POTASSIUM SALT; potassium n-phenylglycine; N-PHENYLGLYCOCOLLPOTASSIUM; Anilinoacetic acid potassium salt |
N-phenyl-4-biphenylamine | 32228-99-2 | C18H15N | 245.32 | N,4-diphenylaniline; N-Phenyl-4-biphenylamine; 32228-99-2; N-Phenyl-[1,1'-biphenyl]-4-amine; 4-Anilinobiphenyl; N-phenylbiphenyl-4-amine |
N-Phenyl-2-anthramine | 109871-20-7 | C20H15N | 269.34 | 2-Anilinoanthracene |
N-Phenyl-1-naphthylamine | 90-30-2 | C16H13N | 219.28 | 1-ANILINONAPHTHALENE; BIS-(4,4')-N-PHENYL-1-NAPHTHYLAMINE; TIMTEC-BB SBB000591; N-1-NAPHTHYLANILINE; NAPHTHALEN-1-YL-PHENYL-AMINE; PHENYL ALPHA NAPHTHYLAMINE; PANA; N-PHENYL-1-NAPHTHYLAMINE |
N-PHENACYLTHIAZOLIUM BROMIDE | 5304-34-7 | C11H10BrNOS | 284.17 | N-PHENACYLTHIAZOLIUM BROMIDE; 3-Phenacylthiazoliumbromide |
n-Pentacosanol | 26040-98-2 | C25H52O | 368.6798 | 1-PENTACOSANOL; N-PENTACOSANOL; pentacosyl alcohol; Einecs 247-427-0 |
Novobiocin sodium | 1476-53-5 | C31H35N2NaO11 | 634.61 | Albamycin; Cathomycin |
Novobiocin | 303-81-1 | C31H36N2O11 | 612.62 | |
NOVIFLUMURON | 121451-02-3 | C17H7Cl2F9N2O3 | 529.141 | 5-dimethylphenyl]azo-n-[3-(2-phenoxyethoxy)propyl]-; benzamide,4-[[4-[[5-cyano-2,6-bis(2-methoxyethyl)-4-methyl-3-pyridinyl]azo]-2,; benzamide,n-3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylaminocarbonyl-2,6-difluoro; benzamide,n-3,5-dichl |
Novaluron | 116714-46-6 | C17H9ClF8N2O4 | 492.7 | |
Nourseothricin (streptothricin) sulfate | 96736-11-7 | C31H58N12O10.C19H34N8O8.H2SO4 | 1359.46 | |
Notopterol | 88206-46-6 | C21H22O5 | 354.4 | (E)-4-[(5-Hydroxy-3,7-dimethyl-2,6-octadien-1-yl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one; 4-[[(2E)-5-Hydroxy-3,7-dimethyl-2,6-octadien-1-yl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one,4-[[(2E)-5-hydroxy-3,7-diMethyl-2,6-octadi |
Nosiheptide | 56377-79-8 | C51H43N13O12S6 | 1222.4 | Nosiheptine, Multhiomycin, Primofax, RP 9671 |
Noscapine-13C, d3 | 1217680-57-3 | C22H20NO7D3 | 417.44 | (3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-1(3H)-isobenzofuranone-13C,d3 |
Noscapine hydrochloride | 912-60-7 | C22H23NO7.HCl | 449.88 | (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one; hydrate; hydrochloride; Narcotine hydrochloride; 912-60-7; C22H23NO7.ClH.H2O; 2579AH; D02172 |
Nortriptyline Impurity H | 24755-73-5 | C18H16 | 232.33 | 5-Prop-2-en-1-ylidene-10,11-dihydro-5H-dibenzo[a,d][7]annulene; |
Nortriptyline Impurity G | 16234-88-1 | C22H25NO2 | 335.45 | Nortriptyline N-Ethyl Carbamate; [3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl]methylcarbamic Acid Ethyl Ester; |
Nortriptyline Impurity F | 549-18-8 | C20H23N.HCl | 313.86 | 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine Hydrochloride; |
Nortriptyline Impurity E | 6202-23-9 | C20H22ClN | 311.85 | Aurantica |
Nortriptyline HCl | 894-71-3 | C19H22NCl | 299.84 | Pamelor;Allegron;Altilev;Psychostyl;Acetexa;3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-ylidene)-n-methyl-1-propanamin;5-(3-(methylamino)propylidene)dibenzo(a,e)cyclohepta(1,5)dienehydrochloride;3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene) |
nortriptyline | 72-69-5 | C19H21N | 263.38 | 10,11-dihydro-5-(3-methylaminopropylidene)-5h-dibenzo[a,d][1,4]cycloheptene;10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptane-delta,gamma-propylamine;10,11-dihydro-n-methyl-5h-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamin;10,11-dihydro-n-methyl-5h-; |
Nortetraphyllicine | 68160-76-9 | C19H22N2O | 294.398 | |
Nortadalafil | 171596-36-4 | C21H17N3O4 | 375.38 | Demethyl Tadalafil |
NORFLUOXETINE HYDROCHLORIDE | 83891-03-6 | C16H17ClF3NO | 331.76 | |
Norfluoxetine b-D-glucuronide | 96735-72-7 | C22H24F3NO7 | 471.42 | |
Norfloxacin-d8 | 1216601-32-9 | C16H10FN3O3D8 | 327.34 | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl-d8)-3-quinolinecarboxylic Acid; Baccidal-d8 |
Norfloxacin-D5 | 1015856-57-1 | 1-Ethyl-D5-6-fluoro-4- oxo-7-piperazin-1-yl-1,4- dihydroquinoline-3- carboxylic acid hydrate | ||
Norfloxacin Nicotinic | 118803-81-9 | C10H7NO2 | 173.17 | 3-quinolinecarboxylicacid,1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl; mono-3-pyridinecarboxylate; RARECHEM AL BO 1256; AKOS BBS-00005333; 3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, mono-3-pyridinecarboxylat |
Norfloxacin Impurity K | 70459-07-3 | C15H16FN3O3 | 305.31 | 6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid ; |
Norfloxacin impurity H | 105440-01-5 | C19H22FN3O5 | 391.4 | N-Ethoxycarbonyl Norfloxacin; 7-[4-(Ethoxycarbonyl)-1-piperazinyl]-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; Norfloxacin impurity H; |
Norfloxacin Impurity G | 70459-04-0 | C17H18FN3O4 | 347.35 | N-Formyl Norfloxacin; 1-Ethyl-6-fluoro-7-(4-formyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 1-Ethyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid; Norfloxacin impurity G |
Norfloxacin impurity F | 67681-86-1 | C16H18ClN3O3 | 335.79 | Norfloxacin 6-Chloro Analog ; 6-Chloro-1-ethyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid ; |
Norfloxacin impurity E | 75001-78-4 | C16H18ClN3O3 | 335.79 | Norfloxacin HCl 7-Chloro Analog ; 7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid ; |
Norfloxacin impurity D | 75001-82-0 | C15H18FN3O | 275.33 | Norfloxacin Descarboxy Impurity ; 1-Ethyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one ; |
Norfloxacin impurity C | 177554-64-2 | C20H27N5O3 | 385.47 | 1-Ethyl-1,4-dihydro-4-oxo-6,7-di-1-piperazinyl-3-quinolinecarboxylic acid; |
Norfloxacin impurity B | 75001-77-3 | C14H17ClFN3O3 | 329.75 | Norfloxacin Desethylene Impurity ;7-[(2-Aminoethyl)amino]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; |
Norfloxacin impurity A | 68077-26-9 | C12H9ClFNO3 | 269.66 | 7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid; 7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 1-Ethyl-1,4-dihydro-4-oxo-6-fluoro-7-chloro-3-quinolinecarboxylic Acid; |
Norfloxacin Impurity 8 | 67681-84-9 | C16H18ClN3O3 | 335.79 | 6-Chloro-1-Ethyl-4-Oxo-7-(Piperazin-1-yl)-1,4-Dihydroquinoline-3-Carboxylic acid; |
Norfloxacin Impurity 1 | 106847-40-9 | C12H9ClFNO3 | 269.66 | 5-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid; 3-Quinolinecarboxylic acid, 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-; |
Norfloxacin hydrochloride (1:x) | 104142-93-0 | C16H18FN3O3.xHCl | 319.336 (free base) | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid hydrochloride |
Norfloxacin hydrochloride | 68077-27-0 | C16H19ClFN3O3 | 355.79 | Noroxin hydrochloride; Chibroxin hydrochloride |
NORFLOXACIN GLUTAMATE | 85181-48-2 | C16H18FN3O3.C5H9NO4 | 466.463 | NORFLOXACIN GLUTAMATE |
Norfloxacin | 70458-96-7 | C16H18FN3O3 | 319.33 | Noroxin; Chibroxin; AM-715, MK-366; AM 715, MK 366; AM715, MK366 |
Norethisterone Octoate | 120793-85-3 | C28H40O3 | 424.63 | (17alpha)-17-[(1-Oxooctyl)oxy]-19-norpregn-4-en-20-yn-3-one; |
Norethisterone Hexanoate | 89094-33-7 | C26H36O3 | 396.58 | (17alpha)-17-[(1-Oxohexyl)oxy]-19-norpregn-4-en-20-yn-3-one; |
Norepinephrine bitartrate monohydrate | 69815-49-2 | C12H19NO10 | 337.28 | |
Norepinephrine | 51-41-2 | C8H11NO3 | 169.18 | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol |
Nor Neostigmine | 16088-19-0 | C11H16N2O2 | 208.26 | 3-dimethylaminophenyl dimethylcarbamate; Dimethylcarbamic Acid 3-(Dimethylamino)phenyl Ester; Dimethylcarbamic Acid m-(Dimethylamino)phenyl Ester; 3-(Dimethylamino)phenyl Dimethylcarbamate; Norneostigmine; |
Nor Doxepin-d3 Hydrochloride | 1331665-54-3 | C13H16D3NO·HCl | 304.83 | |
Nopol | 128-50-7 | C11H18O | 166.26 | NOPOL; 2-(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethanol; 6,6-Dimethyl-2-(2-hydroxyethyl)-2-norpinene; 6,6-dimethyl-2-norpinene-2-ethano; 6,6-Dimethylbicyclo-(3.1.1)-2-heptene-2-ethanol; 6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-ethano; Bicyclo[3.1.1]hept |
Nopco 2272R (9CI) | 101975-70-6 | C14H10O4S2 | 306.3568;g/mol | NSC682450; AC1L8V23; CHEMBL359225; SCHEMBL6995584; CTK8C7961; NGBBUFDTQZQCTF-UHFFFAOYSA-N |
Nopaline | 22350-70-5 | C11H20N4O6 | 304.3 | N2-(1,3-DICARBOXYLPROPYL)-L-ARGININE; NOPALINE; N2-(1,3-Dicarboxypropyl)-L-arginine; N-[(S)-4-[[Amino(imino)methyl]amino]-1-carboxybutyl]-D-glutamic acid; (S)-N-(4-((Aminoiminomethyl)amino)-1-carboxybutyl)-D-glutamic acid; D-Glutamic acid, N-(4-((aminoimi |
NOOTKATONE (CRYSTALS 98+%) | 4674-50-4 | C15H22O | 218.34 | 2(3H)-Naphthalenone, 4,4a,5,6,7,8-hexahydro-4,4a-dimethyl-6-(1-methylethenyl)-, (4R,4aS,6R)-, NOOTKATONE (CRYSTALS 98+%) |
Noopept | 157115-85-0 | C17H22N2O4 | 318.37 | GVS-111; GVS111; GVS 111; SGS-111; SGS 111; SGS111 |
NONYLPHENYL-POLYETHYLENEGLYCOL ACETATE | 54612-40-7 | H19C9C6H4(OCH2CH2)nOCOCH3 | 227.26182;g/mol | 2-amino-N'-phenylbenzohydrazide; 30086-49-8; aminophenylbenzohydrazide; 2-Amino-N'-phenylbenzhydrazide; CTK4G4398; MolPort-006-672-300 |
NONYLMAGNESIUM BROMIDE 1.0M SOLUTION I& | 39691-62-8 | C9H19BrMg | 231.45616 | NONYLMAGNESIUM BROMIDE 1.0M SOLUTION I&; NONYLMAGNESIUM BROMIDE, 1.0M SOLUTION IN; nonylmagnesium bromide solution; Nonylbromomagnesium |
Nonyl octanoate | 7786-48-3 | C17H34O2 | 270.45100 | |
Nonyl b-D-thiomaltopyranoside | 148565-55-3 | C21H40O10S | 484.6 | n-Nonyl-b-D-thiomaltoside |
Nonyl b-D-thioglucopyranoside | 98854-15-0 | C15H30O5S | 322.46 | n-Nonyl b-D-thioglucoside |
Nonyl b-D-maltopyranoside | 106402-05-5 | C21H40O11 | 468.54 | n-Nonyl b-D-maltoside |
Nonyl b-D-glucopyranoside | 69984-73-2 | C15H30O6 | 306.4 | |
Nonyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 173725-23-0 | C23H39NO9 | 473.56 | |
Nonyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 173725-28-5 | C17H33NO6 | 347.45 | |
NONOXYNOL 9 | 14409-72-4 | C33H60O10 | 616.82 | ALPHA-(P-NONYLPHENYL)-OMEGA-HYDROXYNONA(OXYETHYLENE); NONOXYNOL 9; 1-Nonyl-4-(26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosane-1-yloxy)benzene; 2-[2-[2-[2-[2-[2-[2-[2-[2-(4-Nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol; 26- |
Nonoxinol 9 | 26027-38-3 | C33H60O10 | 616.82 | 2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Advantage S Advantage-S Delfen Cream Delfen Creams Emulgen 911 Emulgin 913 Mertz Brand of Nonoxinol Nonoxinol Nonoxinol Mertz Brand Nonoxin |
Nonivamide | 2444-46-4 | C17H27NO3 | 293.40 | N-[(4-hydroxy-3-methoxyphenyl)methyl]nonanamide N-vanillylnonanamide vanillyl-N-nonylamide vanillylnonanamide |
Non-ionic polyacrylamide | 9003-05-8 | (C3H5NO)n | 71.0779 | |
Nonin A | 1357351-29-1 | C17H16O5 | 300.31 | 6-Hydroxy-2-(hydroxymethyl)-2-methyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester |
Nonidet P-40 | 9016-45-9 | C15H24O.(C2H4O)n | NP-40; Tergitol-type NP-40; Nonyl phenoxypolyethoxylethanol | |
Nonapyrimine | 5626-36-8 | C15H24N4 | 260.383 | |
Nonapeptide-1 | 158563-45-2 | C61H87N15O9S | 1206.523 | Melanostatine; Oxytocin Intermediate-nine peptide |
Nonanoyl-N-Hydroxyethylglucamide | 869653-90-7 | C17H35NO7 | 365.46 | HEGA-9 |
Nonanoyl-D-glucopyranoside | 191039-78-8 | C15H28O7 | 320.38 | |
Nonanoic acid, 9-oxo-,methyl ester | 1931-63-1 | C10H18O3 | 186.24812 | 9-OXO-NONANOIC ACID METHYL ESTER; 8-Formyloctanoic acid methyl ester; 9-Ketononanoic acid methyl ester; Methyl 9-oxononanoate |
Nonanoic acid, 4-sulfophenyl ester, sodium salt | 89740-11-4 | C15H21NaO5S | 336.379 | |
Nonanoic acid 8-methylnonyl ester | 109-32-0 | C19H38O2 | 298.504 g/mol | 8-methylnonylnonanoate; 109-32-0; Nonanoicacid,8-methylnonylester; 8-Methylnonylnonan-1-oate; Nonanoicacid8-methylnonylester; ISODECYLPELARGONATE |
Nonanedioic acid,1,9-bis(2-ethylhexyl) ester | 103-24-2 | C25H48 O4 | 412.73 | BIS(2-ETHYLHEXYL) AZELATE; BIS(2-ETHYLHEXYL) NONANEDIOATE; AZELAIC ACID DIOCTYL ESTER; AZELAIC ACID BIS(2-ETHYLHEXYL) ESTER; AZELAIC ACID DI(2-ETHYLHEXYL) ESTER; DI(2-ETHYLHEXYL) AZELATE; DIOCTYL AZELATE; DIISOOCYL AZELATE |
Nonamethylenedicarboxylic Acid | 1852-04-6 | C11H20O4 | 216.27 | undecanedioicacid;UNDECANEDIOICACID;1852-04-6;1,9-Nonanedicarboxylicacid;1,11-Undecanedioicacid;Undecanedionicacid |
NONAFLUOROHEXYLTRIMETHOXYSILANE | 85877-79-8 | C9H13F9O3Si | 368.27 | NONAFLUOROHEXYLTRIMETHOXYSILANE |
NONAFLUOROHEXYLTRIETHOXYSILANE | 102390-98-7 | C12H19F9O3Si | 0 | NONAFLUOROHEXYLTRIETHOXYSILANE |
Nonactin | 6833-84-7 | C40H64O12 | 736.9 | Werramycin, FH 3582A, NSC 52141, AKD 1A, KD 1A |